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Expression of the RNA binding protein CIRP is up regulated in mammalian cells upon 
perception of mild cold shock (27-32°C), conditions that can result in enhanced 
recombinant protein yields from mammalian cells and improved protein folding and 
activity.  CIRP also binds to key proteins involved in the control of mRNA translation 
initiation, potentially acting as a bridge between the RNA and protein synthesis 
machinery. CIRP has two domains, an N-terminal RNA binding domain and an 
arginine/glycine rich C-terminal domain that is natively disordered. The N-terminal 
domain includes two RNA-binding sites, RNP1 and RNP2 that are conserved across 
many RNA binding proteins. Here, the RNA binding of the N-terminal domain of CIRP 
was investigated by introducing mutations into the RNP1 and RNP2 RNA binding sites 
and monitoring subsequent RNA binding using electromobility shift assays and NMR. 
These studies show that the F49 and F9 residues in these regions are important for RNA 
interactions. Further, NMR dynamics studies showed that the region (β2-β3 loop) just 
before the RNP1 sequence that includes the F49 residue has increased motion compared 
to the rest of the protein. Chemical shift analysis was used to map those residues in CIRP 
involved in RNA binding that mapped onto the RNP1 and RNP2 sites. Mutation of the 
F49 and F9 sites to Ala residues disrupted RNA binding as shown by NMR studies. 
Mutation of each residue resulted in some conformational change in the structure of the 
domain as determined by HSQC-NMR, particularly for the F49 residue in RNP1. The 
mutation of one of the phenylalanine residues affected the chemical shift of the other, 
confirming their proximity in space. The C-terminal is a natively disordered domain but 
the studies presented here suggest this plays a role in RNA binding and ligand specificity. 
Cell lines stably expressing CIRP were also generated to further investigate the function 
of CIRP and to determine binding partners. CIRP was found to interact with the 
translation initiation factor eIF4G, both the full length CIRP and N-CIRP molecule, 
suggesting that binding to 4G occurs through the N-terminal domain. The over-expression 
of CIRP enhanced recombinant firefly luciferase expression when the luciferase mRNA 
contained a CIRP 3’UTR binding sequence. CIRP over-expression also enhanced growth 
of Chinese hamster ovary cells at 37°C but not at reduced temperature. From these studies 
it is hypothesised that CIRP can bind specific mRNAs and enhance their expression 
through its interaction with both the specific mRNA and the translation machinery via 
eIF4G leading to increased protein expression of the target mRNA under conditions of 
mild cold-stress (32°C).  
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1.1 Introduction  
The first recombinant protein produced by mammalian cells and used as a therapeutic 
was human tissue plasminogen activator approved for clinical use in 1986 (Becerra, 
Berrios, Osses, & Altamirano, 2012). The recombinant protein biopharmaceutical 
product market has ever since been rapidly growing with sales reaching 138 billion 
US dollars in 2010 (Vergara et al., 2014).  As there is an ever-increasing demand for 
recombinant protein biopharmaceuticals, much research has being undertaken to 
improve recombinant protein production and quality of the protein product in 
mammalian cells. Around 60-70% of recombinant protein therapeutics are produced 
in mammalian cells where the CHO (Chinese hamster ovary) cell expression host is 
most commonly used (Kim, Kim, & Lee, 2012; Kumar, Gammell, Meleady, Henry, & 
Clynes, 2008).   
 
Mammalian cells are the most commonly used expression system for biotherapeutic 
recombinant protein production destined for use in the clinic as they have the ability 
to undertake the required human-like assembly, folding and post-translational 
modifications of such proteins for their activity and to avoid antigenicity issues (Lim 
et al., 2010). Mammalian production systems have improved in terms of the viable 
cell concentration that can be achieved in the bioreactor (from 1-2 to 10-15 million 
cells/ml) as well as the recombinant protein productivity that can be obtained (from 
0.05-0.1 to 1-5+ g/l) in the past 20 years (Vergara et al., 2014). Productivity of cells is 
proportional to the number of viable cells and culture viability and longevity. To date, 
researchers have investigated and adopted a number of strategies to increase viable 
cell concentration, extending culture longevity by inhibiting apoptosis and by 
application of environmental stress (Kou et al., 2011). In particular there is much 
interest in the area of reduced temperature cultivation to prolong culture viability and 
hence the productive lifetime of a culture.  
 
Mild cold-shock (27-32°C) perception by mammalian cells has been reported to result 
in improved recombinant protein yields and to facilitate improved protein folding and 
product quality (Masterton et al 2010, Al-Fageeh et al., 2006). A study by Fox et al 
(2005) reported that enhanced interferon gamma expression from CHO cells at 
reduced temperatures was the result of elevated mRNA levels compared to those 
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observed at 37°C. The cold stress response(s) of mammalian cells have not only been 
taken advantage of in the biopharmaceutical industry, but have also been implicated 
and applied in adaptive thermogenesis, cold tolerance, storage of tissue, organ and 
cells and in the treatment of brain damage in the medical setting (Al-Fageeh, 
Marchant, Carden, & Smales, 2005).  
 
The response of cells to elevated temperatures (heat-shock) have been extensively 
studied in prokaryotes and eukaryotes, this response involves the coordinated 
expression of a large number of heat shock proteins (HSPs) (Li & Srivastava, 2004).  
However, the mechanism(s) by which mammalian cells respond to cold-stress are 
much less well defined and how these relate to improved recombinant protein 
production under mild hypothermic conditions is not well understood. It is thought 
that the cellular responses involve coordination and modulation of transcription, 
translation, the cell cycle and cell cytoskeleton organization (Robool et al, 2009). 
Under conditions of mild hypothermia (32°C), mammalian cells can survive and 
continue to divide (Fujita, 1999) and culturing of the cells at these temperatures can 
result in prolonged generation time, maintenance of cell viability, supressed release of 
waste products, delayed apoptosis and improved tolerance against shear stress and 
reduced proteolytic degradation of the recombinant protein (Yoon et al, 2003). There 
have been an increasing number of reports where cultivation of mammalian cells at 
low temperatures has been used to improve recombinant protein production (Al-
Fageeh & Smales, 2006; Fogolín, Wagner, Etcheverrigaray, & Kratje, 2004; Fox et 
al., 2005; Huang et al., 2010; Roobol, Carden, Newsam, & Smales, 2009; Wagstaff, 
Masterton, Povey, Smales, & Howard, 2013;Yoon, Song, & Lee, 2003). The cold-
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1.2 The Cold Shock Response in Mammalian Cells   
Unlike the heat shock response, which is largely conserved across eukaryotes, the 
mammalian cell response to sub-physiological temperatures has been studied in only a 
few organisms and in less detail and is therefore less well understood (Al-Fageeh et 
al., 2005). During therapeutic recombinant protein manufacturing, mammalian cells 
are normally cultured at 37°C to replicate in vivo conditions, however there have been 
an increasing number of reports which use lower temperature (28-34°C) culturing to 
improve recombinant protein yields (Masterton & Smales, 2014).  At very low 
temperatures proliferation is compromised but at mild hypothermic conditions e.g. 
32°C cells are able to survive and proliferate (Al-Fageeh et al., 2005).  
 
Cold stress can potentially result in two different stresses being imposed upon 
mammalian cells; one related to reduced temperature and one that is related to 
changes in available oxygen concentration due to low temperature (Ohsaka, Ohgiya, 
Hoshino, & Ishizaki, 2002). Cells respond to sub-physiological conditions by the up-
regulation of a small group of proteins called cold shock proteins (CSPs). Both 
prokaryotes and eukaryotes respond by synthesising cold shock proteins but there is 
little conservation between prokaryotes and eukaryotes in the nature of these proteins 
other than the fact most are involved in binding RNA. This is discussed in more detail 
below. 
 
The cellular processes that are reported to be affected as a result of the responses of 
mammalian cells to cold stress are summarised in figure 1.1. Expression of cold shock 
proteins has been shown to ensure accurate and enhanced translation of mRNA and at 
mild hypothermic temperatures mRNA levels are generally increased (due to 
increased stability/reduced turnover) and degradation of RNA decreased (Marchant, 
Al-Fageeh, Underhill, Racher, & Smales, 2008; Sahara, Goda, & Ohgiya, 2002; 
Sonna, Fujita, Gaffin, & Lilly, 2002). Early experiments investigating temperature 
manipulation in cell culture date back to 1965, where it was shown that an 




















It has been suggested that mammalian cells respond to cold stress by attenuating 
global cap dependant mRNA translation (Ermolenko & Makhatadze, 2002), and that 
instead translation of specific transcripts can occur via a cap independent mechanism 
where an internal RNA structure within the 5’UTR of the mRNA called an IRES is 
involved in recruiting the ribosome (Holcik & Sonenberg, 2005).  IRESs are 
sequences which allow translation initiation of an mRNA independent of the 5’ cap 
recognition by initiation factors (Baranick et al., 2008). The cell membrane has also 
been shown to be remodelled upon perception of cold stress conditions where the 
rigidity is increased, this remodelling mitigating against this increased rigidity. The 
actual cellular architecture is maintained under mild hypothermia conditions and is 
only disrupted at more drastic low temperatures such as 4°C. As such, for some 
mammalian cells the cellular architecture at 37°C and at mild cold conditions (32°C) 
are indistinguishable (Roobol et al., 2009).   
 
Another well characterised response to cold-shock is the arrest of the cell cycle at the 
G1 phase and this phase has been correlated with increased cellular productivity in 
mammalian cells (Fussenegger, 2001). Mammalian cells are able to proliferate at 
32°C but when the temperature drops below approximately 22-25°C, proliferation 
ceases, even though it can be restored upon return to 37°C (Roobol et al., 2009). As a 
Figure 1.1 Summary of the reported cellular processes that are modified and cell responses 
observed in mammalian cells upon exposure to cold stress.!
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result, the positive effects observed in terms of recombinant protein expression from 
mammalian cells at reduced temperatures are achieved under mild cold-shock 
conditions (27-35°C) rather then extreme temperature reductions (Roobol et al., 
2009). The reported cell cycle arrest of mammalian cells at the G1 phase is due to the 
activation of the p53 signalling pathway, p53 being activated as a result of activation 
of ataxia telangiectasia mutated and Rad3-related kinase (ATR)-p53-p21 pathway. 
The activation of ATR is thought to be due to changes in the lipid composition of the 
cell membrane at reduced temperature (Roobol et al., 2011).  At reduced 
temperatures, the lipid composition of the cell membrane changes leading to increased 
rigidity and reduction in cellular membrane associated functions (Los & Murata, 
2004; Panadero, Pallotti, Rodríguez-Vargas, Randez-Gil, & Prieto, 2006; Roobol et 
al., 2009; Zhang, Zhao, & Ma, 2007). The levels of polyunsaturated fatty acids are 
increased under cold conditions to maintain fluidity and this activates ATR and its 
down stream effectors, the p53-p21 signalling pathway, leading to cell cycle arrest 
(Roobol et al., 2011).  
 
With regard to mRNA translation in mammalian cells upon cold-shock, one of the 
mammalian cold shock induced proteins, CIRP (discussed in detail in section 1.4) 
interacts with the 3’UTR mRNA of ATR and it has been proposed that this interaction 
results in enhanced translation of ATR mRNA (Yang et al., 2010). It has been 
suggested that under cold conditions an increase in ATR protein is required for the 
activation of cell cycle arrest. Through this interaction with the 3’UTR and the 
interaction between CIRP and eIF4G , CIRP may act as a bridge to facilitate the 
translation of ATR mRNA under cold stress in a similar way to the function of the 
polyA-binding protein (Yang et al., 2010). This is discussed in more detail later in this 
chapter (section 1.4.3). 
 
The cold shock of mammalian cells has also been linked to the formation of 
cytoplasmic structure called stress granules (SGs) (Hofmann, Cherkasova, Bankhead, 
Bukau, & Stoecklin, 2012). These structures contain stalled translation pre-initiation 
complexes (Hofmann et al., 2012).  The attenuation of global protein synthesis at the 
initiation stage has been shown to be controlled by the phosphorylation of the 
translation initiation factor eIF2α (Holcik & Pestova, 2007; Joshi, Kulkarni, & Pal, 
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2013; Maquat, Tarn, & Isken, 2010). Further, there has been recent data that has 
suggested that activation of AMP-activated protein kinase (AMPK) is initiated under 
cold-shock conditions as well as inhibition of mTOR signalling and reduced 
mitochondrial function in parallel with attenuation of protein synthesis (Hofmann et 
al., 2012). Another response of mammalian cells to cold shock that is involved in 
translational control is that some microRNA (miR) expression is elevated or reduced 
at sub physiological temperatures. microRNAs act as negative regulators of 
translation of specific targets (Barron et al., 2011). With respect to cold, upon 
temperature shift to 31°C, Barron and colleagues reported that six microRNAs were 
up-regulated (miR-518d, miR-30e, miR-345, miR-219, miR-489 and miR219) and 
four were down-regulated (miR-7, miR-101, miR-320, miR-199) where miR-7 is 
specifically associated with cell cycle arrest (Barron et al., 2011). 
 
The responses of mammalian cells to temperature downshift therefore generally 
involves suppression of protein synthesis and it has been suggested that there are 5 
general mechanisms by which these responses are elicited – some passive and others 
active responses of the cells. These are;  (1) increased transcription of specific target 
genes via elements in the promoter region of such genes, (2) alternative pre-mRNA 
splicing (3) cold shock specific IRESs (internal ribosome entry segments) in mRNAs 
resulting in the preferential and enhanced translation of such mRNAs upon cold 
shock, (4) reduction of RNA degradation, (5) a general reduction in transcription and 
translation (Sonna et al, 2002). The supressed protein synthesis is associated with 
growth arrest, but paradoxically, the up-regulation of specific cold inducible proteins. 
There has been little characterisation of those proteins whose expression is up-
regulated upon cold-shock in mammalian cells, however there are two that are 
considered cold-shock inducible proteins (although they are induced by other stresses 
as well), Rbm3 (RNA binding motif protein 3, NCBI: AAH06825.1) and CIRP (cold 
inducible RNA binding protein or a18 hnRNP, NCBI: AAC04895.1), which are up 
regulated upon mild hypothermia but also by hypoxia and other stresses too (Lleonart, 
2010). 
 
Although the cold-shock response in mammalian cells is poorly characterised 
compared to the heat shock response, the cold shock response has been widely 
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investigated in a number of prokaryotes where the responses to such temperature 
fluctuations are better defined.  Bacterial cold shock proteins (CSPs) are highly 
conserved, although the E.coli cold response is the most characterised (Al-Fageeh & 
Smales, 2006). A quick change in temperature from 37°C to 10°C leads to the 
expression of approximately 27 CSPs in E.coli while global transcription and 
translation is down regulated (Gualerzi, Maria Giuliodori, & Pon, 2003). These CSPs 
are required for mRNA stability and bind single stranded RNA to enhance translation 
(Bae, Jones, & Inouye, 1997; Giuliodori, Brandi, Gualerzi, & Pon, 2004), in a manner 
that may be similar to that proposed for, but not yet confirmed, the two mammalian 
CSPs.  
 
The major CSPs in E.coli consist of 9 homologous genes and have been named in 
alphabetical order from CspA to CspI. The synthesis of CspA, B, G and I is very 
sensitive to temperature and their expression is dramatically up-regulated upon cold 
perception (Horn, Hofweber, Kremer, & Kalbitzer, 2007). Synthesis of CspA reaches 
approximately 10-13% of total protein synthesis under cold stress at 10°C. CspA is a 
7.4 kDa protein, and similar to the mammalian RNA binding proteins, contains the 
RNP1 and RNP2 (see section 1.3 for a detailed description of these) sequences that 
bind RNA. This again provides further evidence that a key response to cold-shock is 
the up-regulation of proteins involved in RNA binding/chaperoning.  
 
CspA is the most well characterised cold-shock protein. For example, promoters have 
been identified which drive cold shock protein CspA gene expression in E.coli and has 
led to the development of a cold-inducible expression vector which contains the CspA 
gene promoter and the CspA 5’UTR sequence and has been shown to improve the 
expression of recombinant proteins in E.coli under sub-physiological conditions 
(Takaya, Nomura, & Kato, 2002). However, even though the bacterial CSPs seem to 
have a similar function of RNA binding, and use a similar mechanism to mammalian 
CSPs, no close homology is found between the bacterial and mammalian CSPs 
outside of the presence of the RNP1 and RNP2 RNA binding sequences. Figure 1.2(a) 
below shows a sequence and secondary structure alignment of the E.coli CspA and 
mouse CIRP sequences which confirms little similarity between the two (approx. 10% 
as determined by the Clustal alignment tool). The PDB structure of CspA and the 
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RNA binding domain of human CIRP also confirm that there is no homology between 
them and the two proteins have different folds (figure 1.2 (b)). The RNA binding 
domain of CIRP is composed of two α-helix and four β-strands in an order of 
β1α1β2β3α2β4 whilst CspA has a secondary structure composition of 
β1α1β2β3α2β4β5. The RNA binding motifs RNP1 and RNP2 of CIRP are located on 









Figure 1.2 Sequence and structural comparison of the bacterial cold shock protein CspA and 
mammalian cold shock protein CIRP  (a) Amino acid sequence and secondary structure 
alignment of CspA and mouse CIRP. (b) Structural comparison of CspA PDB structure 1MJC and 
human CIRP PDB structure 1X5S!
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1.3 Cold Shock Proteins  
As described in section 1.2, prokaryotic and eukaryotic cells generally respond to sub 
physiological temperature by up regulating a small group of proteins called cold 
shock proteins (CSP) (Al-Fageeh & Smales, 2006).  Further, these CSPs are involved 
in the modulation of a number of cellular processes including transcription, translation 
and DNA-dependent processes like recombination and repair by their mechanism of 
binding to single stranded nucleic acids (Chaikam & Karlson, 2010). Whilst CSPs are 
induced upon a reduction in temperature and are involved in adaptation to low 
temperatures, some are also functional under normal temperature growth conditions 
(Ermolenko & Makhatadze, 2002; Horn et al., 2007). Cold shock proteins are 
characterised by the presence of a cold shock domain with two consensus RNA 
binding motifs which are also present in RNA recognition motif (RRM) type RNA 
binding proteins and as such is referred to as an RNA binding domain (Manival, 
Ghisolfi-Nieto, Joseph, Bouvet, & Erard, 2001).  
 
The cold shock domain (CSD) is one of the oldest and most well-conserved nucleic 
acid binding domains from bacteria to higher animals to plants (Chaikam & Karlson, 
2010).  Most functions associated with cold shock proteins are through their RNA 
binding activity, where upon hypothermia translocation of the CSP from the nucleus 
to cytoplasm occurs (Chaikam & Karlson, 2010). There are two RNA binding motifs 
that are conserved across the majority of RNA binding proteins and these are termed 
the RNP1 and RNP2 sequence. RNP1 and RNP2 are generally located on the β1 and 
β3 strands and are located adjacent to each other in the structure (Mihailovich, Militti, 




















RNP1 ! ! !
1 3 5 
RNP1:![R/K]/G/[F/Y]/[G/A]/[F/Y]/[I/L/V]/X/[F/Y] 
RNP2:![I/L/V]/[F/Y]/[I/L/V]/X/N/L 
1 3 5 
2 
Figure 1.3 Model showing RNP1, RNP2 motifs and residues essential for RNA binding.  
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The CSD was initially identified in bacterial proteins. In prokaryotes, CSDs are 
contained within small (approximately 7 kDa) proteins that have only a single cold 
shock domain (Chaikam & Karlson, 2010). In animal and plant systems C-terminal 
auxiliary domains can be present as well as an N-terminal CSD (Chaikam & Karlson, 
2010).  The C-terminal domains of most of these eukaryotic CSD containing proteins 
have unknown functions but it is proposed this domain has non-specific affinity for 
RNA and to be docking sites for protein ligands (Evdokimova & Ovchinnikov, 1999; 
Wolffe, 1994).  The 3D protein structure of a number of prokaryotic and eukaryotic 
CSPs have now been solved, although no 3D structures of plant CSPs have yet been 
reported.  Proteins structures described as cold shock proteins in the protein data bank 
are listed below in table 1.1 
 
Protein Name Organism PDB ID 
CSPB B. Subtilis 1CSP 
KIAA0885 Human 1WQF 
CSPA E.Coli 1MJC 
TmCsp T. Maritima 1G6P 
Cold Shock Like Protein R. Ricketsii 2LSS 
Enoyl-ACP Reductase B. Subtilis 3O1F 
Yfia E.Coli 1N36 
YB1 Human 1H95 
Lm-CSPa U. Monocytogenes 2LXJ 
Cold Shock Protein 1 T. Thermophilus 3AOJ 




As described in section 1.2, CSPs are generally thought to act as RNA chaperones and 
to be involved in the regulation of gene expression under cold-shock conditions via 
modulation of global or specific RNA transcription, translation and RNA turnover. 
Reports suggest that CSPs bind single stranded nucleic acids with a Kd value in the 
micro to nano molar range (Mihailovich et al., 2010). The aromatic residues found in 
the RNP1 and RNP2 sequences are essential for RNA binding by enabling base 
stacking (Maris, Dominguez, & Allain, 2005) (figure 1.3). Bacterial CSPs are also 
Table 1.1 Cold shock proteins, which have 3D structures solved as listed in the PDB to date. !
Chapter 1: Introduction 
12"
reported to be involved in the maintenance of chromosome structure and DNA 
replication as well as their RNA binding function (Gaudreault, Guay, & Lebel, 2004; 
Ise et al., 1999).  The involvement of CSPs in modulation of mRNA translation is via 
binding to mRNA and stabilising these RNA ligands. For example, CspA destabilises 
RNA secondary structures that form in the cold and that inhibit ribosome scanning 
and thus mRNA translation (Jiang, Hou, & Inouye, 1997), whilst CspE melts partially 
double stranded and hairpin structures and binds polyA tails (Phadtare & Severinov, 
2005).  
 
Eukaryotic CSPs have also been reported to participate in DNA maintenance. For 
example, the human YB1 protein which is a member of the Y-box protein family, has 
affinity towards secondary structure in damaged DNA and aids DNA repair. 
(Gaudreault et al., 2004). Y-box binding proteins are DNA and RNA binding proteins 
functioning as nucleic acid chaperones and also have functions in proliferation, 
differentiation and stress responses (Eliseeva, Kim, Guryanov, Ovchinnikov, & 
Lyabin, 2011). Eukaryotic CSPs are also involved in translation regulation 
specifically during the initiation stage, for example the YB1 protein promotes the 43S 
pre-initiation complex to scan the 5’UTR of mRNA (Evdokimova et al., 1998; 
Nekrasov et al., 2003). Although there are now a large number of processes that CSPs 
are reported to be involved with modulating upon cold perception, little is known 
about their RNA and protein binding mechanisms and ligands and how the binding of 
these works at a mechanistic level to elicit the desired cellular response(s) to the cold.  
 
1.3.1 The Mammalian CSPs, CIRP and Rbm3 
There are two mammalian cold shock proteins that have been characterised, CIRP 
(Cold inducible RNA binding protein) and Rbm3 (RNA binding motif protein 3) 
(Derry, Kerns, & Francke, 1995; Sheikh, 1997). CIRP was initially identified in a 
screen for transcripts that are induced upon DNA damage due to UV stress (Fornace, 
Alamo, & Hollander, 1988; Sheikh, 1997) and subsequently CIRP was the first cold 
induced protein identified in mammalian cells (Nishiyama, Itoh, et al., 1997).  Rbm3 
was initially discovered in cancer cell lines upon cold shock stress (Danno et al., 
1997). These proteins are also up-regulated upon other stresses such as hypoxia and 
UV irradiation (Lleonart, 2010). 
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CIRP and Rbm3 belong to highly conserved glycine rich RNA binding family of 
proteins, which contain an RNA binding N-terminal cold shock domain containing the 
RNP1 and RNP2 sequences and a glycine rich C-terminal domain (Al-Fageeh & 
Smales, 2009). The two proteins are highly homologous (Liu et al., 2013) (figure 1.4), 
they share a 61% identity at the amino acid level over the entire sequence and an 80% 
identity in the N-terminal RNA binding domain. However, as stated above, they show 
little homology to the CSPs induced upon cold-shock in bacterial systems (Roobol et 







The overexpression of CIRP and RBM3 in mammalian cells can lead to an increase in 
general protein synthesis (Dresios et al., 2005; Sakurai et al., 2006; Smart et al., 
2007). Both proteins are thought to act as RNA chaperones and modulate 
transcription and translation under cold stress (Liu et al., 2013) by interacting with 
components of the transaltional machinery to stimulate translation. The meraction of 
CIRP with the translational machinery is discussed in more detail in section 1.4.3.  
The cellular control of the response to cold stress and recovery have also been 
suggested to be regulated or partially regulated by p53 and eIF3i levels  (Roobol et 
al., 2009) and it is higly likely that CIRP and RBM3 have cruicial roles in this 
process, possibly through interaction with their mRNA to stabilise them and 
upregulate their protein synthesis.  
 
CIRP has been associated with modulation of both cap-dependant and cap-
independent mRNA translation, but it has been shown that RBM3 does not posess the 
sequence required for IRES sites for cap-independent translation (Baranick et al., 
Figure 1.4 Amino acid sequence alignment of human CIRP and human Rbm3 proteins. The 
yellow region is the N-terminal RNA binding domain and the orange region is the glycine C-
terminal region. The RNA recognition motifs RNP1 and RNP2 are highlighted in green. 
!
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2008). It has been suggested that Rbm3 is involved in regulation of global protein 
synthesis at 37°C and 32°C via the alteration of microRNA containing complexes 
(Dresios et al., 2005) and that CIRP plays a key role in the activation of the extra 
cellular signal regulated kinase pathway, protecting the cells from apoptosis by 
induction of tumor necrosis factor TNFα (Sakurai et al., 2006).  CIRP and Rbm3 
translocate from the nucleus to the cytoplasm upon cold stress and the localisation is 
reported to be regulated by methylation of arginine residues (De Leeuw et al., 2007). 
Rbm3 methylation has been shown to take place by stimulation of primary cortical 
neurons with a glutamate receptor agonist (Pilotte, Cunningham, Edelman, & 
Vanderklish, 2009). As well as their proposed role in protein synthesis through 
interaction with the translation machinery and specific mRNAs under cold stress, the 
two proteins have also been shown to be proliferative and proto oncogenic proteins. 
Their inhbition has been  shown to decrease cell proliferation (Zeng, Kulkarni, Inoue, 
& Getzenberg, 2009). The possible cellular pathways in which CIRP and Rbm3 are 
suggested to be involved, and hence through which they can elicit their responses, are 







Figure 1.5 Pathways that CIRP and RBM3 are suggested to interact with, leading to 
modulation of transcription and translation under cold stress conditions in mammalian cells. 
(Lleonart, 2010) 
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1.3.1.1 Rbm3 
The gene for the Rbm3 protein is found on the Xp11.2 region of the human 
chromosome and encodes for a 157 amino acid, 17 kDa protein closely related to 
other human RNA-binding proteins and shares 94% identity with the 18 kDa mouse 
protein (Derry et al., 1995). Rbm3 is expressed in the pancreas, adrenal gland, 
cerebellum, lung, spleen, intestine, uterus and testis and Rbm3 mRNA levels have 
been found to be increased in HepG2, NC65, HeLa, T24, K562 and TAMA26 
cultured cells upon a temperature shift from 37°C to 32°C with maximal expression 
between 6-12 hours after temperature shift (Danno, Itoh, Matsuda, & Fujita, 2000; Y. 
Liu et al., 2013; Lleonart, 2010). During cold shock, oxygen levels in cells are 
reduced (hypoxia) and consistent with this Rbm3 up-regulation also occurs in 
response to hypoxia (Wellmann et al., 2004). There is also evidence to suggest that 
Rbm3 alters global translational under cold stress by altering microRNA levels, 
counteracting their effect (Dresios et al., 2005). microRNAs either induce the 
cleavage of their target mRNAs or inhibit their translation by interacting with the 
mRNAs through the RNA-inducing silencing complex (White-Grindley & Si, 2006). 
In this way, Rbm3 removes translation repression of microRNAs by removal of the 
microRNA itself. With regard to translation, over expression of Rbm3 under mild 
hypothermia was reported to result in increased levels of 80S monosomes and 
polysomes suggesting increased association of ribosomal subunits during translation 
initiation and direct interaction of Rbm3 with 60S ribosomal subunits has been 
reported (Dresios et al., 2005).  
 
As well as a reported role in modulating translation under cold stress conditions, 
Rbm3 has been reported to also be involved in cytokine dependant proliferation 
(Baghdoyan, Dubreuil, Eberlé, & Gomez, 2000), poxvirus replication (Wright, 
Oswald, & Dellis, 2001), development of cancer (Baldi et al., 2003) and apoptosis 
(Kita, 2002).  It is considered to be a proto-oncogene as it enhances the stability and 
translation of mRNAs for cyclooxygenase 2, VEGF and interleukin 8 and its 
overexpression has been shown to induce NIH3T3 cells to grow in a cancerous type 
manner (Cok, Acton, Sexton, & Morrison, 2004; Sureban et al., 2008; Zeng et al., 
2009). Its expression in sertolli cells of mice during testis development may also 
suggest a developmental function (Danno et al., 2000) 
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1.4 Cold inducible RNA binding protein (CIRP) 
As mentioned previously in this chapter, expression of CIRP (Cold-Inducible-RNA-
Binding-Protein) is up-regulated in mammalian cells upon perception of mild cold-
shock  (27-32°C) (Nishiyama, Higashitsuji, et al., 1997). CIRP has also been 
suggested to bind to key proteins involved in the control of mRNA translation 
initiation, potentially acting as a bridge between the mRNA and the protein synthesis 
machinery (Yang, Weber, & Carrier, 2006).  RNA binds to the RNP1 and RNP2 
sequence present on the N-terminal domain (figure 1.6) of CIRP as described in 
Chapter 3 (section 3.3.3).  CIRP also has an arginine/glycine rich C-terminal domain 





CIRP transcription is up regulated in response to mild cold shock (Fajita, 1999). The 
promoter regions responsible for this up-regulation have also been mapped (Al-
Fageeh & Smales, 2013). Human CIRP is usually nuclear but translocates to the 
cytoplasm upon perception of mild cold stress. The CIRP gene is located on the 
chromosomal locus 19p13.3 and encodes a 172 amino acid, 18 kDa protein with 
95.3% identity to mouse CIRP (Nishiyama, Higashitsuji, et al., 1997). CIRP is 
thought to function as an RNA chaperone, i.e. protect and restore RNA conformations 
thus enhancing translation of its target RNA, preventing formation of mRNA 
secondary structure and it has been suggested that CIRP gene expression is controlled 
by cold responsive elements within its promoter (Al-Fageeh & Smales, 2013; Fujita, 
1999).  
 
CIRP has been shown to have a role in adapting cells to cold shock and in supressing 
cell proliferation. This was determined by overexpression of CIRP at 37ºC which 
caused extended doubling time and cells accumulating in the G1 phase of the cell 
cycle (Nishiyama, Itoh, et al., 1997). Up regulation of CIRP at physiological 
Figure 1.6 Schematic representation of the N-CIRP and full-length CIRP constructs. 
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temperature has also been shown to enhance recombinant protein production; 40% for 
gamma interferon (Tan, Lee, Yap, & Wang, 2008).  CIRP presumably exerts its 
effects through its RNA binding activity but it is not well defined as to how it does 
this. CIRP has been reported to bind to a limited number of RNAs (discussed further 
in section 1.4.2, see table 1.2), one being thioredoxin mRNA (Yang et al., 2006), 
interacting specifically at the 3’ untranslated region of the RNA, where it may be 
involved in modulating the efficiency of translation and RNA stability.  RNA 
constructs that contain the CIRP binding region have enhanced resistance to 
degradation by RNases and cells transfected with an antisense CIRP vector have 
diminished response to stress (Yang et al, 2001). 
 
1.4.1 Induction and Regulation of CIRP under Mild Hypothermia 
The CIRP gene was initially isolated from mouse testis by cDNA cloning of an RNA 
recognition motif containing RNA binding protein (Nishiyama, Itoh, et al., 1997). As 
mentioned in the previous section, CIRP gene expression is transcriptionally 
controlled during mild cold shock. Al-Fageeh et al characterised the 5’UTR of the 
transcript encoding CIRP at varying temperatures and times (Al-Fageeh & Smales, 
2009). The study showed the generation of three major CIRP transcripts with different 
transcription start sites that as a result had 5’UTRs of varied lengths, which were 
regulated in response to temperature and time. The longer of the 5’UTRs possesses 
IRES-like activity, which is associated with cap-independent translation. Upon 
temperature downshift two CIRP 5’UTRs with different transcription sites are 
generated, the levels of these transcripts control CIRP protein expression. Further, the 
stability of the long transcript up regulated at 32°C is enhanced. The major shorter 
transcript found at 37°C does not encode for full-length CIRP or may be inactive 
through being a truncated version (Al-Fageeh & Smales, 2009). This type of gene 
expression control via alternative 5’UTRs has been previously reported in a number 
of systems (Hughes, 2006; Tan, Mohandas, & Conboy, 2006).  
 
Work by these investigators on the CIRP 5’UTRs showed that the expression levels of 
the longer 5’UTR transcripts are regulated over time at 32°C where their stability 
increases. During the first 6 hours of low temperature, levels of all 5’UTR transcripts 
are up-regulated and beyond this time the levels decrease except for the longer 5’UTR 
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whose levels and stability are increased. The IRES activity of the longer 5’UTR 
results in a several fold increase in translation.  More recently, studies by Al-Fageeh 
et al discovered a core promoter localised between -264 and +1 relative to the 
transcription start site (TSS), which controls the basal transcription level of CIRP (Al-
Fageeh & Smales, 2013). This promoter contains a TATA box at -37 and is a single 
peak promoter, which means that it has a compactly defined transcription start site 
and is involved in tightly regulated gene expression (Müller, Demény, & Tora, 2007).  
Further, a CAAT box at -92 and an inverted CAAT box at -187 were identified 
suggesting specific regulation of the CIRP gene and the deletion of these CAAT 
motifs led to a loss of CIRP promoter activity. The NF-Y CAAT motif binding 
protein binds to the CAAT box which is estimated to be present in 30% of eukaryotic 
gene promoters and is required for expression of many genes (Mantovani, 1998).   
 
The longer CIRP 5’UTR mRNA was found to be transcribed by a different promoter 
upstream of the core promoter characterised as a broad peak promoter which is 
associated with ubiquitously expressed genes and does not contain a TATA box 
(Müller et al., 2007). Electro mobility shift assays (EMSA) showed that the two CIRP 
promoters bind to factors in a nuclear extract yielding different sized complexes, 
suggesting that the two promoter bind different factors. Luciferase reporter assays 
showed expression from the core promoter but little from the upstream promoter at 
37°C. These findings suggest that when the global transcription efficiency is 
decreased upon cold stress, the CIRP alternative promoter, which is weakly active at 
37°C, is induced and generates the CIRP mRNA containing IRES which leads to 
more efficient translation at these temperatures (Al-Fageeh & Smales, 2013).  
 
Transcriptional regulation is thus key for gene expression of CIRP at mild 
hypothermic temperatures. Studies have found that the half life of CIRP mRNA is not 
highly influenced by cold stress (Al-Fageeh & Smales, 2009; Nishiyama, Itoh, et al., 
1997).  Further support for the transcriptional regulation of CIRP expression was the 
identification of a mild cold responsive element (MCRE) in the 5’ flanking region of 
the mouse CIRP gene which was shown to enhance gene expression at 32°C in 
cultured mammalian cells (Sumitomo et al., 2012). The Sp1 transcription factor binds 
to this MCRE to induce CIRP expression and Sp1 down-regulation supressed CIRP 
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induction. It was also shown that the levels of Sp1 protein in the nucleus was 
increased at 32°C for binding to the MCRE region on the CIRP gene. This enhancer 
element increases the gene expression of CIRP 3- to 7-fold in various cell lines at 
32°C. 
 
RNA binding protein regulation can also be mediated by post-translational 
modifications (Yang et al., 2006). As described previously, CIRP is localised to 
nucleus and translocates into the cytoplasm upon mild cold shock. This process is 
thought to be regulated by methylation. CIRP has been identified as an arginine 
methylated protein by Bedford et al (Bedford, 2007). There has been an increased 
interest in the regulation of protein function through methylation and many RNA 
binding proteins have been shown to undergo methylation (Liu & Dreyfuss, 1995; 
McBride & Silver, 2001).  Arginine residues are methylated by arginine methyl 
transferase I, which catalyses asymetric dimethylation (Tang et al., 2000).  The 
recognition motif for the transferase PRMT1 has been identified as 
(F/G)GGRGG(G/F) (Kim et al., 1997). Many RNA binding proteins have a C- 
terminal RGG domain including CIRP.  Aoki et al identified the Xenopus homolog of 
PRMT1 as a binding partner of Xenopus CIRP (XCIRP2), showing that the 
methylation of XCIRP2 leads to accumulation of XCIRP2 in the cytoplasm and 
confirmed the interaction of XCIRP2 with PRMT1 in vitro (Aoki, Ishii, Matsumoto, 
& Tsujimoto, 2002). The study identified a 43 amino acid region at the C-terminal of 
XCIRP2 as the methylation site named RG4 which when mutated led to accumulation 
of XCIRP in the nucleus and that upon over expression of PRMT1, cytoplasmic 
XCIRP2 levels increased.  
 
There is a high amino acid sequence homology between XCIRP2 and mammalian 
CIRP showing 74% identity to mouse CIRP (Aoki et al., 2002). Leeuw et al also 
showed that methylation of arginine residues in the RGG motif on the C-terminal of 
human CIRP is required for nuclear exit of the protein in mammalian cells (De Leeuw 
et al., 2007). The nucleocytoplasmic distribution of CIRP is determined by the RGG 
motifs of the glycine rich C-terminal domain and the exit of CIRP from the nucleus is 
in a methylation dependant manner.  The capacity of CIRP to stimulate translation 
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and cell survival under stress conditions is related to this translocation in stress 
playing a protective role as discussed in the next section. 
 
1.4.2 RNA Binding of CIRP 
It is not known how the up-regulation of CIRP leads to improved recombinant protein 
production but it has been described as an RNA chaperone in several investigations 
(Nishiyama, Itoh, et al., 1997; Sonna et al., 2002). To date some mRNAs have been 
identified which specifically CIRP binds to (Yang & Carrier, 2001) but a sequence 
specifity has not been identified. However Yang et al (2001) identified a 51 base 
oligonucleotide common RNA motif which was found 11 times more in the 3’UTR of 
the sequences tested than in the 3’UTR of the whole gene database. This sequence 
was also found to be present in the 3’UTR of the identified targets (table 1.2).   The 
over expression of CIRP has been shown to stabilise mRNAs by binding to them and 
it has been also been shown that CIRP also binds mRNA of ribosomal proteins which 
could lead to an increase in their translation (Yang & Carrier, 2001).  
 
RNA binding proteins have an important function in the response of cells to cold 
stress (Liu et al., 2013). The effect of temperature on mRNA structure is not well 
understood but under mild hypothermia cells display increased recombinant mRNA 
levels and improved mRNA half life suggesting increased mRNA stability (Fox et al., 
2005).  Cold inducible RNA binding proteins are thought to ensure and improve 
translation of specific mRNAs at low temperatures (Becerra et al., 2012). The 
translation and stability of mRNAs is regulated by RNA binding proteins and small 
RNAs as stable ribonucleoprotein complexes (RNP) (Nishiyama, Higashitsuji, et al., 
1997).  CIRP is a member of a family of RNA binding proteins that consist of an N-
terminal RNA binding domain and a glycine rich terminal domain (Nishiyama, Itoh, 
et al., 1997). The RNA binding domain consists of approximately 90 amino acids and 
includes two highly conserved RNA binding sequence RNP1 and RNP2 and a number 
of other conserved amino acids, which are mostly hydrophobic (figure 1.7) (Sheikh, 
1997). 







As described above (section 1.4.1), CIRP (hnRNP A18) translocates from to nucleus 
to the cytoplasm under cold/UV stress or hypoxia and binds to stress responsive 
3’UTR of specific mRNAs increasing their translation (Yang & Carrier, 2001). Yang 
et al (2001) identified 46 mRNA ligands, which CIRP binds to. More than 20 of these 
were identified as stress-responsive mRNA targets (table 1.2). Two of these mRNAs 
that CIRP has been reported to specifically bind to are the 3’UTR mRNA of 
thioredoxin (TRX) and replication protein A (RPA2), which are both stress responsive 
transcripts. Their translation and stability was reported to increase upon binding by 
CIRP (Yang & Carrier, 2001).  
 
The levels of TRX protein correlate with CIRP levels. TRX plays an important role 
during oxidative stress through its up-regulation in stress conditions. It has a 
regulatory role in cell signalling and gene transcription. Its ability to bind DNA and 
activate of transcription factors is increased through its redox activity and it also 
protects cells under stress conditions by quenching reactive oxygen species which 
increase under cellular stress and are damaging to the cells (Yang et al., 2006).  The 
TRX 3’UTR is reportedly able to bind both the RNA binding domain and the C-
terminal glycine rich domain when expressed independently, but maximal binding is 
observed when both domains are present suggesting that the C-terminal domain must 
have a function in RNA binding (Yang et al., 2006). More recently, the ATR 3’UTR 
mRNA was also identified as an mRNA target of CIRP and overexpression of CIRP 
resulted in increased ATR protein levels (Yang et al., 2010). The significance of this 
is discussed later in this chapter (section 1.4.3). 
Figure 1.7 Sequence alignment indicating the conserved RNP1 and RNP2 and other regions 
in several mammalian cold shock proteins. (Sheikh et al, 1997) 























Replication protein A2 
Thioredoxin 
Ferritin L chain 
Nucleophosmin 
Glutathione transferase Ω 
Translational elongation factor 1α 
TIM 22 homolog 
Cyclophilin B 
NADH-ubiquinone oxidoreductase 
Human Wilm’s tumor related 
Myosin regulatory light-chain 
Laminin-binding protein 
Human G10 homolog edg-2 
Translational elongation factor1/β2 
Protein kinase C inhibitor I 
Putative C-myc responsive (rcl) 
ATPase 
TAXREB107 
18 S rRNA 
Novel sequence 1 





Novel sequence 2 
Hypothetical protein FLJ20420 
Tubulin-α 




CIRP has a typical RNA binding protein topology with the RNP1 and RNP2 motifs 
located on the β3 and β1 strands respectively. There are highly conserved aromatic 
residues exposed on the surface of these β sheets which interact with the RNA (Maris 
et al., 2005). An RNA binding model shows that residues in position 3 and 5 on RNP1 
(β3) and the residue in position 2 on RNP2 (β1) are the essential residues for RNA 
binding (Maris et al., 2005) (figure 1.8). The interaction of these CIRP residues with 
RNA ligand was previously confirmed by NMR chemical shift studies undertaken on 
the N-terminal domain of CIRP, referred to as N-CIRP (Hsieh, 2010). Upon mixing 
with RNA ligand, the aromatic side chains in position 2 (RNP2) and 5 (RNP1) stack 
with adjacent RNA bases. The aromatic residue in position 3 (RNP1) interacts in a 
hydrophobic manner with adjacent sugar rings in the RNA ligand. The positively 
charged residue (Arg) in position 1 (RNP1) forms a salt bridge with the phosphate 
backbone of the RNA ligand (Maris et al., 2005) (figure 1.8). 
Table 1.2 mRNA ligands reported to bind CIRP. (Yang & Carrier, 2001)!






As mentioned earlier, previous studies have reported that the 3’UTR of the 
thioredoxin (TRX) mRNA binds to CIRP (Yang et al., 2006) and these findings were 
further confirmed by Hseih (2010).  Human thioredoxin 3’UTR mRNA is 166 
nucleotides long excluding the poly-adenine (polyA) tail and the mouse TRX 3’UTR 
mRNA is 532 nucleotide long, however the first 127 nucleotides of the TRX 3’UTR 
from the two species is 69% identical. Electromobility shift assay studies by Hseih 
showed that full length CIRP and N-CIRP bind to full length human TRX 3’UTR 
mRNA, the first 127 nucleotides of human TRX 3’UR mRNA and also the first 113 
nucleotides of mouse TRX 3’UTR mRNA (Hseih, 2010).  
 
Binding studies of N-CIRP with mRNA by NMR also showed binding of N-CIRP to 
the TRX 3’UTR and also to a 10mer polyA RNA fragment which showed the largest 
chemical shift changes on minimal chemical shift maps (Hseih, 2010). As described 
above, it has also been shown that both the RNA binding domain and the glycine rich 
C-terminal domain are required for maximal RNA binding of CIRP (Yang et al., 
2006). The exact nature of these interactions and the subsequent effect of CIRP 
binding on cellular responses remain unclear. However, reports have now suggested 
that the increased translation of specific mRNAs upon CIRP up-regulation is 
mediated by interaction with the initiation factor eIF4G of the translational machinery 
(Yang et al., 2010). A model whereby the 3’UTR RNA binding proteins can regulate 
translation initiation at the 5’UTR end has been proposed, where 3’UTR and 5’UTR 
of mRNA are bridged by the interaction of CIRP with eIF4G.  This proposed model 
!
Figure 1.8 Model of RNA binding showing residues essential for RNA binding in RNP1 and 
RNP2 and their interaction with RNA (Maris et al., 2005)!
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results in circularization of the mRNA where the 3’ and 5’ end form a ‘kissing’ loop 
(Yang et al., 2006). The interaction of CIRP with the translational machinery is 
further discussed in section 1.4.3. 
 
1.4.3 Interaction of CIRP with the Translational Machinery 
As described above, CIRP binds to the 3’UTR (untranslated region) of particular 
mRNAs resulting in an increase in their translation (Yang & Carrier, 2001; Yang et 
al., 2010) and one of these is the 3’UTR of the ATR protein (ataxia telangiectasia 
mutated and Rad3 related kinase) resulting in increased ATR protein expression 
(Yang et al., 2010).  ATR belongs to a family of protein serine threonine kinases and 
the ATR signalling pathway is associated with cell cycle arrest due to compromised 
DNA replication (Abraham, 2001).  It has been suggested that the binding of CIRP to 
the 3’UTR of specific mRNAs results in an increase in their translation and is 
mediated by an interaction between CIRP, the mRNA and the translational machinery 
(Yang et al., 2006). This proposal is supported by the studies of Yang et al who 
reported that CIRP binds to the eukaryotic initiation factor 4G (eIF4G).  From these 
observations it is suggested that through the interaction with 3’UTRs and eIF4G, 
CIRP acts as a bridge between 3’ and 5’UTRs to increase translation.  
 
Translation initiation is the assembly of the ribosome on an mRNA for protein 
synthesis and involves the binding of the 40S ribosomal subunit to the eIF4F complex 
that forms at the capped 5’ end of an mRNA. This is a complicated event with two 
major stages; formation of the 48S pre-initiation complex followed by the recruitment 
of the large 60S ribosomal subunit once the AUG start codon is found to assemble the 
80S intact ribosome (figure 1.9) (Alekhina & Vassilenko, 2012).  
 
The binding partners eIF3 (bound to eIF4G), eIF2 and eIF1A subsequently interact 
with the 40S subunit forging a link between mRNA and ribosome. mRNA 
circularisation is aided by the eIF4G interaction of eIF4A and polyA binding protein 
(PABP) which are bound to the 3’ and 5’ of the mRNA respectively where eIF4G acts 
as the central protein to bring together the 5’ and 3’ termini of the mRNA (Lamphear, 
Kirchweger, Skern, & Rhoads, 1995). Indeed, during this project the hypothesis that 
the eIF4G-CIRP-3’UTR RNA interaction can also circularise the mRNA under mild 
hypothermic conditions when CIRP is expressed and facilitate the translation of 
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specific mRNAs that contain CIRP binding 3’-UTRs was investigated using the ATR 






































Figure 1.9 Pathway of translation initiation in eukaryotes (Klann & Dever, 2004). This event 
requires multiple initiation factors including eIF4E, eIF4A, eIF3, and PABP, which in turn aids 
binding of mRNA to the 40S ribosomal to form the 48S pre-initiation complex (Korneeva, 
Lamphear, Hennigan, & Rhoads, 2000).  eIF4G is the central protein for the initiation factors 
involved in mRNA recruitment to the ribosome (Keiper, Gan, & Rhoads, 1999). eIF4G serves as a 
scaffold protein for the binding of the initiation factors eIF4E, eIF4A and PABP at the 5’ cap of an 
mRNA to promote the recruitment of RNA by ribosome (Hinton, Coldwell, Carpenter, Morley, & 
Pain, 2007).  The central region (figure 1.10) of eIF4G binds ATP dependent RNA helicase eIF4A, 
the 40S binding factor eIF3 and RNA (Korneeva et al., 2000).  
!
Figure 1.10 Schematic figure of the eIF4G initiation factor, with the binding domains 
indicated. Figure adapted from Yángüez & Nieto, 2011.!
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1.4.4 Structure and Function of CIRP 
CIRP consists of a well-characterised N-terminal RNA binding domain and a glycine 
rich C-terminal domain that is natively disordered. Although the function of the 
unstructured C-terminal domain remains unknown, it has been shown previously that 
both the RNA binding domain and the glycine rich domain is required for maximal 
RNA binding (Yang et al., 2006).  In recent years interest in natively disordered 
proteins has increased and NMR spectroscopy is recognised as a good method to 
study intrinsically disordered proteins (IDPs) (Cavanagh, Fairbrother, Palmer, 
Skelton, & Rance, 2007). Structured proteins give resonance peaks that are spread out 
due to the difference in the local environment of the nuclei but IDP spectra peaks are 
closely spaced or overlapping as the nuclei environments are indistinct. The C-
terminal glycine rich domain of CIRP has been shown to be natively disordered by 






























H HSQC spectra of full length CIRP (red) and N-CIRP (black). 
15
N-labelled 
N-CIRP gave well-resolved NMR data typical of a stable folded protein domain. The peaks 
originating from the C-terminal region (red) were found to predominate in the central region of the 
spectrum (shown by the blue box). Backbone amide 
1
H resonances in this region are characteristic 
of a random coil structure suggesting that the C-terminal region of CIRP is unstructured. Data from 
PhD thesis of Hsieh (2010), University of Kent. 
!
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The structure and function of recombinant full-length CIRP has not been studied in 
detail and the contribution of the C-terminal region towards the function of CIRP is 
not known. Unstructured regions of proteins have been identified to act as decision 
points for specificity in binding and function (Pancsa & Fuxreiter, 2012).  Intrinsically 
disordered regions of proteins lack a stable structure but still exhibit biological 
activities (Dunker et al., 2001). Due to their amino acid sequence, in the case of CIRP 
being rich in glycine residues, they have flexible characteristics and are known to be 
involved in functions such as recognition of proteins and nucleic acids and facilitate 
interactions and chemical reactions, accommodate post translational modification, 
alternative splicing, protein fusions and insertions or deletions (Oldfield & Dunker, 
2014). IDPs may lack structure in the absence of a ligand but can fold when bound to 
a ligand and allow for the binding to multiple partners. For example the IDP human 
cell-cycle control protein p21, becomes structured when bound to its ligand cyclin 
(Kriwacki, Hengst, Tennant, Reed, & Wright, 1996).  
 
A number of proteins with natively disordered regions have been shown to be 
important in cell cycle regulation (Follis, Galea, & Kriwacki, 2012). For example, the 
disordered region of p27 causes cell cycle arrest by binding and closing of the cycling 
A/CDk2 complex (Galea et al., 2008). These findings are fitting with CIRP studies 
showing that over expression of CIRP in cultured cells results in cell cycle arrest in 
the G1 phase (Nishiyama, Itoh, et al., 1997). Studies show that IDPs have weak 
binding affinities for their binding partners and fast on/off binding rates (Shammas, 
Travis, & Clarke, 2013). Also consistent with CIRP function, IDPs and IDP regions 
are also associated with having function as RNA chaperones (Tompa & Csermely, 
2004). All these findings strongly suggest that the C-terminal domain of CIRP has 
important functional roles that are currently ill defined. 
 
On-the-other-hand, the N-terminal region of CIRP has a clear RNA binding function 
(Manival et al., 2001; Maris et al., 2005; Nishiyama et al., 1998; Yang & Carrier, 
2001;Yang et al., 2006). The N-terminal binding domain has a β1α1β2β3α2β4 
topology and consists of two RNA binding consensus sequences on strands β1 and β3; 
these are called RNP1 and RNP2 as described earlier (fig 1.6) (Sheikh et al, 1997).  
The RNA binding of this domain is discussed in detail in section 1.4.2. Studies have 
identified RNP1 and RNP2 as the specific binding regions for RNA with some 
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residues being more important than others. The highly conserved aromatic residues 
exposed on the surface of the β sheets 1 and 3 are thought to interact closely with the 
RNA (Manival et al, 2001). Fitting with this model, CIRP possesses these conserved 
sequences RNP1 and RNP2 on the β sheets 1 and 3 and the essential phenylalanine 
aromatic residues in position 2 of RNP2 and positions 3 and 5 in RNP1.  The RNA 
binding domain of human CIRP has been deposited in the protein data bank (1X5S) 
(figure 1.2) but not been published whilst there is no structural data publicly available 
for the mouse protein studied in this project. 
 
Aside from CIRP being involved in RNA binding and stabilising leading to increased 
translation of specific RNAs, the specific function of CIRP is still largely unknown. 
The RNA binding function and interaction of CIRP with the translational machinery 
is discussed in detail in previous sections in this chapter (sections 1.4.2. and 1.4.3). 
The main focus to date and of this project has been upon the observation that the over 
expression of CIRP leads to an increase in recombinant protein production under cold 
stress conditions via unknown mechanisms. The current understanding is therefore 
that CIRP stabilises and facilitates the translation of specific mRNAs necessary for 
the cells survival under stress conditions (e.g. cold-shock) and several additional 
interactions of CIRP to those discussed above have now been reported. For example, 
Qiang et al (2013) have identified CIRP as a DAMP (damage associated molecular 
pattern) where CIRP levels were reported to be elevated in the blood of haemorrhagic 
shock patients. Haemorrhagic shock is associated with an inflammatory response. 
CIRP was found to be up-regulated in the heart and liver and released into the blood 
stream by translocating from nucleus to cytoplasm in the macrophages. Release of 
tumour necrosis factor α (TNFα) and HMGB1 from macrophages and induction of 
inflammatory response and tissue injury was stimulated by recombinant CIRP. This 
effect of TNFα and HMGB1 was reduced in CIRP deficient mice. It was also reported 
human CIRP residues 106-125 bind toll-like receptor 4 (TLR4)-myeloid differentiate 
factor 2 (MD2) complex to mediate this extracellular activity and as such CIRP is 
thought to be associated with promotion of inflammatory responses in shock and 
sepsis (Qiang et al., 2013). A further study by Sakurai et al (2006) reported that under 
mild hypothermic conditions CIRP protects cells via the activation of the ERK 
(extracellular signal regulated kinase) pathway, which in turns inhibits TNFα induced 
apoptosis. It was discovered that in BALB/3T3 cells which had been treated with 
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tumour necrosis factor α, reduction of temperature lead to an increase in CIRP 
expression and levels of phosphorylated ERK, leading to inhibition of apoptosis 
(Sakurai et al., 2006). 
 
Another mechanism that CIRP may be involved in modulating upon its expression 
was reported in a study by Masuda et al (2012) where proliferation of undifferentiated 
spermatogonia was stimulated by the interaction of CIRP with Dyrk1b (Masuda et al., 
2012). CIRP is expressed in the mouse testis’ germ cells. It was found that CIRP 
knockout mice lead to a reduction in undifferentiated spermatogonia. The study 
showed that proliferation of spermatogonia is stimulated by CIRP confirming its 
proliferative role. It was found that CIRP supressed the kinase activity of the Dyrk1b 
protein by interacting with it, which stops its kinase activity to phosphorylate p27. 
When active, p27 has a role toward preventing cell cycle progression at G1 by 
inhibiting cyclin E/CDK2. Also, p27 phosphorylation by Drkb1 was increased in the 
absence of CIRP. CIRP increases cell proliferation by leading to a reduction in p27 
levels. This supports the onco-protein role, which has been linked to CIRP (Masuda et 
al., 2012).  
 
A number of studies have implicated up-regulation of CIRP in cancer cells.  As 
mentioned previously, CIRP is up-regulated in response to hypoxia and in the 
environment of tumour cancer cells, there is a reduction in oxygen levels as tumours 
grow (Harris, 2002) and initiation and progression of cancer has been linked to 
oxidative stress. The proteins TRX and RPA2 have both been associated as being 
prognostic indicators in certain cancer and potential therapeutic targets (Givalos et al., 
2007; Noike, Miwa, Soeda, Kobayashi, & Miyagawa, 2008) and as described above, 
CIRP specifically binds to the 3’UTR mRNA of both these proteins. Further, CIRP’s 
role in protecting cells against apoptosis under stress conditions supports this (Sakurai 
et al., 2006). CIRP has been found to be overexpressed in various human tumours, for 
example in a study involving 193 patients, CIRP was overexpressed in 33% of colon 
and 45% of breast carcinomas providing further support of CIRP having a role in 
tumourignesis (Lleonart, 2010). The potential of CIRP as a target in cancer therapy 
has also been suggested as Zeng et al (2009) showed that the inhibition of CIRP 
reduced cell proliferation in prostate cell lines and as well as impairing cell survival, 
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CIRP knock down also enhances chemosensitivity to cisplatin and adriamycin (Zeng 
et al., 2009).  
 
Liu et al (2013) have also reported that CIRP regulates circadian gene expression by 
controlling alternative polyadenylation (APA), a further link to the translational 
apparatus. These authors found that the 3’UTR binding sites for CIRP were enriched 
near the polyadenylation sites of mRNA (PASs), they identified common RNA 
binding protein binding motifs on target 3’UTR mRNAs using computational 
methods and also showed that reduced levels of CIRP lead to shortening of the 3’UTR 
and up-regulation of CIRP lengthened the 3’UTR. APA is an important mechanism of 
post-transcriptional regulation, many mammalian genes have tandem UTRs generated 
by multiple PASs and so without changing the mRNA code, the length of 3’UTRs can 
be altered which changes the accessibility of RNA binding proteins and has an effect 
on mRNA stability, translation and localisation (Liu et al., 2013). For example, 
3’UTR are shortened during T lymphocyte activation but lengthened in embryonic 
development (Ji, Lee, Pan, Jiang, & Tian, 2009; Mayr & Bartel, 2009). 
 
1.5 Cold Shock and Recombinant Protein Production 
Under conditions of mild hypothermia (32°C), mammalian cells can continue to 
survive and divide (Fujita, 1999) and culturing of the cells at these temperatures can 
result in enhanced recombinant protein (Yoon, Song, et al., 2003). In the 
biopharmaceutical manufacturing industry, mammalian cells are used routinely for the 
production of recombinant proteins used as therapeutics in the clinic. Normally 
mammalian cells are cultured at 36.5-37°C to mirror the conditions found in the body 
(Yoon, Song, et al., 2003).  Cell proliferations takes place during exponential growth 
of the culture at which time recombinant protein synthesis is not optimal as the cell’s 
resources are focused on processes necessary for doubling of cell biomass (Masterton 
& Smales, 2014). Recombinant protein production from mammalian cells is optimal 
during the stationary phase as there is less competition between cellular processes and 
protein synthesis (Gammell, Barron, Kumar, & Clynes, 2007). During late phase of 
culture, mammalian cell viability rapidly declines due to apoptosis limiting 
production (Goswami, Sinskey, Steller, Stephanopoulos, & Wang, 1999). However, 
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reduced temperature can be used to prolong the culture lifetime before cell death to 
extend production.  
 
Low temperature culturing of mammalian cells for the synthesis of therapeutic 
recombinant proteins is widely used (Masterton & Smales, 2014).  The temperatures 
described as mild hypothermia in this sense are 27-32°C, below these temperatures 
translation is halted and protein production will not increase (Roobol et al., 2009). 
One of the first studies to develop a process of temperature manipulation was reported 
by Jenkins and Hovey (Jenkins & Hovey, 1993), where they changed culture 
temperature between 39°C and 34°C and the temperatures less than 37
o
C resulted in 
maintenance of a viable culture for longer and a 35% increase in protein yield.  
 
At mild hypothermic conditions growth rate of the cells is reduced and cell doubling 
time increases (Marchant et al., 2008). As a result of culturing cells at lowered 
temperatures, metabolite depletion and build up of toxic by-products is also 
decreased.  As the metabolism is reduced, apoptosis is also delayed as cells arrest at 
the G1 phase of the cell cycle, cells are not apoptotic and protein synthesis is active. 
Delayed apoptosis is advantageous in the sense that cell viability is elongated and 
cells are productive for longer periods of time (Hwang, Yoon, Koh, & Lee, 2011; 
Marchant et al., 2008). However, this does mean running cultures for extended 
periods of time, therefore a biphasic approach was developed where cells are cultured 
at 37°C during the first phase to achieve the desired biomass when the cells rapidly 
grow until stationary phase of growth is achieved. This is followed by the second 
phase where the temperature is reduced (27-35°C) for protein production (Sunley, 
Tharmalingam, & Butler, 2008; Yoon, Kim, Song, & Lee, 2006). This biphasic 
strategy was applied to enhance the synthesis of recombinant human IFN-γ from CHO 
cells (Fox, Patel, Yap, & Wang, 2004).  
 
Most reports suggest that the cells major response to reduced temperature is the 
decrease in the rates of global protein synthesis (Roobol et al., 2009) which conflicts 
with the general observations that recombinant protein production is increased at 
these temperatures. This observation can be explained by the fact that under these 
conditions there is reduced metabolic burden on the cell and the mRNA levels are 
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increased and mRNA stabilised. Therefore, as well as the increased recombinant 
mRNA levels, there is less competition from the translation of endogenous mRNA 
and protein folding leading to enhanced recombinant protein yields (Masterton & 
Smales, 2014). 
 
The effects achieved from culturing mammalian cells at reduced temperatures is cell 
line and product dependent.  For example, the synthesis of recombinant human 
growth hormone from CHO cells was improved at reduced temperature but leads to 
decreased cell viability (Rezaei, Zarkesh-Esfahani, & Gharagozloo, 2013). It has also 
been reported that culturing cells at mild hypothermic temperatures results in no 
change or a decrease in productivity. For example Yoon et al (2003) found that 
expressing anti-4-1BB antibody in CHO cells at sub physiological temperature did not 
have an effect on yield at 33°C and lead to an 3.9 fold decrease at 30°C (Yoon, Song, 
et al., 2003).  Marchant et al (2008) showed that expression of the IgG4 monoclonal 
antibody (cB72.3) is host cell specific. Temperature shift from 37°C to 32°C in CHO 
cells lead to 50% increase in productivity whereas a negative effect on production was 
observed in NS0 murine myeloma cells (Marchant et al., 2008). This difference 
between two cell lines was attributed to metabolite utilization, cell growth and 
recombinant mRNA level differences between the cells lines. Further, it has been 
suggested that improved recombinant protein products at lower temperature 
cultivation is not only due to growth arrest of the cells but also because of the elevated 
levels of recombinant mRNA at sub physiological temperatures as a result of 
increased mRNA stability through secondary structure formation of the mRNA and 
reduction in the rate of mRNA degradation (Fox et al., 2005; Kou et al., 2011; 
Marchant et al., 2008; Roobol et al., 2009).  For example increased mRNA levels of 
recombinant IFN-γ mRNA at sub physiological levels was associated with elevated 
IFN-γ protein levels from CHO cells (Fox et al., 2005). 
 
As well as improving product levels, culturing mammalian cells at reduced 
temperatures have been reported to improve product quality i.e. more accurate protein 
folding (Masterton et al., 2010) and more accurate post-translational modifications, 
specifically glycosylation  (Borys et al., 2010). This in turn leads to reduced protein 
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aggregation.  Studies have shown that there is no difference between the biological 
activity of protein produced at 37°C and at 32°C (Becerra et al., 2012). 
 
1.6 Project Aims 
Mammalian cells respond to culturing at sub-physiological temperatures through 
activation of a number of mechanisms as described in the previous sections of this 
introduction. However, the exact cellular mechanisms which are activated and the 
relationships between these mechanisms are not well understood. Gaining a higher 
level of understanding as to how the mechanisms are initiated and how this 
coordinated response leads to the improved recombinant protein production and 
quality is crucial if new strategies, cell lines and vector systems to exploit these 
responses to improve recombinant protein product yield and quality at such 
temperatures are to be devised. Further, a better understanding of the mechanisms 
activated during cold stress could also potentially help develop strategies for diseases 
which involve cold shock proteins such as male infertility and cancer. 
 
In this study the structure and function of the cold-shock inducible protein CIRP were 
investigated. CIRP plays a crucial role in the response to cold shock in mammalian 
cells and is involved in the modulation of many of the cellular responses to cold-
shock and cold-stress. Extending our knowledge of this protein and how its up-
regulation is involved in modulating these responses will aid in defining the role of 
CIRP in these responses and how CIRP and cold-shock responses may be 
manipulated in the cell. Specifically here the following were investigated; 
o RNA binding of full-length CIRP, N-CIRP and C-CIRP domains and 
investigating the essential residues for the RNA binding of CIRP.  
o Function of the glycine rich C-terminal domain. 
o The structure of the RNA binding domain of mouse CIRP and its dynamic 
properties in space.  
o Mechanisms by which CIRP expression might lead to an increase in 
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2.1.1 Recombinant Protein Expression and Purification 
To investigate the structure and ligand binding activity of the N-terminal domain (N-
CIRP), NMR was chosen as a suitable method. N-CIRP is a good candidate for NMR 
studies as it is of an appropriate size, soluble in the necessary buffers to at least 1 mM 





experiments were used and a minimum protein concentration of 0.1 mM is required. 
For structural studies the protein concentration must be 0.5-1 mM for which 6-12 
mg/ml of CIRP is required. To achieve such yields using mammalian cell systems is 
expensive and requires the production of stable cell lines, which can take a long time. 
Another point to be considered is that for NMR experiments, it is required for the 





C or both. The cost of isotopic labelling is much cheaper in E.coli than 
mammalian cells. Full-length protein can also be characterised using similar NMR 
experiments as used for N-CIRP and also similar RNA binding studies carried out to 
investigate any changes in binding when both the N- and C- regions are present.  
 
To achieve as high a yield as possible, the proteins were expressed in the E.coli 
system because of its many advantages such as short culture time, low cost of media 
and high expression yields (Baneyx 1999; Sorensen & Mortensen 2005a). Depending 
on the culture size and the media used, a suitable yield can be obtained within 24 h 
after the cells have been transformed. For the purposes of this project, E.coli 
expression was found suitable as we believe that CIRP does not possess any essential 
post translation modifications that would require the use of eukaryotic systems for 
expression.  
 
For NMR experiments, protein samples are required to be of high purity (>95%). The 
pET vector system (Novagen) encoding CIRP/N-CIRP was used (figure 2.1). The 
pET28a vector has T7 promoter, lacI repressor for the induction of expression and 
kanamycin resistance and results in high expression yields due to the strong T7 
promoter (Rosenberg et al. 1987; Studier & Moffatt 1986; Studier et al. 1990). The 
pET system codes for a number of tags to aid purification, we used the His-tag to 
enable nickel affinity purification.  pET28a(+) with the CIRP/N-CIRP gene insert was 
kindly provided by Shu-Ju Hsieh. 























2.1.2 Protein Purification 
The first purification method used was nickel chelating affinity chromatography 
achieved through the presence of the His tag on CIRP/N-CIRP protein. The matrix is 
charged with Ni
2+
 ions, which histidine amino acids can associate with via their 
electron donor groups on their side chain (Janson & Ryden 1998; Schlitz 1984). 
Cysteine and tryptophan are other amino acids which can associate with the Ni
2+ 
ions 




Protein is loaded on to the nickel affinity chromatography column, the His tagged 
protein binds to the matrix. Once the tagged protein is bound it can be eluted by 
introducing a competing agent such as imidazole which competes with the His-tag 
(Simpson 2009; Janson & Ryden 1998). Ion exchange chromatography was chosen to 
further purify N-CIRP after nickel affinity chromatography to remove further 
contaminants. Ion exchange chromatography relies on charged interactions between 
the protein and charges immobilised on the matrix (Gräslund et al. 2008). The bound 
protein is eluted using a salt gradient (Simpson 2009; Millner 1999).  
Figure 2.1 Schematic representation of the pET28a (+) vector map. (Novagen pET System 
Manual) 




NMR experiments can be used to study protein-ligand interactions by looking at 
chemical shift changes of the protein in the presence and absence of ligand. N-CIRP 
consists of two RNA binding consensus sequences on strands β1 and β3; these are 
called RNP2 and RNP1 (figure 1.6) (Sheikh 1997). Studies have identified RNP1 and 
RNP2 as the specific binding regions for RNA with some residues being more 
important than others (Chapter 1, section 1.4.2). The highly conserved aromatic 
residues exposed on the surface of the β strands 1 and 3 are thought to interact closely 
with the RNA (Manival et al. 2001). To confirm the ligand-binding site in the N-
terminal domain of CIRP and the role of the N-terminal domain in full-length CIRP, 
the highly conserved aromatic residues F9 (RNP2, position 3) and F49 (RNP1, 
position 2) were mutated.  The importance of these residues could be assessed by their 
effect on the binding activity of N-CIRP and the structure and stability of the protein.  
 
Site directed mutagenesis by overlap extension PCR is a convenient method to 
introduce mutations into a known sequence (Ling & Robinson 1997). Using PCR, 
complementary primers are used to generate two DNA fragments having overlapping 
ends (figure 2.2). These fragments are combined in a subsequent overlap reaction in 
which the overlapping ends anneal, allowing the 3' overlap of each strand to serve as a 
primer for the 3' extension of the complementary strand (Ho et al. 1989; Aiyar et al. 
1996).  
 
The overlapped product is then amplified further by PCR using a pair of primers i.e. 
the two end primers. Mutations to the sequence are introduced by incorporating 
changes into the overlapping primers. pET28a vector coding N-CIRP was used as the 
template DNA to generate these mutant fragments, which were then cloned back into 































2.1.3 Protein Solubility 
There are several factors that can contribute to protein aggregation; pH, protein 
hydrophobicity (Luan et al. 2004) and hydrogen bonding (Pace et al. 1996; Myers & 
Pace 1996) N-terminal and C-terminal  amino acid composition (Sati et al. 2002, 
Doray et al. 2001; Oswald et al. 1994), and high protein concentration (Idicula-
Thomas & Balaji 2005). Studies by Shu-Ju Hseih showed that the C-terminal region 
of CIRP is natively unstructured presumably due to the high glycine and arginine 
residue content in this region (figure 2.3), whereas the N-terminal region is stable and 
soluble on its own. The studies also showed that full length CIRP is unstable and has 































Figure 2.2 Schematic diagram of site-directed mutagenesis by overlap extension. Site of 
mutagenesis is indicated by the small black star. 


























Various techniques were tested in this chapter to increase final soluble CIRP protein 
yields by looking at protein which was soluble on expression and also protein which 
was soluble on expression but formed precipitate in vitro.  There are many approaches 
to improve protein solubility on expression such as the use of tags or fusions at the N- 
or C-terminus of the protein, modification of growth conditions, such as temperature, 
medium or induction time (Jana & Deb 2005; Smith 2007; Sorensen & Mortensen 
2005b). Culture temperature can be dropped from 37°C to 20°C following the 
addition of the induction molecule IPTG and cells can be induced overnight at this 
lowered temperature instead of the regular 2-3 hour induction time at 37°C.  Protein 
expression at reduced temperatures can increase the solubility of aggregation-prone 
recombinant proteins and limit their degradation by proteases (Vasina & Baneyx 
1996). However, around 50% of proteins over expressed in E.coli are still insoluble 
despite the approaches mentioned above, these can be recovered using a 
denaturation/refolding technique (Maxwell et al. 2003).  
Figure 2.3 The amino acid sequence of mouse CIRP.  The hexaHis tag, N-terminal region and 
C-terminal region are shown in red, green and blue respectively. Highlighted regions indicate the 
two RNA binding sequences and amino acid residues chosen for mutagenesis are circled. 
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The aggregates are generally captured by centrifugation. A popular method of 
solubilisation of aggregates is by the addition of concentrated chemical denaturants 
such as guanidine or urea and a reducing agent like DTT to reduce any incorrect 
disulphide bonds(Middelberg 2002). These solubilised aggregated proteins can be 
further purified using chromatography techniques before refolding as contaminants 
can interfere with refolding (Maxwell et al. 2003). Refolding of the protein is initiated 
by the reduction of denaturant concentration by rapid dilution or dialysis with uniform 
mixing. Efficiency of refolding depends on the competition between aggregation and 
correct folding.  For maximum refolding and to minimize aggregation, protein 
concentration should be low around 10-100 µg/ml (Jungbauer & Kaar 2007).  
Renatured protein should be obtained using a minimally complex method with as few 
steps as possible. Chemical denaturation and refolding by dilution or dialysis is a 
simple and repeatable method to obtain soluble protein.  The refolded proteins should 
be analysed to check for correct activity and structure. 
 
Another solubility problem which was investigated can be the formation of inclusion 
bodies on expression and the method of obtaining soluble protein is by inclusion body 
washing. Inclusion bodies are densely packed protein molecules formed from partially 
folded protein intermediates (Singh & Panda 2005). These are found insoluble in the 
pellet following cell lysis. Inclusion body washing helps to isolate and purify the 
aggregates and once isolated the protein can be solubilized and refolded. Protein 
recovery steps include, isolation of inclusion bodies, solubilisation of inclusion 
bodies, refolding, and purification (Ramón et al. 2014; Burgess 2009; Basu et al. 
2011). It is important to wash the inclusion bodies before solubilisation to remove any 
contaminants as these can interfere with refolding. Pellets are washed with a buffer 
containing detergent by resuspending the pellet and homogenizing followed by a 
centrifugation step. This wash can be repeated several times. The washed inclusion 
bodies can then be solubilized using chemical denaturants such as urea or guanidine 
HCl and refolded by dilution or dialysis methods (Basu et al. 2011).  
 
As well as insolubility on expression, in vitro solubility can be a problem i.e. the 
protein precipitating after expression and purification. Many methods have been 
proposed to recover insoluble proteins (Marston & Hartley 1990; Tsumoto et al. 
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2010). Studies by Shu-Ju Hseih showed that CIRP could be partially re-solubilized in 
sodium acetate buffer at pH 4.8 when the precipitate was washed with this buffer as 
CIRP precipitated in vitro after purification.  Additions of some amino acids can 
further improve solubility and stability of protein formulations (Arakawa et al. 2007). 
Addition of the two amino acids arginine and glutamic acid together in particular have 
been shown to enhance the solubility of proteins with poor in vitro solubility 
(Golovanov et al. 2004). The presence of these molecules leads to enhanced crowding 
which suppresses protein-protein association reducing intermolecular interactions 
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2.2 Materials and Methods 
2.2.1 Site-directed Mutagenesis by Overlap Method 
To generate the F9A, F49A and F9AF49A mutants, site directed mutagenesis by the 
overlap method was used, where two set of primers are used in two seperate PCR 
reactions which generate overlapping DNA fragments (figure 2.2). pET28a(+) 
plasmid containing wildtype N-CIRP between the Nde1 and EcoR1 and restriction 
sites (figure 2.1) was used as the template DNA for the PCR reactions. Forward and 
reverse primers (table 2.1) were designed to contain the mutation sequence 
complementary to the region of N-CIRP where the mutation was to be introduced. 
These were paired with T7 promoter forward and T7 terminator reverse primers in 
two separate PCR reactions. Two fragments were produced with overlapping 
sequences containing the desired mutation. The two fragments were mixed and used 
as the template in a PCR reaction using the T7 promoter and terminator primers to 
produce the final fragment (figure 2.2.). To make the double mutant F9AF49A, the 
F9A mutant DNA was used as the template and the F49A mutation was introduced 






2.2.2 Polymerase Chain Reaction 
For the PCR reactions Pfu DNA polymerase (Promega, 3U/µl) or Taq DNA 
polymerase (Roche, 5U/µl) was used. PCR reactions were run in a thermo cycler with 
a heated lid (Techne TC-3000). To produce the two overlapping fragments, Pfu was 
used in the reactions. The primer pairs and DNA template used are described above 
(section 2.2.1). A total reaction volume of 50 µl was used in the PCR tube.  A final 
Primer Name Sequence (5’>3’) Tm 
(°C) 
T7 Promoter Forward TAATACGACTCACTATAGGG 53.2 
T7 Terminator Reverse CTAGTTATTGCTCAGCGGT 54.5 
F9A Forward AGCTTGCCGTGGGAG 53.3 
F9A Reverse CTC CCA CGG CAA GCT TG 57.6 
F49A Forward GAT CCC GAG GCG CTG GGT TTG TC 67.8 
F49A Reverse GAC AAA CCC SGC GCC TCG GGA TC 67.8 
Table 2.1 Primer sequences used for site directed mutagenesis of N-CIRP and their melting 
temperatures. 
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concentration of 0.5 µM of each primer was added from a 5 µM stock.  For the 
dNTPs (Promega 100 mM) a 10 mM stock of dTTP, dCTP, dATP and dGTP was 
used and a final concentration of 20 µM. A maximum of 250 ng of template was 
added to each reaction and 1 unit of Pfu polymerase. Two master mixes were made 
for each reaction and these were mixed together just before placing the tube in the 
instrument. Master mix 1 consisted of the DNTPs, primers and template DNA made 
up to a total volume of 25 µl with sterile water. Master mix 2 contained the 
polymerase and the 10x polymerase buffer, also made up to a total volume of 25 µl. 
The PCR program was as follows: initial denaturation at 95°C for 2 min followed by 
25 cycles of; denaturation at 95°C for 1 min, annealing for 1 min at 5°C below the 
melting temperature of the primer with the lowest melting point extension at 72°C for 
2 min. After the 25 cycles, there was a final extension step at 72°C for 5 min. PCR 
products were analysed on 1% agarose gels (section 2.2.3) and visualised with 
ethidium bromide to confirm that the correct sized product was present. PCR products 
were purified using a PCR clean up (QIAGEN, QIAquick PCR Purification Kit) or 
gel extraction kit (QIAGEN, QIAquick Gel Extraction Kit) following the kit 
protocols. 
 
To produce the full fragment from the two overlapping fragments, Taq polymerase 
was used. Taq polymerase was used for this step as the enzyme adds A tails to the 3’ 
end of the fragments and this was required for the cloning of the fragment into pGEM 
T-easy vector. For the PCR reaction, the T7 promoter and terminator primer pair was 
used. The same protocol as the Pfu polymerase described above was used to set up the 
PCR reaction. For the template DNA, 5 µl of each purified fragment was added into 
master mix 1. The extension time during the 25 cycles was increased to 3 min due to 
size of the final product being longer. Products were analysed on 1% agarose gels 
(section 2.2.3). 
 
2.2.3 DNA Gel Electrophoresis 
1% agarose gels were prepared in TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM 
EDTA, pH 8.5). 0.5 µg/ml ethidium bromide was added to the gel mixture before 
pouring. Wells were loaded with samples prepared with 6x sample buffer (0.4% 
orange G, 0.03% bromophenol blue, 0.03% xylene cyanol FF, 15% Ficoll 400, 10mM 
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Tris, 50 mM EDTA pH 8.0) to a final concentration of 1x. The gels were run in TAE 
buffer at 100 V for 45 min and visualized under UV light. 
 
2.2.4 Cloning of PCR Fragments into the pGEM T-easy Vector System 
The pGEM T-easy vector system (Promega) was used as a convenient system for 
cloning of PCR products (figure 2.4). The vector is linearised with 3’ terminal 
thymidine at both ends to aid the ligation of A tailed products. It makes the restriction 
digestion of the products to give them the correct sticky ends to clone into final 
plasmid easier as restriction digest of small PCR products can be difficult. The vector 
contains T7 and SP6 RNA polymerase promoters within the alpha-peptide coding 
region of the enzyme beta-galactosidase. A successful insert inactivates the alpha-



















Final DNA fragments after the overlap PCR reaction were analysed on agarose gels 
and purified either using a gel extraction or PCR cleanup kit. As Taq polymerase was 
used, the A tailed fragments were ligated directly into the pGEM T-easy vector. 
Figure 2.4 Schematic representation of the pGEM T easy vector map (www.promega.co.uk). 
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Ligation mixes were set up according to the pGEM protocol in a 10 µl volume with 
50 ng of pGEM vector, 3 units of T4 DNA ligase (Promega, 3 U/µl), 2x rapid ligation 
buffer and insert DNA. DNA was quantified using Nanodrop equipment.  Various 
ratios of insert:vector were tested; 5:1, 2:1, 1:1. The amount of insert DNA to be 
added was calculated using the equation 2.1 below. 
 
Equation 2.1:  
 
 ng of vector x kb size of insert   x insert: vector molar ratio = ng of insert 
       kb size of vector 
 
Two different controls were used. One ligation was carried out using the control insert 
DNA provided with the pGEM system as a positive control. One ligation was setup 
using the vector but with no insert added as a negative control to see the amount of 
background self-ligation. Ligation mixtures were incubated for 1.5-2 h at room 
temperature and 3-4 µl were transformed into competent DH5α cells.  100 µl of 
transformed cells were spread onto LB agar plates containing 100 µg/ml ampicillin 
and incubated overnight at 37 °C. For the blue white/screening, the plates were spread 
with 100 mM IPTG and 50 mg/ml Xgal and incubated for 30 min at 37°C before use. 
A transformation control was also set up by transforming DH5α cells with 1 µl of 
plasmid DNA. Any white colonies were checked for the correct size insert by PCR 
screening using the T7 promoter and T7 terminator forward and reverse primers and 
running products on 1% agarose gels. 
 
2.2.5 PCR Screening of Colonies 
For PCR screening, colonies were picked with a sterile 200 µl pipette tip and dipped 
into 50 µl of water and pipetted up and down 2-3 times. The samples were boiled for 
2 min and centrifuged at 13 000 rpm for 2 min. 33 µl of the supernatant was then used 
for the PCR reaction using appropriate primers and Taq polymerase. Cycle and 
temperature settings were set up as described in section 2.2.2. Size of the PCR 
products were then analysed by running on 1% agarose gels. Colonies corresponding 
to the PCR products with the correct size were grown overnight at 200 rpm, 37 °C in 
5 ml/ 10 ml (high copy number pGEM/low copy number pET28a) of LB containing 
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100 µg/ml ampicillin (pGEM) or 50 µg/ml kanamycin (pET28a) for DNA extraction 
using the miniprep kit (QIAGEN, QIAPrep Spin Miniprep Kit). The extracted DNA 
was then sent off for sequencing for further confirmation (Beckman Coulter 
Genomics). 
 
2.2.6 Restriction Enzyme Digestion 
To isolate the N-CIRP mutant DNA fragment from the pGEM T-easy vector, 
restriction enzyme digestion was used with Nde1 and EcoR1 (Roche) enzymes. 1 µg 
of DNA was cut using 1 unit of each enzyme in a 10-20 µl reaction volume in buffer 
H.  The reaction was incubated at 37°C for 1 h as recommended by the supplier.  To 
purify the excised fragment, the entire reaction volume was run on a 1% agarose gel. 
The gel piece containing the fragment was cut out and purified using a gel extraction 
kit. 
 
2.2.7 Ligation of DNA Fragments into pET28a (+) Vector 
For the expression of the N-CIRP mutants, the fragments were cut out from the 
pGEM T-easy vector and ligated into the pET28a (+). Prior to ligation, the pET28a 
(+) vector was linearized by digesting with the EcoR1 and Nde1 enzymes and purified 
using the methods described above (section 2.26).  A ratio of 15:1 (insert: vector) was 
used as suggested in the pET manual in 10 µl reaction (vector quantity = 50 ng).   1 µl 
of T4 DNA ligase was added per reaction and the samples incubated for 1.5-2 h at 
room temperature. After incubation, 3-4 µl of the ligation mix was transformed into 
competent DH5α cells.  Negative (no insert) and positive (1 µl of plasmid DNA) 
controls were also included. 100 µl of transformed cells were spread on LB agar 
plates containing 50 µg/ml kanamycin and incubated overnight at 37°C. Colonies 
were checked by PCR screening using the T7 promoter and T7 terminator forward 
and reverse primers as described above (2.2.5).  Constructs with correct sequences 
were transformed into BL21 (DE3) cells for protein expression and purification. 
 
2.2.8 Competent Cells 
DH5α competent cells were generated for the purpose of DNA extraction from cells 
for cloning and DNA amplification. BL21 (DE3) competent cells were generated for 
protein expression. LB agar plates not containing antibiotics were streaked with BL21 
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or DH5α glycerol stocks and incubated at 37°C overnight. 50 ml of super optimal 
broth (SOB) medium was inoculated with a single colony and shaken at 150 rpm, 
37°C until an A600 of 0.4-0.5 was reached. Cells were harvested by centrifuging at 
3000 rpm for 15 min. The pellet was resuspended in 25 ml of ice cold 50 mM CaCl2 
and incubated on ice for 30 min.  Cells were then pelleted by centrifuging at 3000 rpm 
for 15 min and resuspended in 2 ml of ice cold 50 mM CaCl2.  50% (v/v) sterile 
glycerol was added to a final concentration of 10% and cells were divided into 100 µl 
aliquots in microfuge tubes. The aliquots were flash frozen in liquid nitrogen and 
stored at -80°C. 
 
2.2.9 Transformation 
Aliquots of competent cells in microfuge tubes were thawed on ice and 1 µl of DNA 
were added to 30 µl of cells and gently mixed. The cells were incubated on ice for 10 
min followed by a heat shock treatment in a 42°C water bath for 45 s.  Cells were 
returned to ice for 5 min, 200 µl of LB medium was added and the cells shaken at 150 
rpm and 37°C for 45 min to 1 h. Several dilutions of transformed cells were spread on 
to LB agar plates containing 50 µg/ml kanamycin (Sigma) and incubated in a static 
incubator overnight at 37 °C.  
 
2.2.10 Glycerol Stocks 
For the generation of glycerol stocks 50 ml LB medium containing 50 µg/ml 
kanamycin was inoculated with a single colony of the transformed BL21 cells. The 
cells were incubated with shaking at 200 rpm, 37°C until an A600 of 0.5-0.6 was 
reached. 500 µl of the culture was removed and placed into a cryo tube, 50% (v/v) 
sterile glycerol was added to a final concentration of 10%. Cells were flash frozen in 
liquid nitrogen and stored at –80 °C. 
 
2.2.11 Protein expression 
LB agar plates containing 50 µg/l kanamycin were streaked with glycerol stocks of 
BL21 cells transformed with pET28a (+) plasmid containing the full-length CIRP, N-
CIRP or N-CIRP mutant gene. Plates were incubated overnight at 37°C. For N-CIRP 
and N-CIRP mutant expression, cells were grown in minimal media (appendix A) 
containing (
15
NH4)2SO4. For all full-length CIRP and unlabelled preparations of N-
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CIRP and N-CIRP mutants, the same procedures were followed using LB media. 50 
ml of minimal media containing 50 µg/l kanamycin and 0.6 g/l (
15
NH4)2SO4 was 
inoculated with a single colony from the LB plates grown overnight.  The culture was 
incubated by shaking at 200 rpm and 37°C until A600 reached 0.6-1.0.  Cells were 
pelleted by centrifuging at 3000 rpm for 15 min and the pellet resuspended in 1ml of 
fresh minimal medium. The resuspended cells were used to inoculate a 1 l main 





The culture was incubated by shaking at 200 rpm, 37°C, until A600 reached 0.6.  When 
an A600 of 0.6 was reached, 1 mM IPTG was added to induce protein expression and 
the culture incubated further for 2.5-3 h. Before the addition of IPTG, a 500 µl pre-
induction sample was taken and the cells pelleted by centrifuging at 13000 rpm for 5 
min. Pellets was stored at -20°C for analysis by SDS-PAGE. Following induction, a 
500 µl post-induction sample was taken from the culture. Cells were harvested by 
centrifuging at 10000 rpm for 15 min at 4°C (Beckman Coulter Avanti J-25, JA10 
rotor). The pellet was resuspended in 25 ml of 20 mM sodium phosphate buffer 
containing 0.5 M sodium chloride, pH 7.3 (lysis buffer), and frozen at -20°C for lysis. 
 
For small-scale expression of full-length CIRP, a main culture of 50-200 ml LB 
containing kanamycin was used without a starter culture and induced at A600 of 0.6. 
Amount of lysis buffer to take up the harvested cells was adjusted in proportion to 
culture size.  
 
2.2.12 Cell Lysis 
Lysis was carried out to recover soluble proteins from the cells for the purification of 
full-length CIRP, N-CIRP or N-CIRP mutants. For lysis, the frozen, resuspended 
pellet was thawed at room temperature.  Lysozyme was added to a final concentration 
of 100µg/ml from a 10mg/ml stock in lysis buffer and 5% (v/v) Triton X-100 in lysis 
buffer was added to a final concentration of 0.1%. The lysate was mixed and 
incubated at room temperature for 20-30 min. At the end of the incubation, 2 M 
MgCl2 was added to a final concentration of 10 mM and 2 mg/ml DNase1 to a final 
concentration of 20 µg/ml. The lysate was incubated for a further 20-30 min at room 
temperature until the viscosity was reduced.  A 500 µl total lysate sample was taken 
for analysis by SDS-PAGE. To separate the soluble fraction, the lysate was 
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centrifuged at 13000 rpm, 4°C for 15 min (Beckman Coulter, Avanti J-25, JA25.50 
rotor). The supernatant was stored on ice for further purification. The pellet was 
resuspended in 25 ml lysis buffer. 500 µl samples were taken from both the pellet and 
the supernatant for SDS PAGE analysis. 
 
2.2.13 Nickel Affinity Chromatography Purification 
Full-length CIRP, N-CIRP and N-CIRP mutants were purified by nickel affinity 
chromatography using the His tag derived from the pET28a (+) vector. Nickel-bound 
chelating sepharose was used to purify hexaHis-CIRP and hexaHis-N-CIRP. A 3 ml 
column was prepared from 6 ml of 50% slurry of chelating sepharose fast flow (GE 
Healthcare UK Ltd.). The column was allowed to flow by gravity. Before use, 5 
column volumes (CV) of water was passed through to remove the storage solution 
(20% ethanol). The column was charged with 2 CV of charging solution (0.2 M nickel 
sulphate). 3 CV of water was then passed through to wash off unbound Ni
2+
 ions, 
followed by 5 CV of acidic buffer (20 mM sodium acetate, 0.5 M NaCl, pH 4). The 
column was then equilibrated with 5 CV of equilibration buffer (20 mM sodium 
phosphate, 0.5 M NaCl, pH 7.4) and the lysate was loaded on to the column. 5 CV of 
equilibration buffer was passed through following loading followed by 8 CV of wash 
buffer (20 mM sodium phosphate buffer, 0.5 M sodium chloride, 60 mM imidazole, 
pH7.4) to remove loosely bound proteins. To elute N-CIRP or N-CIRP mutants, 8 CV 
of elution buffer (20 mM sodium phosphate, 0.5 M sodium chloride, 150 mM 
imidazole, pH 7.4) was used and 2 ml fractions were collected. When purifying full-
length CIRP, 8 CV of EDTA buffer (20 mM sodium phosphate, 0.5 M sodium 
chloride, 20 mM EDTA pH 7.4) was used.  
 
After use, column was then stripped with 3 CV of strip buffer (20 mM sodium 
phosphate, 0.5 M sodium chloride ,20 mM EDTA), was washed with 10 CV water 
and stored in 20% ethanol. The collected fractions and the flow through from the 
loading of the lysate were analysed by SDS-PAGE. The fractions containing CIRP 
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2.2.14 Urea Nickel Affinity Chromatography Purification 
To purify full length CIRP in the presence of urea, the same procedure was followed 
as described in section 2.2.13 with the change that the acidic, wash, equilibration and 
the EDTA elution buffers was made with the addition of 6M urea and 1 ml fractions 
were collected of the elution. 
 
2.2.15 Dialysis 
Dialysis tubing (Medicell Membranes Ltd, MWCO = 12-14000 Daltons) was 
prepared by boiling for 10 min in 500 ml of soaking buffer (1 % w/v sodium 
bicarbonate, 10 mM EDTA, pH 8.0).  The  tubing was then rinsed with water and 
boiled in water for 5 min. Tubing was stored in 20% ethanol at 4°C. Dialysis was 
carried out with stirring overnight at 4°C against 2 l of buffer unless stated otherwise.  
 
2.2.16 Inclusion Body Wash 
For the inclusion body washing procedure, 50 mM Tris-HCl, 10 mM EDTA, 0.5 % 
Triton X100, pH 8.0 was used as the wash buffer.  The lysis pellet which had been 
resuspended in lysis buffer following centrifugation and frozen, was thawed at room 
temperature. It was centrifuged at 13000 rpm for 15 minutes and the supernatant 
removed.  The pellet was resuspended in 12.5 ml of inclusion body wash buffer and 
homogonised with a glass homogeniser for 5 minutes and centrifuged at 12000 rpm 
for 5 minutes. The supernatant was removed and stored on ice. The wash procedure 
was repeated once with wash buffer and once with water. The final pellet of inclusion 
bodies was resuspended in 2.5 ml water. Samples were taken from the pellets and 
supernatants at the end of each step for SDS-PAGE analysis. 
 
2.2.17 Protein Refolding  
After solubilising CIRP in urea, it was refolded by diluting the concentration of the 
urea present. This was done by either dilution or dialysis.  For dilution, the protein 
sample in 6 M urea was added dropwise into refolding buffer. The volumes used were 
dependant on the protein concentration and are described in the results section. For 
the dilution method the protein was added drop wise while stirring into refolding 
buffer 50 mM Tris, 100 mM NaCl, 50 mM Arg, 50 mM Glu pH 7.4, to reduce the 
concentration of urea from 6 M to 200 mM. This was stirred overnight at 4°C. The 
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total volume was then concentrated down to 2ml using spin concentrator and 20 ml of 
refolding buffer was added to further reduce the urea concentration to 2 mM. The 
total volume was then concentrated to 2 ml again. To remove the urea with dialysis, 
the purified sample was dialysed in two steps. First step reduced urea concentration to 
200 mM and the second down to 6.7 mM. Each step was an 8 hours dialysis at 4 °C 
with stirring. The diluted sample was stirred overnight at 4°C to allow the protein  to 
refold. The sample was then  concentrated using spin concentrators and then buffer 
exchanged by adding the same volume of refolding buffer as the first step. The 
refolded protein was then concentrated to 0.5 mg/ml (Vivaspin 20 concentrator, 
10,000 MWCO, Sartorius).  
 
2.2.18 Anion Exchange Chromotography Purification 
Anion exchange was carried out on an AKTA FPLC purification system (Amersham 
Pharmacia Biotech). A 3 ml anion exchange  column was prepared with quaternary 
ammonium (Q) Sepharose Fast Flow (GE Healthcare UK Ltd.) media. A flow rate of 
2 ml/min was used throughout the purification process. All buffers were degassed and 
filtered through a  0.45 µm nitrocellulose membrane. The column was washed with 
water initially to remove the 20% ethanol storage solution. It was then equilibrated 
with 5 CV of equilibration buffer (20 mM Tris-HCl, pH 8.0). The sample was filtered  
(0.45 µm membrane) and loaded via a 50 ml superloop. 2 ml fractions of the flow 
through were collected. Following loading, the column was washed with 5 CV 
equilibration buffer. The elution buffer used was 20 mM Tris-HCl, 0.5 M sodium 
chloride pH 8.0. To elute the protein, a linear gradient of 0-0.5M NaCl was used over  
20 CV, followed by a further 5 CV of the high salt solution. The elution was collected 
in 1 ml fractions.  Protein was detected by absorbance at 280 nm and fractions 
containing protein were  analysed by SDS-PAGE.  
 
2.2.19 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE)  
Protein samples were analysed using a discontinuous gel system containing a 
resolving (12.5% or 15% acrylamide, 375 mM Tris-HCl, pH 8.8, 0.1% SDS, 0.1% 
ammonium persulfate and 0.02% TEMED) and stacking (4% acrylamide, 125 mM 
Tris pH 6.8, 0.1% SDS, 0.1% ammonium persulfate and 0.02% TEMED) gel. For 
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full-length CIRP samples, 12.5% gels were used, and 15% for N-CIRP and mutants. 
Samples were prepared in reducing sample buffer (50 mM Tris-HCl, pH 6.8, 100 mM 
dithiothreitol, 2% SDS, 0.1% bromophenol blue, 10% glycerol) and boiled for 3 min 
before loading. Gels were run using Tris-glycine running buffer (25 mM Tris-HCl, 
250 mM glycine, 0.1% SDS, pH 8.3) at 100 V and stained with coomassie brilliant 
blue R-250 (0.2% coomassie R-250, 50% methanol, 10% acetic acid) and destained 
with a solution of 10% methanol and 10% acetic acid.  Gels were stored in water. 
 
2.2.20 Quantifying Protein Concentration  
To quantify the amount of purified protein (N-CIRP or N-CIRP mutants) band 
intensities on SDS-PAGE were compared with intensities of known standards 
(lysozyme). Varying amount of lysozyme was loaded on the gel from 0.5 µg to 4 ug 
and different amounts of N-CIRP was also run on the same gel. After the gels were 
stained, they were scanned and the intensity of all bands was estimated using the 
software ImageJ. A standard curve was constructed from lysozyme samples, which 





















2.3.1 Site-directed Mutagenesis 
For RNA binding experiments of N-CIRP, three mutant constructs were generated; 
F9A, F49A and F9AF49A.  These residues were selected for mutation as they were 
identified as the key residues for binding in the RNA binding sequences RNP1 and 
RNP2 (figure 2.3). They were changed to an alanine removing the aromatic ring, 
which contributes to the binding of the RNA ligands to N-CIRP.  
 
2.3.1.1 Generation of Mutant DNA Fragments by Overlap PCR 
6 PCR reactions were run, to produce two overlapping fragments for the mutants 
F9A, F49A and F9AF49A. Two fragments with overlapping 5’ and 3’ ends of 
expected size were amplified successfully by PCR for all three mutants. The 
overlapping upstream and downstream DNA fragments were purified. The expected 
full-length fragment for all 3 mutants was 540 bp, which was the length of DNA to be 
amplified between the T7 promoter and T7 terminator. The full-length fragments were 
successfully generated and analysis of the PCR products on a 2% agarose gel showed 
a band between the 500 and 600 bp markers matching the expected size. Figure 2.5 
shows the overlapping fragments generated for the F9A mutants and the final product 
























1 2 3 4 
Figure 2.5 2% agarose gel showing the overlapping  PCR products and the full-length 
fragment for the F9A mutant. Lane 1: 100 bp ladder, lane 2: downstream fragment (expected 
size: 369 bp), lane 3: upstream fragment (expected size: 184 bp), lane 4: PCR product from the 
overlap reaction (expected size: 540 bp) indicated by red arrow.!
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2.3.1.2 Cloning Mutant DNA Fragments into pET28a(+) vector via the pGEM T-
easy system 
The pGEM T-easy system was used as a method in between the generation of DNA 
fragments by PCR and cloning of the fragments into the final plasmid pET28a(+).The 
ligation reaction set up with a 5:1 molar ratio (insert:vector) was found to be 
successful and this ratio was used for subsequent ligations of all 3 mutants. White 
colonies were observed on the transformation plates and these were checked for the 
correct inserts by PCR colony screening. 
 
PCR products from many of the screened colonies showed bands between the 500 and 
600 bp marker around the correct expected size of 540 bp for all 3 mutants. An 
example PCR colony screen for the F9AF49A mutant is shown by figure 2.6(a) and 
similar results were seen for the other two mutants. DNA from the positive colonies 
was taken for double restriction digest with the Nde1 and EcoR1 enzymes to isolate 
the N-CIRP DNA for cloning into the pET28a (+) vector.  An example gel is shown 
in figure 2.6(b) for the digestion of pGEM T-easy vector with the F9AF49A mutant 
insert. The analysis of the digested plasmid on agarose gel showed a main band for 
the positive clones at around 260 bp (figure 2.6 (b)), which was as expected as the 
size of the N-CIRP DNA between the two restriction sites was calculated to be 263 
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Figure 2.6 2% agarose gels. (a) PCR products from colony screen of the F9AF49A mutant 
fragment ligations into pGEM T-easy plasmid. Arrow indicates the position of the correct sized 
inserts. Lane 1: 100 bp ladder, lane 2: positive control, lanes 3-10: PCR product from screen of 
colonies 1-8. (b) Restriction digest of the pGEM T-easy vector containing F9AF49A mutant 
DNA insert with Nde1 and EcoR1 enzymes.  Bands belonging to N-CIRP fragments are shown 
by the red arrow. Lane 1: 100 bp ladder, lane 2-5: clones 1-4. 
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2.3.2 Expression and purification of WT N-CIRP and Mutants 
2.3.2.1 Growth, Induction and Cell Lysis  
Once the sequence of the mutants in the pET28a (+) vector had been confirmed, 
plasmids were transformed into BL21 (DE3) E.coli cells for protein expression. In the 
wild-type pre-induction sample (figure 2.7 (a)), N-CIRP expression was absent but in 
the post-induction sample which was taken from the culture after 2.5-3 h of induction, 
a band was observed at the expected size of N-CIRP (11.6 kDa). Supernatant and 
pellet samples taken after centrifugation showed that there was very little N-CIRP in 
the pellet and a band similar to intensity of the band seen in total lysate sample was 
observed in the supernatant suggesting that all recombinant N-CIRP is soluble. This 
supernatant fraction was then taken forward to isolate N-CIRP from the rest of the 
soluble proteins. Post induction expression levels and behaviour of the mutants was 
similar to that of the wild type although a small amount of each (<10%) remained in 




























































































































































Figure 2.7 15% Reducing SDS PAGE analysis of pre/post induction, total lysate, lysis 
supernatant and lysis pellet samples of wild type N-CIRP and N-CIRP mutants (a) Wild type 
(b) F9A mutant (c) F49A mutant (d) F9AF49A mutant. Red arrow indicates the N-CIRP band. 
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2.3.2.2 Nickel Affinity Chromatography Purification 
WT and mutant N-CIRP was purified from the lysis supernatants by nickel affinity 
chromatography. The nickel affinity chromatography profile of the mutant F9AF49A 














All the protein loaded on to the nickel affinity column had bound as no N-CIRP 
protein was seen in the flow through sample on the gel (figure 2.8). There were a 
large number of proteins in the 60 mM Imidazole wash but no N-CIRP was seen here 
as the purpose of the low concentration imidazole wash is to remove loosely bound 
proteins. To elute N-CIRP, 150 mM Imidazole was used, the elution fractions on the 
gel showed that all of the protein eluted in 12 fractions. N-CIRP bands at the correct 
size were observed as well as some high MW contaminants.  The WT protein and all 
3 mutants showed a very similar elution profile with bands of similar intensity i.e. a 
similar amount of protein (figure 2.8). Fractions containing wild type or mutant N-




































Figure 2.8 15% Reducing SDS PAGE analysis of nickel affinity purification of F9AF49A N-
CIRP mutant.  
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2.3.2.3 Ion Exchange Chromatography Purification 
The pooled fractions from nickel affinity chromatography of wild type N-CIRP and 
all three mutants were buffer exchanged by dialysis. The elution profile of the F9A 























The elution profile of the F9A protein showed that N-CIRP eluted in a single peak 
(figure 2.9 (a)). A low concentration of salt was adequate to elute the protein from the 
IEX matrix. There was a small increase in the absorbance during loading, suggesting 
some protein was present in the flow through, however SDS-PAGE analysis showed 
no presence of N-CIRP in this fraction. A broad peak with a lower absorbance than N-
CIRP appeared later on in the gradient. All 3 mutants and wild type showed a very 
similar profile. The proteins were eluted at the same point of the gradient as the wild 
type over 18-20 fractions (figure 2.9 (a)). The SDS-PAGE analysis showed a purified 
Figure 2.9 (a) Ion exchange chromatogram and (b) 15% reducing SDS-PAGE analysis of 
individual fractions taken from the purification of N-CIRP mutant F9A. Elution fractions were 
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N-CIRP band for the wild type and the mutants at the correct molecular mass (figure 
2.9 (b)). The fractions containing N-CIRP or mutants were pooled (18-20 ml). 
 
2.3.2.4 Mass spectrometry analysis of WT N-CIRP and mutants 
The mass of the purified wild type and mutant proteins were determined by 
electrospray mass spectrometry. The theoretical mass was calculated using the 
ExPASy ProtParam tool. The expected average mass for the wild type was 11488.6 
Da with the N-terminal methionine removed. For the F9A and F49A mutants, the 
calculated value was 11412.6 Da, 76 Da less than the wild type as this is the 
difference between the mass of a phenyalanine and alanine residue. For the F9AF49A 
mutants the expected mass was 11336.6, 152 Da less than the wild type as two 
phenylalanines are changed to alanines.  
Two major peaks were seen on all of the spectra (figure 2.10). The major peak being 
the expected product for the wild type and the mutants. The second peak was 178 Da 
bigger than the main product consistent with  the His-tag modification (alpha-N-6-
phosphogluconoylation) previously observed in E.coli (Geoghegan et al. 1999), this 
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2.3.2.5 Protein Concentration Estimation 
To estimate the amount of protein expressed at the end of each prep, increasing 
amounts of protein from 2.5 µl to 10 µl was run on a SDS PAGE gel alongside some 
known protein standards (figure 2.11(a)).  The amount of protein had to be estimated 
in this way as N-CIRP does not possess any tryptophan residues, so estimation by 
absorbance could not be carried out as this is the usual method. 
 
Image J analysis allowed quantification of the staining density of each band, which 
was used to construct a standard curve from the know amounts of lysozyme loaded on 
the gel (figure 2.11 (b)). R
2 
values for the fits were 0.97-0.99 in every calculation.  
The equation of the line was used to estimate the amounts of N-CIRP. A 1 l culture 




































































































Figure 2.11 (a) 15% Reducing SDS-PAGE for the estimation of the amount of N-CIRP 
protein expressed and purified using lysozyme standards. (b) Lysozyme standard curve.!
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2.3.3 Expression and Purification of Full-Length CIRP 
2.3.3.1 Small Scale expression and Purification 
A small test expression of full-length CIRP was carried out in 50 ml LB media.  
 
The calculated theoretical mass of CIRP is 20797.3 Da. In the pre-induction sample, 
there were no bands at the expected size for CIRP. The post induction sample showed 
that CIRP was expressed. A band just below the 20 kDa marker (figure 2.12) was 
seen running at a slightly smaller size than expected. After lysis CIRP was observed 
in the total lysate sample. The intensity of the CIRP band was reduced in the lysate 
supernatant and a small amount of CIRP was remaining in the lysis pellet. The lysate 
supernatant sample was purified by nickel affinity chromatography on a 1 ml small-
scale purification column and 1 ml fractions of the elution was collected. Out of the 
15 elution fractions collected, 3 of them contained small amounts of CIRP. Due to the 
low yields, SDS-PAGE gels are not shown here. These fractions from nickel affinity 
purification was analysed by mass spectrometry (figure 2.12). A peak was present at 
the correct size (20796.58 Da) for CIRP. Various other peaks were also present 
indicating the presence of other proteins in the sample. All of the other peak masses 
were identified as CIRP fragments by using the ExPASy FindPept tool confirming 






























Figure 2.12 ESI-mass spectrum of nickel affinity purified full-length CIRP and 12.5% SDS 
PAGE analysis of the small-scale expression of full-length CIRP, pre and post induction. 
CIRP band indicated by red arrow.!
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2.3.3.2 Effect of protease inhibitors, expression temperature and sonication on 
CIRP 
To inhibit the degradation of CIRP and to increase the amount of CIRP in the soluble 
fraction, expression at lower temperatures was tested and lysis was carried in the 
presence of protease inhibitors. The effect of sonicating the lysate to aid cell lysis was 
also investigated. A small-scale expression was carried out in 200 ml LB media. For 
lower temperature expression, the culture temperature was lowered to 20°C following 
the addition of IPTG and cells were induced overnight instead of for 2.5-3 hours. For 
the additional sonication step, the original lysis procedure was followed as normal, 
but prior to the centrifugation step to separate the soluble and insoluble fractions of 
the lysate, the lysate was sonicated on ice for 2 min. To test the effect of protease 
inhibitors, at the end of induction at 37°C, the culture was divided into two and 
harvested as normal. Each harvested cell pellet was taken up in 5 ml of lysis buffer 
with/without protease inhibitors (Roche- Complete Mini Protease inhibitor cocktail 
tablets).  
 
The total lysate sample without and with inhibitors  (figure 2.13(a)) contains a similar 
amount of CIRP protein. When the lysis supernatant samples were compared, the 
sample which includes the inhibitors had a larger amount of CIRP compared to the 
sample without inhibitors. The same conclusion was also made for the lysis pellet 
samples. Sample with the inhibitors showed more total protein as well as CIRP 
protein. Some of the CIRP protein expressed remained insoluble in the pellet. As the 
culture size increased, the ratio of soluble: insoluble CIRP decreased. Induction at 
20°C lead to an increase in the amount of CIRP protein expressed as well as total 
protein in the cells (figure 2.13(c)). When the amount of CIRP in the lysis pellet 
compared to the lysis supernatant was compared between 37°C (figure 2.13(b)) and 
20°C, a higher proportion of CIRP was seen in the pellet vs. the supernatant for the 
20°C expression compared to 37°C. About 10% of total CIRP was in soluble in the 
lysis pellet when expressed at 20°C whereas this number was about 30% at 37°C 
expression. Sonication of the total lysate lead to small increase in the amount of CIRP 
that remained soluble in the lysis supernatant, this was increased in the 37°C 
expression sample. 
 










2.3.3.3 Large Scale Expression and Purification 
 To provide material for further characterization studies on full-length CIRP, large-
scale expressions were carried out in 1-liter of LB media.  
 
Full length CIRP was successfully expressed in a 1-litre culture (Figure 2.14(a)). The 
total lysate sample showed a band for CIRP similar to the post induction sample. A 














The small amount of remaining soluble CIRP in the supernatant was purified.  SDS 
PAGE analysis of the nickel affinity fractions showed that there was some CIRP in 
Figure 2.13 12.5% SDS PAGE analysis of the effect of low temperature expression, sonication 
and protease inhibitors on CIRP degradation. (a) Effect of protease inhibitors, the -/+ notations 
indicate the absence and presence of protease inhibitors (b) 37°C expression (c) 20°C expression, 
the -/+ notations indicate not sonicated and sonicated samples. CIRP band position is indicated by 
red arrow. 
Figure 2.14 12.5 % SDS PAGE analysis of expression and lysis (panel a) and purification 
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the flow through of the load so not all of it bound to the column and some was also 
washed out in the wash fractions (figure 2.14(b).  The protein that was bound to the 
column was eluted over 8 fractions. 5 out of the 8 fractions, which were the fractions 
that contained the most protein as seen from the SDS PAGE analysis, contained some 
precipitate upon short storage (approx. 1 h at 4°C). The fractions containing the 
aggregates were centrifuged and the supernatants were taken off and pooled together. 
The pellets were resuspended in the same volume of buffer as the original fraction (1 
ml) and pooled together.  The soluble fractions were then dialysed overnight into 50 
mM sodium acetate pH 4.8 buffer as previous studies by Shu-Ju Hsieh had shown that 
CIRP is more stable and soluble in this buffer condition. At the end of the dialysis 
process more precipitates had formed, the precipitates were pelleted by centrifugation 
and the supernatant was removed. The insoluble and soluble fractions before and after 
dialysis were analysed by SDS PAGE. 
 
The pooled soluble fractions of CIRP (figure 2.15(a)) contained some CIRP protein 
but also contaminating proteins as well. After dialysis, the majority of this protein 
remained soluble in the sodium acetate buffer.  The analysis of the precipitate seen 
after dialysis showed that a very small amount of CIRP protein was present in this 
precipitate but this was very small compared to the fraction that remained soluble. 
Analysis of the precipitate observed in the elution fractions after nickel affinity 
showed that it contained a large proportion of the CIRP protein, this insoluble protein 
did not contain any contaminants and was quite pure (figure 2.15 (a)). Approximately 
60% of CIRP precipitate was soluble after resuspending in the sodium acetate buffer 
(figure 2.15(b)). The total amount of soluble CIRP protein was estimated to be 800 µg 
at a concentration of 400 µg/ml. To test the optimal storage conditions for the protein, 
it was divided into two. One half was stored at 4°C and the other half at -20 °C for a 
week (figure 2.15(c)).  CIRP which was stored at 4°C showed degradation products 
on the gel. Storage at -20°C did not show any degradation, however, the amount of 




















It was noted that one of the degradation products seen on the gel was at 13-14 kDa. 
This is 1-2 kDa larger than the size of the N-terminal region. As the C-terminal region 
is natively disordered it was thought that it could be this region undergoing 
proteolysis. To confirm this, the CIRP sample that was stored at 4°C which showed 
degradation (figure 2.15(c)) was run through a small nickel affinity column. As CIRP 
contains an N-terminal His tag, the degradation product would bind to the column if it 
were the N-terminal region of the protein.  
 
SDS PAGE analysis of the nickel affinity purification showed that all of the 13-14 
kDa product bound to and could be eluted from the Ni
2+
 affinity column (figure 2.16). 
This behaviour suggests that this fragment is the N-terminal region of CIRP. By the 
time this experiment was carried out, all full-length protein had degraded; therefore 
the samples on gel do not contain any full length CIRP. Fractions were analysed by 
mass spectrometry (figure 2.16). Various peptides between 13 and 15 kD were present 
and no full length CIRP was present. The position of these peptides in the CIRP 
amino acid sequence were estimated by using the ExPASy FindPept tool, the results 
showed that most the peptides found in the sample were consistent with the N-






Figure 2.15 12.5% SDS PAGE analysis of soluble and insoluble CIRP and re-solubilisation. 
(a) Soluble and insoluble fraction analysis following nickel affinity purification, followed by 
dialysis in sodium acetate. (b) Resolubilisation of insoluble protein following nickel affinity in 
sodium acetate. (c) Resolublised N-CIRP storage at 4°C and -20°C. CIRP band position is 












































































































































































































































Figure 2.16 Analysis of the purified CIRP degradation products by nickel affinity 
chromatography and ESI mass spectrometry.!
Table 2.2 Peptides identified in CIRP degradation products and their position in the protein 
sequence. The masses which include the His tag are shown in red.  
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2.3.3.4 Effect of Arginine and Glutamic Acid on Solubility of CIRP 
As described in the previous section 2.3.3.3, CIRP precipitated in the fractions eluted 
from Ni-affinity chromatography and a proportion of this precipitate could be re-
solubilised in sodium acetate buffer. The amino acids arginine and glutamic acid (50 
mM of each) were added to the sodium acetate buffer to investigate their affect on 
CIRP solubility. 
 
When the buffer containing Arg and Glu was compared with the buffer without Arg 
and Glu, there was only a small difference between the amounts of protein that re-
solubilised (figure 2.17).  The buffer containing Arg and Glu contained a little more 

























Figure 2.17 The effect of arginine and glutamic acid on CIRP solubility. CIRP was 
resolubilised in sodium acetate buffer with (+) or without (-) Arg and Glu following precipitation 
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2.3.3.5 Inclusion Body Washing of Lysis Pellet To Recover CIRP 
Following lysis, a large proportion of the CIRP protein was found to be in the lysis 
pellet. The amount of protein which could be purified from the lysis supernatant was 
not enough for further experiments and hence experiments were carried out to try and 
recover the CIRP from the lysis pellet.  
 
The CIRP protein in the lysis pellet was unexpectedly solubilized by the inclusion 
body wash buffer (figure 2.18(a)). After each wash, approximately 50% of the CIRP 
protein in the pellet was solubilised. After wash 2, the majority of the protein had 
been solubilised and after wash 3 almost no CIRP was left in the pellet.  
 
The supernatants of the inclusion body washes 1 and 2 were pooled together and 
dialysed overnight into the nickel affinity equilibration buffer for purification.  
Majority of the CIRP from the inclusion body wash remained soluble through dialysis 
(figure 2.18(b)).  There was a small amount of CIRP in the aggregate seen in the 
sample after dialysis. The soluble fraction after dialysis was purified by nickel affinity 
chromatography. The elution fractions had some aggregates in them. Each fraction 
was centrifuged and the pelleted aggregates were resuspended in 1ml sodium acetate 
buffer as described previously. However, the aggregates were not successfully re-















Figure 2.18 12.5 % SDS PAGE analysis of CIRP lysis pellet inclusion body washes and 
purification of solubilised CIRP. (a) Inclusion body washing of CIRP lysis pellet, W= wash (b) 
Dialysis, purification and solubilisation of CIRP recovered by inclusion body washing. CIRP band 
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2.3.3.6 CIRP Refolding Experiments  
Another approach taken to recover soluble CIRP was by denaturation of the inclusion 
bodies with urea and refolding by dilution. Urea was added to the wash buffer 
solubilized lysis pellet and the CIRP protein purified in the presence of the denaturant 
to avoid multiple precipitation and re-solubilisations of the protein and therefore also 
minimizing the amount of protein loss throughout the different steps.  Once the 
protein was purified, it could then be refolded by diluting the denaturant present.  
 
Similar to previous purifications without urea, some CIRP protein was seen in the 
flow through of the load, which had not bound to the column (figure 2.19(a)) The 
protein was eluted with EDTA and CIRP was found to have eluted over 8 fractions 
similar to previous purifications. Two methods of refolding were tested, these were 
dilution and dialysis. At the end of both techniques the final refolded sample had a 

















Both methods of refolding showed formation of large amounts of aggregated protein 
upon the dilution of the urea concentration. CIRP protein did not remain soluble when 
the urea was removed. The dialysis refolding method showed that a very small 
amount of CIRP was still soluble (figure 2.19(b)) but most of the protein precipitated. 


























































































(a) (b) Elution!Fractions!3*11 
Figure 2.19 12.5% SDS PAGE analysis of the 6 M urea nickel affinity purification and 
refolding. (a) Nickel affinity purification in the presence of urea fractions (b) Refolding of CIRP 
by removing urea using the dialysis or the dilution method.!
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urea was removed. It was also noticed that the amount of precipitated CIRP was much 
less than the initial total protein so some protein was lost. This could be due to use of 


































In this chapter, the generation of the N-CIRP mutants and the process by which the 
wild type N-CIRP and mutants were expressed and purified was described. To 
generate the mutants, a PCR-based site-directed mutagenesis method was used. The 
residues F9 and F49 were both changed to alanine, removing the aromatic ring, which 
is a key element for binding (chapter 1, section 1.4.2). A double mutant was also 
made containing both mutations.  The DNA overlap fragments upstream/downstream 
of the mutation were made successfully for all mutants after some primer 
optimization. The full-length fragment was successfully generated for the F9A 
fragment. However, initially no product was made from the overlap reaction for the 
F49A mutants. The annealing temperature required for the overlap regions must be 
taken into consideration when using this method. A new step to the PCR program was 
introduced where 5 cycles would run prior to 25 main cycles and these 5 cycles were 
set to have a low annealing temperature of 43°C compared to the 48°C of the main 
cycles. The overlap primers used had a Tm of 67.8°C which corresponds with the Tm 
of the region of overlap so the need for a temperature of 43°C for annealing of this 
region was unexpected. However this approach successfully produced the full 
fragment for the F49A mutant. Full length fragments were successfully cloned into 
the pET28a(+) plasmid successfully via the pGEM T-easy system. The constructs 
were confirmed by PCR screening and DNA sequencing.  
 
Wild type N-CIRP and all mutants were expressed successfully. 
15
N was added to the 
expression media as the sole nitrogen source for NMR experiments. Post induction 
samples showed a band for N-CIRP and mutants at the expected size of 11.6 kDa, 
therefore the mutations had no effect on the expression of the protein.  Wild type N-
CIRP and mutants remained stable throughout the lysis procedure and there was no 
evidence to suggest that mutant proteins were more susceptible to proteolysis. The 
mutants behaved in the same way as the wild type in terms of binding and elution 
from the nickel affinity and ion exchange columns. Furthermore, there was not a 
difference between protein yields for the wild type and the mutants after purification. 
Wild type and mutants N-CIRP were therefore successfully generated, expressed and 
purified for further structure and binding activity analysis by NMR as described in 
chapters 3 and 4. The structure of N-CIRP mutants was confirmed by mass 
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spectrometry and the mutants were found to be as soluble and as stable as the wild 
type upon storage. A 1 liter culture yielded around 10-15 mg of protein after 
purification. This was the same for all 3 of the mutants.  
 
Various methods were tested to express and purify soluble full-length CIRP protein.  
It was necessary to express the full-length protein to fully characterise CIRP function 
as a whole and to investigate the function of the C-terminal region. This disordered 
region may have made the recombinant expression and purification of the protein 
challenging by reducing the solubility of the protein. The unstructured nature of the 
C-terminal region also makes the protein prone to degradation and!yields were higher 
when the lysis step was carried out in the presence of protease inhibitors. Mass 
characterisation of a degraded sample of CIRP (figure 2.16) confirmed that it is C-
terminal region that is degraded first whereas the folded N-terminal domain is 
relatively resistant to proteolysis. Full-length CIRP was successfully expressed in 
E.coli with a yield of approximately 5 mg/l. However, the final yield of soluble 
protein was significantly less as the protein precipitated after Ni
2+
affinity purification, 
on dialysis and concentration.  Interestingly, intact CIRP runs at a slightly smaller size 
than expected on SDS-PAGE. It is not clear why this so. It may be due to degradation 
and the presence of degradation products were seen on the gel. Mass spec did show 
however the presence of full-length CIRP (figure 2.16). When cells are lysed, 
proteases which normally have regulatory roles are released in to the lysate and all 
proteins are exposed to proteolysis (Ryan 2011). These degradation products were not 
observed when expressing the N-terminal domain of the protein and as the C-terminal 
region is unstructured it is likely to be prone to proteolysis. The lysis without protease 
inhibitors showed a reduced amount of CIRP compared to lysis with inhibitors. 
Studies have shown that unstructured regions of proteins are highly susceptible to 
degradation especially in vitro and in the absence of ligands (Mittag et al. 2010; 
Tompa et al. 2008). Although some degradation products were still observed on the 
gel when protease inhibitors were present, this experiment confirmed that the CIRP is 
prone degradation by proteolysis during the lysis procedure.   
 
It was noted that the larger the scale of expression, the larger proportion of CIRP 
protein present the in the lysis pellet. High local concentration of proteins susceptible 
to aggregation can result in the protein favouring the aggregate form rather than 
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folding correctly (Idicula-Thomas & Balaji 2005). Lysis of cells from a 1 litre 
expression showed that around 2/3 of the total protein was in the insoluble lysis pellet. 
This suggests that the aggregation of CIRP could be concentration dependent and a 
useful future experiment would be to use higher lysis buffer volumes to keep the 
CIRP concentration lower. Reports suggest that induction of recombinant protein 
expression at lower temperatures can improve protein folding and quality of the final 
product (Jana & Deb 2005; Smith 2007; Sorensen & Mortensen 2005b). CIRP was 
induced at 20°C overnight; reduced temperature induction for 16 h increased the 
amount of protein expressed by the cells but the majority of the expressed protein was 
still found in the insoluble lysis pellet. This finding further confirms that the poor 
solubility of CIRP causes it to precipitate at higher concentrations.  
 
Purification of the soluble CIRP in the lysis supernatant resulted in precipitation of 
CIRP in the purified elution fractions, precipitation was seen in the fractions 
containing the highest concentration of CIRP, once again suggesting that solubility is 
influenced by protein concentration. ¾ of the purified protein precipitated, the 
remaining soluble protein was not very pure as it contained contaminating proteins 
and degradation products whereas the precipitated protein sample was much purer. 
Previous studies by Shu-Ju Hsieh had shown that CIRP is more soluble and stable in 
50 mM sodium acetate buffer, pH 4.8. Resuspending the CIRP precipitate in this 
buffer lead to around 60% of the precipitate becoming soluble. This re-solubilisation 
is beneficial as this solubilised protein is higher in purity than the nickel affinity 
eluted fractions. This precipitation step can be seen as an extra purification, which 
also yields the protein at relatively high concentration. 
 
Mass spec analysis of Ni
2+
 affinity purified CIRP samples confirmed that the 
degradation of CIRP is due to the unstructured C-terminal region. The N-terminal 
region of CIRP on its own is stable; whereas the unstructured C-terminal region is 
prone to proteolysis. Aggregation of CIRP upon purification suggests that taking it 
out of the cellular environment causes the protein to precipitate. The addition of the 
amino acids arginine and glutamic acid made a small improvement to the amount of 
CIRP that could be re-solubilised. Molecular crowding of protein in a cellular 
environment can help enhance their solubility which the amino acids assist to achieve 
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(Shukla & Trout 2011). Addition of amino acids have increased the solubility of 
protein in many studies, arginine and glutamic acid in particular help with this 
(Arakawa et al. 2007; Golovanov et al. 2004). 
 
Inclusion body washes were performed on the lysis pellet and it was expected that this 
process would be unable to re-solubilise the CIRP protein. Inclusion bodies are 
typically composed of densely packed denatured protein molecules that are insoluble 
in aqueous buffers (Singh & Panda 2005). The solubilisation of the CIRP protein 
could be due to the buffer components EDTA and Triton X-100 and also due to the 
fact that the amount of CIRP is diluted by the addition of the buffer after every wash 
and so allowing more CIRP to dissolve. If CIRP was forming true inclusion bodies it 
would not be expected to become soluble in the inclusion body wash buffer. The 
CIRP protein solubilised from the lysis pellet was less soluble after Ni
2+
affinity 
purification and none of the precipitate could be re-solubilised in the sodium acetate 
buffer. This suggests that the CIRP protein aggregates from the lysis pellet may be a 
different form compared to the CIRP in the lysis supernatant, as it is more insoluble. 
CIRP was purified in the presence of urea successfully with no loss of protein through 
precipitation, however, the refolding process was unsuccessful and the aggregated 
protein could not be recovered by resuspending in sodium acetate buffer.  
 
The studies described in this chapter suggest that there are various different factors 
that can lead to the precipitation of CIRP, such as protein concentration, buffer 
conditions, presence of other proteins and culture conditions. The difference between 
how much of the protein precipitate could be solubilised form the lysis pellet or the 
aggregated protein following nickel affinity purification suggests that there may be 
more than one form of the protein; 1) soluble, 2) protein prone to aggregation which 
can be re-solubilised 3) insoluble protein.  The fact that some precipitation occurs 
after purification suggests that to be soluble, full-length CIRP requires to be in a 
cellular environment and even in the presence of its ligands The greatest amount of 
purified soluble protein (400 µg per 1 litre culture) was achieved from re-
solubilisation of the precipitates following nickel affinity chromatography in the 
sodium acetate buffer; this was also the most pure CIRP sample that was achieved.  
CIRP protein in the lysis pellet could not be salvaged. To maximise the amount of 
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soluble refolded protein, there are many conditions that should be taken into 
consideration, such as buffer type and pH, protein concentration, temperature, storage 
conditions, and there are many additives available that can be included to assist with 
protein solubility (Jungbauer & Kaar 2007). These could be further optimised to 
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3.1 Introduction 
Nuclear Magnetic Resonance is an ideal tool to investigate structure-function 
relationships of proteins and N-CIRP is well suited to such analysis as it is a well-
behaved, soluble, small molecule. NMR has been developed for many decades for 
both small and large biomolecules (Bloch, Hansen, & Packard, 1946; Bloembergen, 
Purcell, & Pound, 1947; Rollin & Hatton, 1947).  NMR is based on the fundamental 






N isotopes have nuclei with spin 
½ and give rise to well resolved high-resolution resonances, therefore they are 
deemed as NMR active isotopes. Isotopes with a spin of 0 do not give rise to NMR 





N, with a spin of 1, gives broad line shapes so it cannot be used 










P are all common NMR active 















C-glucose to enable acquisition of NMR spectra from these isotopes 
together with 
1
H. The chemical shift of a nucleus depends on the chemical group that 
it belongs to and its microenvironment, therefore chemical shift changes of a 
resonance indicate a change in its microenvironment and hence a chemical or 
structural change. NMR can also deal with folded and unfolded proteins and can be 
used to identify unfolded regions of proteins. Regions of proteins, which are of a 
disordered nature or where there is degradation, give resonances in the random coil 
region of the spectrum (Jacobsen, 2007). 
 
One of the aims of this project was to characterise the contribution of the N- and C-
terminal regions of CIRP to its function. This chapter describes the investigation of 
the N-terminal domain of CIRP and its binding to RNA by the use of NMR 
spectroscopy. N-CIRP has a β1α1β2β3α2β4 topology which contains two RNA 
binding sequences RNP1 and RNP2 on strands β1 and β3 (Sheikh, 1997) (figure 1.6). 
Some residues on these strands have been identified as being more involved in RNA 
binding than others and the aromatic residues are highly conserved(Manival, Ghisolfi-
Nieto, Joseph, Bouvet, & Erard, 2001).  Residues in positions 3 and 5 on RNP1 and 
position 2 on RNP2 are essential for RNA binding (Maris, Dominguez, & Allain, 
2005) as described in detail in section 1.4.2. As described in chapter 2, two of these 
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residues (position 3 of RNP1 and position 2 of RNP2) were chosen for mutagenesis to 
determine the effect on RNA binding. Interaction of these residues with RNA ligands 
was previously confirmed by NMR chemical shift perturbation studies on N-CIRP by 
Shu-Ju Hseih (2010). Further structural characterisation of N-CIRP will help to reveal 
the importance of the structure-function relationship of this protein in the mammalian 






HSQC experiments to study the effects of mutations, and the RNA binding of full-
length CIRP, N-CIRP and mutants were investigated. Further structural analysis 







H Heteronuclear Single Quantum Coherence NMR 
15






HSQC experiments are usually first to be performed on labelled protein as it is an 
ideal experiment to check whether the protein is folded and stable by looking at the 






HSQC data can be used to measure chemical shift changes and these provide detailed 
information about hydrogen bonding interactions, oxidation states, the ring current 
influence of aromatic residues and nature of hydrogen exchange dynamics (Mielke & 
Krishnan, 2009). Each residue of the protein (except proline) has an amide proton 
attached to a nitrogen in the peptide bond. The HSQC informs on the correlation 
between the nitrogen and amide proton (figure 3.1) and each amide yields an 
observable peak in the spectra with the exception of proline, which lack the amide 
proton.  
 
Changes in chemical shifts provide indications of structural changes. Each residue has 










HSQC experiments are 
therefore a simple way to determine whether a protein conformationally or 
structurally changes under different conditions by the chemical shift changes 






HSQC spectra should have been assigned. Backbone assignments of N-CIRP were 
completed by Shu-Ju Hseih previously. 
 
 



















3.1.2 RNA Binding Studies 
One of the aims of this project was to study the RNA binding of CIRP to RNA 
ligands and to investigate the role of the N- and the C- terminal domains in binding.  
As described above, N-CIRP has two RNA binding consensus sequences, which have 
been found to be conserved across many RNA binding proteins. These sequences are 
the RNP1 and the RNP2 sequences on the β1 and β3 strands of the N-terminal domain 
(figure 1.6). Previous studies have reported that the 3’UTR of the thioredoxin (TRX) 
mRNA binds to CIRP (Yang, Weber, & Carrier, 2006) and these findings were further 
confirmed by Shu-Ju Hseih (2010).  Human thioredoxin 3’UTR mRNA is 166 
nucleotides long excluding the poly-adenine (polyA) tail and the mouse TRX 3’UTR 
mRNA is 532 nucleotide long, however the first 127 nucleotides TRX 3’UTR from 
the two species is 69% identical. Electro mobility shift assays studies by Shu-Ju Hseih 
showed that CIRP and N-CIRP binds to full length human TRX 3’UTR mRNA, the 
first 127 nucleotides of human TRX 3’UR mRNA and also the first 113 nucleotides of 
mouse TRX 3’UTR mRNA. Binding studies of N-CIRP by NMR also showed 
binding to these RNAs and also to a 10mer polyA RNA fragment which showed the 
largest chemical shift changes on minimal chemical shift maps. The identified RNA 
ligands from these studies were used here to test the RNA binding of CIRP, N-CIRP 
and N-CIRP mutants. If the mutations successfully inactivate the RNA binding of the 
Figure 3.1 Magnetisation is transferred from hydrogen to the 
15
N labelled nitrogen and 
transferred back to the hydrogen for detection. http://www.protein-nmr.org.uk 
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N-terminal domain, this could be exploited to investigate the function of the C- 
terminal of region CIRP.  
 
For the investigation of RNA binding by NMR, 10mer polyA RNA was used as this 
showed the largest chemical shifts in Shu-Ju Hseih’s findings.  Nuclear magnetic 
resonance can have many applications, it can be used to detect intermolecular 
interactions and to study protein-ligand interaction (Coles, Heller, & Kessler, 2003; 





experiments are a good way to study structural changes of a protein under different 
conditions i.e. in the presence or absence of ligands by changes in the chemical shifts 
in the spectra of the backbone amide resonances. It is only necessary to label the 
protein or the ligand, changes of the labeled protein can be detected upon binding to 
unlabeled ligand. The changes in the chemical shifts can then be presented as 
chemical shift maps. Chemical shift mapping is a popular method for the investigation 
of protein-ligand interactions. As well as being able to confirm ligand binding, the 
location of binding site can also be discovered by this method by looking at the 
chemical shift changes of individual resonances (Clarkson & Campbell, 2003; Lee et 
al., 1997; Rajagopal, Waygood, Reizer, Saier, & Klevit, 1997; Yuan, Davydova, 




H spectrum of the protein is assigned, 
the spectra in the presence and absence of ligand can be compared and chemical shifts 
changes of individual amino acid resonances calculated. Therefore those residues that 








HSQC spectra were collected to identify any structural change as a 
consequence of the mutations made to N-CIRP RNP1 and RNP2 sites and the 
addition of RNA to N-CIRP and N-CIRP mutants, perturbations between wild type N-
CIRP and N-CIRP mutant spectra were followed. HSQC spectra were also used to 
confirm the folded nature of N-CIRP and mutants. 
 
Electro mobility shift assays (EMSA) are a sensitive method of studying RNA 
binding of proteins and do not require high concentration of protein and ligand. The 
radiolabelled RNA can be detected at levels as low as nanograms in gels. In vitro 
synthesized and radiolabelled RNA is used to investigate the interaction between the 
mRNA and target protein.  The recombinant radiolabelled RNA is usually synthesized 
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using in vitro transcription systems containing a vector including a T7, SP6 or T3 








H (Krieg & Melton, 1984; Schenborn & 
Mierendorf, 1985). Binding assay can then be used to study the binding once the RNA 
and protein have been generated. EMSA is a popular and powerful method for 
detecting protein ligand interactions (Rio, 2014). If a protein-RNA complex is 
present, it migrates more slowly than the free RNA when ran on a polyacrylamide or 
agarose gel. If binding of the RNA to protein is present, shifts in the migration of the 
radiolabelled RNA band will be observed and an interaction can be confirmed. If 
binding is absent, the migration position of the RNA will remain unchanged in the 
presence of protein.  
 
Using this method the binding between mouse CIRP, N-CIRP and N-CIRP mutants to 
the mouse and human TRX 3’UTR RNAs described above was investigated. Plasmids 
containing the TRX 3’UTR were generated and provided by Shu-Ju Hsieh. RNA 
transcription and radiolabelling was carried out by Dr Helen King at the University of 
Leicester. All EMSA experiments were carried out in collaboration with Prof Anne 
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3.2 Materials and Methods 




labelled N-CIRP was expressed and purified as described in Chapter 2. For the 






HSQC experiments, the 
15
N 
labelled purified proteins were prepared by dialysis and freeze drying in the same 
way. However, the proteins were in the buffer; 20 mM Tris-HCl pH 7.9, 3 mM 
MgCl2, 5 mM DTT, 5 mM NaCl, 1 mM spermidine, RNase inhibitors (RNasin Plus, 






HSQC experiments, samples of 
100 µM protein concentration were prepared. For RNA binding experiments, 25 µM 
of 10mer polyA RNA (MWG) was added to the samples.  
 
All samples for NMR analysis were prepared in 10 % (v/v) deuterium oxide (D2O) 
(Goss Scientific Ltd.) in final sample volumes of 330 µl and transferred into 5 mm 











H HSQC experiments were run with 2048 data points in the F2 dimension and 
256 points in the F1 dimension at 25°C with a 1.5 hour duration with the assistance of 
Dr Michelle Rowe on a Bruker Avanace III, 600 MHz spectrometer using Top Spin 








at 115.532 ppm.  Chemical 
shift referencing was based on the position of the water resonance with the exact 
value being related to the known relationship of the water resonance with temperature 
(Wishart & Sykes, 1994). Experiments were solvent supressed using WATERGATE  
(Piotto, Saudek, & Sklen, 1992). The data was processed using NMRpipe on Linux 
PCs and the NMR spectra were assigned using CcpNmr Analysis version 2.0. 
 
3.2.3 Minimal Chemical Shift Mapping 
Backbone resonances of the N-CIRP mutants were compared to the wild type with the 
assumption of minimal chemical shift. Minimal chemical shift mapping for backbone 
resonances was determined by assuming that the closest peaks in wild type and 
mutant spectra share the same assignment. The shortest distance was calculated with 
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H by using equation 3.1 below. 
 
Equation 3.1:  
 
 
Δ1H and Δ15N are the difference in the proton chemical shift and the nitrogen 
chemical shift respectively. The Δ15N was divided by 7 to allow for the difference in 




H. The number 7 being the factor difference between 
the two ppm axes. 
 
For the RNA binding of N-CIRP, backbone resonances of the N-CIRP mutants with 
RNA were compared to the wild type with the assumption of minimal chemical shift. 
To study the effect of the Phe mutations on RNA binding, minimal chemical shift 
maps were constructed using the wild type chemical shifts and the chemical shifts of 
the mutants in the presence of RNA. The difference between the minimal chemical 
shifts with and without RNA were calculated and plotted as bar charts as shown by 






For the binding of wild type N-CIRP to RNA, minimal chemical shift maps were 
constructed by comparing the chemical shift of wild type N-CIRP with and without 
RNA.  
 
3.2.4 Electro Mobility Shift Assay 
32
P radiolabelled RNA was produced using Ribomax T7 transcription kit (Promega) 
by Dr. Helen King at the University of Leicester. RNase contamination was 
minimised using RNase ZAP and RNase free solutions and equipment. 
Disintegrations per unit time (dpm) of each RNA were counted per µl and 20 000 
dpm of each RNA (0.004 µM) was incubated with different ratios of protein 
Minimal chemical shift value=√((Δ1H)2
 
+ (Δ15N/7)2) 
Mutant RNA Shifts =  
[Minimal map (WT vs. Mutant) – Minimal map (WT vs. Mutant + RNA)] 
!
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(RNA:Protein; 1:0-1:2560). The proteins tested were full-length CIRP and N-CIRP. 
The production of these are described in chapter 2.  Total reaction volume used was 
20 µl, reactions were set up to contain 1x transcription buffer, 1 mg/ml yeast tRNA, 
RNAse inhibitor. The reactions were set up in 96 well plates and incubated at room 
temperature for 20 min. At the end of incubation time, 5x EMSA loading dye (0.1 M 
EDTA, 50% sucrose, 0.2% bromophenol blue) was added to each well to a final 
concentration of 1x.  The samples were loaded onto TBE gels (6% bispolyacrylamide, 
0.1x TBE, 2.5% glycerol, 0.02% TEMED, 0.005% ammonium persulfate) (1xTBE= 
90 mM tris, 90 mM boric acid, 2 mM EDTA). The gels were run in 0.5x TBE buffer 
at 100 V until the dye front reached the bottom of the gel. Loading dye was loaded 
again and the run continued until the second dye front reached the end of the gel. Dye 
was loaded again into the left lane of the gel and allowed to run into the gel to help 
keep track of the orientation of the gel. The gels were dried on to Whatman paper 
using a heated gel dryer under vacuum. The dried gels were exposed to a 























H HSQC NMR Spectra for N-CIRP 
The N-CIRP NMR sample was soluble and gave a well-resolved NMR spectrum 
(figure 3.2). Backbone NH resonance assignments were provided by Shu-Ju Hsieh, 











































































































































H HSQC NMR spectra of 
15
N labelled His tagged N-CIRP!










H HSQC NMR experiments were used to analyse the N-CIRP mutants F9A, 
F49A and F9AF49A described in Chapter 2. HSQC experiments are suitable to 
determine whether a protein is folded or unstructured and if it is soluble and stable. 
 




H HSQC spectra of the N-CIRP mutants and the wild type 
spectrum from section 3.3.1 as a reference (figure 3.2). Similarly to the wild type 
protein, the mutant F9A produced a well-resolved spectrum with dispersed peaks 
typical of a folded protein. When the peak dispersion of the F49A and F9AF49A 
spectra was compared with the wild type spectra, some broadening of peaks was 
observed in the central region, this suggest that these mutants are in conformational 
exchange. 
 
 As some peaks showed quite significant shifts, the backbone assignments from the 
wild type spectra could not be transferred across to the mutant spectra. Specifically 
large shifts of the peaks from residues that were mutated were observed. The F9 and 
F49 peaks are indicated by the red arrows in figure 3.3. When these are compared 
with the mutants’ spectra, these peaks can no longer be seen for the corresponding 







































































































































































































H HSQC NMR spectra of 
15
N labelled His tagged N-CIRP and mutants. 
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Minimal chemical shift maps were created to assess the chemical shifts changes 
between wild type N-CIRP and mutants. Figure 3.4 shows wild type HSQC spectra 
overlaid with the F9AF49A mutant spectra. The overlaid spectra shows that most 
peaks have shifted, this was also true for the overlays of the other two mutants with 
wild type N-CIRP spectra. The extent of these shifts was identified calculating 
































To calculate the minimal chemical shifts, chemical shift values of the two spectra 
were compared. As there were no assignments for the mutant peaks, the peak with the 
chemical shift closest to the known peak on the wild type spectra was taken to 


































H HSQC NMR spectra of 
15
N labelled His tagged wild type N-CIRP (black) 
and F9AF49A mutant (pink) overlaid. 
!


































The minimal chemical shift maps (figure 3.5) show that shifts are smaller for the F9A 
mutant compared to F49A and F9AF49A. This is in agreement with the HSQC 
spectrum where F49A and F9AF49A mutants showed some broadened peaks 





































































































Figure 3.5 Minimal chemical shift values for the comparison of wild type N-CIRP protein to 
N-CIRP mutants. <0.1 ppm = Blue, 0.100-0.125 ppm =Green, 0.125-0.150 ppm = Yellow, 0.150-
0.175 ppm =Orange, >0.175 ppm =Red!
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map showed that the largest shift is at the site of mutation (F9) and the residues on 
either side are also affected. This region is the RNP2 binding site. An interesting 
finding was that the next largest shift was the peaks belonging to residues 49-53, 
those being the residues belonging to the RNP1 sequence. The significance of this is 
discussed later. An average background shift of 0.032 ppm was calculated by taking 
the shift values less than 0.175 ppm for the F9A mutant.  The F49A mutant showed 
larger shifts at the site of mutation and residues either site. Shifts across the whole 
protein were larger as can be observed by the colour coding with an average 
background shift of 0.092 ppm, 2.4 times larger that of the F9A mutant therefore the 
whole protein conformation is effected by this mutation. Similar to the F9A mutant 
shift map, F49A shift map showed large shifts around residues 9-14, which is the 
RNP2 binding site.  The double mutant F9AF49A mutant map also showed larger 
shifts across the whole protein with a similar background shift value to the F49A 
mutant of 0.093 ppm.  As this value has not grown larger due to the double mutation 
it was assumed that the F49A mutation is causing the conformational effect on the 
protein. The largest shifts were seen at the mutation sites of F9 and F49 and residues 
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3.3.3 RNA Binding of N-CIRP by Minimal Chemical Shift Mapping 
The effect of the mutation on the F9 and F49 residues were determined by comparing 
the backbone resonances of the wild type and the mutant proteins in the presence of 
RNA to the backbone resonance of the wild type protein without any RNA and 
minimal chemical shift changes calculated. Minimal chemical shift changes of the 
mutants with no RNA compared to the wild type were subtracted from the minimal 
chemical shift changes of the mutants with RNA compared to the wild type. 
 
RNA binding was followed by observing the 1D 
31
P spectra of the 10mer polyA RNA 
in the presence and the absence of N-CIRP (figure 3.6). Upon the addition of protein 






The minimal chemical shift maps for the RNA binding to wild type N-CIRP showed 
that there are small chemical shift changes all below 0.01 ppm across the protein 
(figure 3.7). Larger changes were observed around the RNP1 and RNP2 sequences 
suggesting that the polyA RNA is binding to these areas. Larger shifts compared to 
the rest of the protein were also at the N- and C-termini of the protein. 
 
When the shift changes of the RNP1 and RNP2 sequences seen for the wild type were 






Figure 3.6 1D 
31
P NMR spectra of the 10mer polyA RNA with (blue) and without   (red) N-
CIRP. 
!
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these regions at almost 0 (figure 3.7).  For the F9A mutant some small general shift 
changes are present across the protein similar to the wild type but less suggesting that 
the RNAs effect on the conformation of this protein is little. However, for the F49A 
and F9AF49A mutants the same background was not observed i.e. the resonances of 
the protein with and without RNA are very similar so RNA is not having any effect on 
the conformation of the protein at all. The unexpected large values seen on the charts 
for the mutants for example the large value for the F49 peak on the F49A mutant chart 
is due to these peaks being absent on the mutant spectra and as a nearest peak 
approach is used to calculate the chemical shift, a value for the next nearest peak is 

































































































































































































































































































































































































































































































Figure 3.7 Minimal chemical shift values for interaction of with 25-µM 10mer polyA RNA. 
Bars for the residues belonging to  RNP1 and RNP2 interaction sites are coloured in orange!
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3.3.4 RNA Binding of CIRP and N-CIRP by Electromobility Shift Assay (EMSA) 
Binding of CIRP and N-CIRP to 3’ UTR of human and mouse thioredoxin RNAs was 
tested by EMSA as this method does not require high concentration of RNA or 






RNA:Protein ratios of 1:10, 1:20, 1:40, 1:80, 1:160,1:320 were also tested but binding 
was not observed at these ratios. Polypyrimidine-tract-binding protein (PTB) which is 
an RNA binding protein (Sawicka, Bushell, Spriggs, & Willis, 2008) provided by 
Professor Anne Willis’ labaratory was used as a positive control at the highest ratio.   
 
No binding was seen for N-CIRP at any of the ratios tested to any of the RNAs (figure 
3.8,lanes 7-10). Band shifts seen at ratios 1:1280 and 1:2560 for full-length human 
thioredoxin 3’UTR and the first 127 nt of human trx 3’UTR and full-length CIRP 
(figure 3.8 (a) and (b) lanes 5 and 6). The shifts could be seen more clearly for the 
first 127 nt of human trx 3’UTR compared to the full length RNA. Shifts of the first 
113 nt of mouse trx 3’UTR RNA bands was seen at lower ratio of 1:640 and also at 
1:1280,1:2560 with full-length CIRP.  Even though band shifts were seen, it was not 
easy to differentiate RNA only and RNA-Protein complex bands on the gels. Band 
shifts could not be seen for the positive control PTB RNA for the human trx 3’UTR 
RNA but a small shift was seen for the mouse trx 3’UTR RNA. Even though shifts 
were not observed for N-CIRP protein with any of the RNAs, a decrease in the 
intensity of the bands for mouse trx 3’UTR free RNA was seen for the highest ratios 
 control CIRP N-CIRP 
Lanes 1 2 3 4 5 6 7 8 9 10 
RNA (µM) 
20000 dpm 
0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 
Protein (µM) 0.00 10.24 0.00 2.56 5.12 10.24 0.00 2.56 5.12 10.24 
Ratio 0 2560 0 640 1280 2560 0 640 1280 2560 
!
Table 3.1 Concentration and ratios of RNA and CIRP/N-CIRP protein in gels for EMSA. 
Red box indicates the ratios at which shifts were observed. 
!
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which may suggest the presence of binding (figure 3.8 (c) lanes 9 and 10).  As binding 












































   1     2      3     4      5     6     7     8     9    10 
Figure 3.8 Electromobility shift analysis (EMSA) of recombinant 
32
P radio labelled RNA 
binding to PTB (positive control, lane 2),  full-length CIRP  (lanes 3-6) and N-CIRP (lanes 7-
10). (a) Full length human thioredoxin (trx) 3' UTR, (b) the first 127 nt of human trx 3' UTR, (c) 
the first 113 nt of mouse trx 3' UTR. Samples with shifted bands are shown by red boxes. 
!
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3.4 Discussion 
This chapter describes investigation of N-CIRP binding to RNA by the use of NMR 
and gel shift techniques. 
15
N labelled wild type and mutant proteins were produced as 
described in Chapter 2.  NMR samples were prepared by freeze drying the proteins in 
the appropriate buffer as concentrating the protein by the use of spin concentrators 







H HSQC NMR spectra were collected to determine whether the proteins are 
folded, soluble and stable. Wild type N-CIRP sample remained soluble and gave a 





H HSQC experiments were collected for recombinant 
N-CIRP mutant proteins F9A, F49A and F9AF49A. All proteins appeared soluble and 
remained soluble through out the experiment.  The F9A mutant gave well-resolved 
spectra with dispersed peaks similar to the wild type protein. Some broadened peaks 
were observed in the random coil region (Jacobsen, 2007) on the F49A and F9AF49A 
spectra, this suggests some conformational disorder in the structure or some 
degradation.  This could be seen more clearly when the spectra was overlaid with the 
wild type spectra (figure 3.4). This was not observed for the F9A mutant; therefore it 
was the F49A mutation that was having this effect on the N-CIRP structure. As 
discussed later in Chapter 4, some motion was also detected in the loop region before 
RNP1 containing the F49 residue in the wild-type protein as changes in the S
2
 and τe 
parameters were seen. Peaks for all residues were present in the mutant spectra as in 
the wild type with large shifts observed.  When mutant spectra were overlaid with 
each other it was seen that all of the peaks had shifted, there were no peaks that 
overlaid over one another.  
 
The F9A chemical shift perturbation map showed that there were generally small 
shifts (average 0.032 ppm for background shifts) across all residues of F9A N-CIRP.  
Large shifts (>0.175 ppm) were seen for the F9 residue and the residues either side. 
Interestingly large shifts were seen in the RNP1 region of β3, suggesting that the 
RNA binding sequences RNP1 and RNP2 are close in space. The F49A mutants shift 
maps showed a larger general shift (0.092 ppm average background shift) for all 
residues compared to F9A. The greatest shifts were at F49 and either side of it and 
!
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similar to the F9A shift map, increased shifts were seen in the RNP2 region too. The 
general larger shift values across the whole protein for the F49A mutant confirms that 
this mutation has a larger structural effect on N-CIRP also agreeing with HSQC 
spectrum and the dynamics data (Chapter 4). This is also shown in figure 3.9, the 
surface representation of the chemical shift changes shown for each mutant shows that 
the F49A and F9AF49A are experiencing much larger structural changes compared to 
the F9A mutant. This could also be confirmed when looking at the shift map of the 
F9AF49A mutant, which also showed larger shift values across the protein compared 
to the F9A mutant. The largest shift were seen at the mutation sites of F9 and F49 as 
expected. 
 
The mutation of the F9 residue of the RNP2 RNA binding sequence to alanine does 
not have an effect on the folding, solubility and stability of the protein. However the 
mutation of F49 into alanine in the RNP1 sequence does have a conformation effect 
on N-CIRP giving data which suggests that both folded and unfolded protein is 
present and the loop before this region appears more dynamic at the pico to 
millisecond time scale compared to the rest of the protein confirming that it is of 
functional and structural importance as discussed in chapter 4 (section 4.3.5). To 
confirm this hypothesis, dynamic studies would need to be carried out on the specific 
mutants to look into the dynamic properties of these regions.  
 
















Figure 3.9 N-CIRP is shown as a surface representation with residues coloured according to the 
chemical shift difference on mutation. The top images show ribbon structure with the F9 and F49 
residues in line style. N-CIRP structure shown is the PDB structure 1x5S. <0.1 ppm = Blue, 0.100-
0.125 ppm = Green, 0.125-0.150 ppm = Yellow, 0.150-0.175 ppm = Orange, >0.175 ppm = Red!
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NMR RNA binding experiments of N-CIRP confirmed that the RNP1 and RNP2 
regions identified in the N-CIRP sequence are the binding sites for the 10mer polyA 
RNA. Changes in chemical shift values were largest in these two regions when the 
resonances of the wild-type spectra were compared to the wild-type spectra with 
RNA. Initially the binding of the 10mer polyA RNA was confirmed by observing the 
1D 
31
P spectra of the RNA as a proof of concept before pursuing the detailed study of 
RNA binding using NMR.  
 
Larger shifts were also seen at both the termini, this was likely due to structural 
rigidity being forced on the termini upon binding as the termini are less ordered 
compared the rest of the protein when in the free state. The changes in chemical shift 
were smaller than expected. This may be due to weak binding or rapid on and off 
exchange between bound and unbound forms. The minimal chemical shift maps also 
confirmed that the F9 and F49 are important residues for RNA binding. When the 
chemical shifts of the mutants with and without RNA were compared, chemical shifts 
changes in the RNP1 and RNP2 regions were small. The F9A mutants showed that 
there was no change in the chemical shift of the RNP2 resonance in the presence of 
RNA therefore the addition of RNA does not have any conformational effect on this 
region of N-CIRP i.e. no binding. Binding was depleted for the RNP1 sequence too, 
this meaning that both the F9 and F49 residues have to be present for binding to take 
place.  Some small changes in shift were still observed particularly for residues 20-40 
of the protein and the N-termini suggesting some conformational effect. The shift map 
for the F49A showed that no changes were present between the mutant protein with or 
without the presence of RNA so the RNA did not have any effect on the protein 
conformation and binding to both RNP1 and RNP2 region was absent. Unlike for the 
F9A mutants there were no other shift changes across the protein so the addition of 
RNA to this mutant has no effect on the conformation of the protein. This was also 
the same for the double mutant F9AF49A with no changes seen between the RNA and 
no RNA spectra.  
 
The data confirms that F49 is more key for binding compared to F9 as the mutation of 
the F49 lead to larger depletion in RNA binding. This fits with the findings from the 




H HSQC mutants spectra 
and chemical shift map comparison of the mutants to the wild-type protein where it 
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was concluded that F49 mutation has a larger structural effect on the protein (figure 
3.3) and the region around this residue posseses more internal motion compared to the 
rest of the protein (figure 4.24). 
 
Electromobility shift assays revealed that full-length CIRP bound to all three RNA 
ligands tested (3’UTR of full-length and first 127 nt of human trx and 3’UTR of 
mouse TRX) at very high ratios of protein (1:640-1:2560). A clear band for the RNA-
Protein complex could not be seen but a clear shift of the free RNA band could be 
seen on the gel in particular for first 127 nt of human TRX 3’UTR and first 113 nt of 
mouse TRX 3’UTR (figure 3.8).  The band shifts for the mouse TRX 3’UTR RNA 
were the strongest out of the 3 with no free RNA band observed at the highest ratio. 
Also, even though a shift was not seen there was reduction in the density of the free 
RNA band for N-CIRP at the two highest ratios with the mouse RNA. It is apparent 
that the binding is preferential toward the mouse RNA. This is expected as the CIRP 
protein is also of the mouse species. Kd could not calculated for any of the binding 
events, as the free RNA and RNA-Protein complex bands could not be clearly 
differentiated from one another.   
 
This data suggests that the CIRP binding to RNA is stronger when the protein is in its 
full-length form rather than the N-terminal domain on it own. This agrees with the 
NMR binding data, as chemical shift changes seen were small with the N-CIRP 
protein binding to the polyA RNA. The C-terminal region must therefore have a 
function towards the binding of the protein to the RNA.  Study by Yang et al (2006) 
has also shown that full length CIRP has a greater interaction with RNA ligands than 
the N-terminal domain alone. The concentration of protein had to be taken to 5 µM to 
see any binding. Even though a Kd was not calculated, the results from the EMSA and 
NMR experiment suggest that the RNAs tested do not bind to CIRP and N-CIRP very 
strongly therefore the identification of a specific ligand is required.  The weak binding 
could also be due to rapid on and off exchange as mentioned above although rapid 
‘off rate’ is synonymous with high Kd (low affinity). RNA binding proteins can bind 
to diverse RNA sequences with different levels of affinities (Dreyfuss, Matunis, 
Piñol-Roma, & Burd, 1993) and they have preferred substrates although this does not 
mean exclusivity, but the determinants towards these are not clear (Maris et al., 2005). 






Structural and Dynamics 
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4.1 Introduction 
This chapter describes the process of the structural and dynamics analysis of N-CIRP. 
Earlier work has provided information on N-CIRP binding to RNA ligands and also 
some insight into the C-terminal domain (chapter 3). As the C-terminal is natively 
disordered and does not produce a resolved NMR spectra, it could not be included in 
structure determination experiments (discussed further in section 1.4.4).  Further 
functional studies of CIRP are described in Chapter 5. To further extend our 
knowledge of CIRP function and how this may be contributing towards improving 
recombinant protein production, a structure-function based knowledge is necessary. 
Even though there is a structure deposited in the protein data bank of the RNA 
recognition domain of CIRP (1X5S) (figure 1.2), this is of the human protein and it 
has not been subject to peer review. This project is based on the mouse protein. The 
two sequences are 95% identical with 8 residues being different. Only one of these 
residues is in the N-terminal domain (figure 4.1) and is a change seen frequently in 







NMR can be used to determine structure of proteins up to 50 kDa and beyond 
(Cavanagh, Fairbrother, Palmer, Skelton, & Rance, 2007). There are two main steps 
to structure determination of proteins; resonance assignment and determination of 
distance constraints for structure calculation. Before the structure of a protein can be 
determined, there are multiple NMR experiments that need to be carried out. These 
experiments allow the assignment of resonances, which belong to the backbone and 




Figure 4.1 Amino acid sequence alignment of the human and mouse CIRP proteins.  Perfectly 
matched residues are indicated by an asterisk (*), conserved residues by a colon (:), and less 
conserved residues by a period (.). The yellow region is the N-terminal RNA binding domain and 
the orange region is the glycine C-terminal region. 
!
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resonances as possible. Dynamic properties of N-CIRP were studied through nuclear 
spin relaxation experiments. Biological molecules are flexible and undergo 
conformational changes on different timescales (Mittermaier & Kay, 2009). Proteins 
do not simply occupy one structure but they are equilibrating as a set of time 
dependant structures and these dynamic properties of proteins are essential for 
describing their function (Kleckner & Foster, 2011). Dynamic characteristics of 
proteins affect a wide a range of functions such as signalling and regulation (Smock & 
Gierasch, 2009), rate and pathway of protein folding (Neudecker, Lundstrom, & Kay, 
2009) and ligand binding (Boehr, Nussinov, & Wright, 2009). NMR experiments are 
run using isotopically enriched protein. Nuclear magnetic resonance and NMR active 
isotopes are described in Chapter 3 (section 3.1).  
 
4.1.1 Resonance Assignment 






N in an amino acid can be used for 
the assignment of resonances (Cavanagh et al., 2007; Griesinger & Sattler, 1999; Kay, 
2005). There are many different experiments that study the connectivity between 
different nuclei, which allow the identification of NMR frequencies of NMR active 






Cα.  A common strategy used for backbone assignment is the through triple 
resonance spectra by sequential assignment (Griesinger & Sattler, 1999; Whitehead, 









Cβ of a residue (Cavanagh et al., 2007), which allow for 
rapid assignment of proteins as large as 700 amino acids by the use of NMR 
experiments which show specific resonances (Kay, 2005). Sequential assignment 
matches distinctive spin systems to the amino acids to which it belongs (Wüthrich, 
1986). The triple resonance spectra collected are CBCANH and CBCA(CO)NH 











Cβ resonance of  the previous residue (i-1). 










Cβ resonance within the same residue. Reference chemical shifts can be used as 
guidelines to identify particular residue types (Wishart, Bigam, Holm, Hodges, & 




Cβ are shown in figure 4.2. 
 















The amino acids serine, threonine, alanine and glycine in particular have distinct 
chemical shifts that are easily distinguished from the rest as shown by the arrows in 
figure 4.2. Serine and threonine have especially high 
13
Cβ shifts, whereas alanine’s 
13
Cβ shift is especially low. Glycine is easily distinguishable as it lacks 
13
Cβ. 
Therefore, once these have been identified in the protein spectra, they can be used as 
starting points and one can sequentially move through the spectra and assign the 
backbone resonances on either side of A, G, S and T amino acids.  As proline lacks an 
NH, it cannot be correlated with its previous residue (i-1).  The assignment of the 
spectra was made using CcpNmr analysis software and how this process is carried out 
is described in further detail in the results section 4.3.1.  
 




C side chain 





C side chain resonances is usually made using HCCH-TOCSY 





C nuclei through 
13





C axis; the 
13
C axis is used to make further 
13
C side chain assignments that 
could not be made with the CBCANH and CBCA(CO)NH spectra.  The 
1
H axis 
provides side chain information by creating identifiable patterns for 
1
H side chain 




H resonance of 
each amino acid which can be used as guidelines to identify particular residue types.  




Cβ (Wishart et 
al., 1995) Blue dots indicate Cα and red squares indicate Cβ. Residues with distinctive shifts are 
indicated by the arrows. 
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This experiment gives a spectrum where there is a strip for each carbon frequency in 
which (in principle) all side chain hydrogen resonances are visible with a diagonal 
which crosses at the proton resonance to which carbon it is bound to (figure 4.8).  Cα, 
Cβ, Hα and Hβ resonances (already assigned from previous experiments) form the 
basic starting points for the side chain assignment. Hα and Hβ resonances can be 
identified from cross peaks at that residue’s Cα and Cβ resonance position and if the 




C nuclei, these will be correlated to the α and β 
resonances and can be identified using reference chemical shift patterns shown in 
figure 4.3. The assignments are essential for the full interpretation of NOESY data to 






























H (Wishart et al., 1995). 
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4.1.2 Secondary Structure Prediction 
There are several secondary structure prediction programs which have been developed 
to date such as TALOS and TALOS+ (Cornilescu, Delaglio, & Bax, 1999; Shen, 
Delaglio, Cornilescu, & Bax, 2009), DANGLE (Cheung, Maguire, Stevens, & 
Broadhurst, 2010), PREDITOR (Berjanskii, Neal, & Wishart, 2006) and SimShiftDB 
(Ginzinger & Coles, 2009).  
 
Secondary structure is determined by the dihedral angles of the protein backbone. Phi 
(Φ) is the angle that rotates around the N-Cα bond and psi (Ψ) is the angle that rotates 
around the Cα-C’ bond (figure 4.4). A Ramachandran plot shows the possible 
combinations of Φ and Ψ angles and the regions of the plot that give rise to α-helices 




C can inform on a helical or beta strand 
conformation (Wishart, Sykes, & Richards, 1992) (figure 4.4). Known chemical shifts 
of helices and strand were used to develop the chemical shift index and secondary 












DANGLE (Dihedral Angles from Global Likelihood Estimate) is the most recent 
algorithm to estimate Φ and Ψ backbone dihedral angles for each residue (and also 
takes into account neighbouring amino acids) to predict a secondary structure of a 
















Figure 4.4 An amino acid unit indicating the angles phi and psi (Φ and Ψ) (left) and 
Ramachnadran Plot (right). In the Ramachadran plot, white areas represent sterically disallowed 
conformations, the red regions are where there are no steric clashes i.e. regions for α-helices and β-
strand conformations. Yellow areas represent conformations allowed if shorted van der Waals radii 
are used for the calculation i.e atoms come closer together. 
!
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shifts (Cheung, Maguire, Stevens, & Broadhurst, 2010). The package is provided by 
CcpNmr Analysis program.  
 
A global likelihood estimate (GLE) diagram is assembled from the B (Φ and Ψ) 
values of each bin in Ramachandran space. The island that contains the largest score 
in the diagram, the Bmax value, is termed the principal island. DANGLE determines 
the angular means of Φ and Ψ within the principal island and these are the prediction 
of the backbone conformation (Cheung et al., 2010).  In this chapter 1H, 15N and 13C 
chemical shift values were used to predict the secondary structure of N-CIRP with 
DANGLE. 
 
4.1.3 Structure Calculation 
The process which ends with the structure determination of a protein can be broken 
down into four parts; (1) collection of experimental data, (2) processing the data, (3) 
determination of structural constraints and (4) calculations of structures which satisfy 
the constraints (Sutcliffe, 1993). Once as many assignments as possible are known, 
these can be used along with additional data, e.g. through space distance restraints and 
dihedral angles, for structure calculation. An iterative process is used to refine the 
calculated structures as the initial calculations invariably produce a list of restraint 
violations which do not satisfy the model. The iterative process involves the analysis 
of the violations before re-calculating the structure and eventually reducing or 
eliminating the list of violations.  
 
4.1.3.1 Distance Restraints 
Experimental data which constrains the geometry of the structure is necessary to 
refine the protein structure. The nuclear Overhauser effect experiments provide 
restraints for protein structures through NOE cross peaks. An NOE cross peak is due 
to a transfer of magnetisation between two 1H nuclei coupled by dipole-dipole 
interaction (Guntert, 1997). These experiments allow through space correlations 
between pairs of 1H nuclei, which may be far away in protein sequence but close in 
three-dimensional space. Therefore these 1H-1H correlations provide distance 
measurements, which can be used as constraints in a protein structure calculation.  For 
most well behaved proteins, NOE cross peaks define distances up to 6Å between 1H 
nuclei (Barsukov & Lian, 1993). NOE experimental data is collected through NOESY 
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experiments, where the intensity of the NOE cross peak is related to the distance 
between the two nuclei. Intensity decreases as distance gets larger and cannot be 
observed more than approximately 6Å as mentioned earlier.  There are other 
experimental data, which can be used for structural information; these include 
dihedral angles, hydrogen-bond restraints and residual dipolar couplings (RDCs) 
(Barsukov & Lian, 1993; Bax, Kontaxis, & Tjandra, 2001; Cavanagh et al., 2007; 
Guntert, 1997; Wüthrich, 1986). 
 
4.1.3.2 Automated Structure Determination 
Determination of protein structure by NMR is a complex and time-consuming 
process. There are a number of methods for the calculation of protein structures using 
resonance assignment data and distance restraints which produce an ensemble of 
closely related structures. Various programs are available which have been developed 
over the years to automate part of or the entire process. Some examples are FLYA 
(López-Méndez & Güntert, 2006), Auremol (Gronwald et al., 2004), ARIA (Nilges, 
1995), CYANA (Güntert, 2004) and CLOUDS (Grishaev & Llinás, 2005). The most 
time consuming aspect of the process is the correct and unambiguous assignment of 
NOE cross peaks which is also prone to errors, this step is considered the bottle neck 
in the process of structure calculation (Wishart, 2005). Overlapping chemical shifts 
increase ambiguity and this gets higher as the molecular weight of the protein 
increases.  
 
The ARIA program can use ambiguous NOEs (Linge, O’Donoghue, & Nilges, 2001), 
it uses the concept of ambiguous distance restraint where an NOE cross-peak with 
several assignment possibilities can be converted into a single distance restraint. This 
single restraint is the sum of the restraints from all of the assignment possibilities 
which is correct as long as one of the assignments is accurate. The data can then be 
fed into CNS (crystallography and NMR system) for automated structure calculations 
using these ambiguous NOEs. There are other automated methods available but these 
rely on complete and accurate chemical shift list for every resonance to make 
unambiguous NOE assignments (Güntert, 2003), for example DYANA and CYANA 
(Oezguen, Adamian, Xu, Rajarathnam, & Braun, 2002). After the calculations, 
structures are validated using computational methods such as RMSD (root mean 
square deviation) calculations of the ensemble backbone, analysis of violation lists, 
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number of restraints, comparison to other similar structures (Spronk, Nabuurs, 
Krieger, Vriend, & Vuister, 2004).  
 
4.1.4 NMR Relaxation Dynamics 
Relaxation is the process where over time magnetisation returns to it equilibrium 
position (Keeler, 2005). Measuring relaxation parameters can give information about 
both internal and global motions.  These motions occur at different timescales and are 
measured by different NMR experiments (figure 4.5).  For example loops and termini 







The nuclear spin relaxation (NSR) time of decay yields T1, T2 relaxation times and 
heteronuclear Nuclear Overhauser Effect (hnNOE) relaxation rates (Igumenova, 
Frederick, & Wand, 2006; Jarymowycz & Stone, 2006; Kempf & Loria, 2003). T1 and 
T2 provide fast movement information on a nano to picosecond timescale. T1 is the 
longitudinal relaxation time and conveys information about the overall size and shape 
of the protein, for example, the more the T1 varies across the protein, the more 
asymmetric the protein is (Palmer, 2001). T2 is the transverse relaxation time and also 
reflects size and shape of protein but this value also fluctuates due to the process of 
chemical exchange as T2 relaxation can extend up to millisecond timescales (Palmer, 
1997). The fundamental time constants produced by NMR relaxation (T1 and T2) 
become relaxation rates (R1 and R2) in reciprocal form (ie 1/T1 and 1/T2). Rate of 












Figure 4.5 Different timescales that can be viewed by different NMR experiments. Based on 
figure from (Henzler-Wildman & Kern, 2007) 
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relaxation is dependent on the physical environment and motions the molecule is 
experiencing. 
 
 hnNOE is obtained by comparing signal intensities in the presence of and absence of 
heteronuclear dipolar relaxation which is a through space interaction between pairs of 
nuclear spins that affects the magnetic field experienced by each spin (Kleckner & 




N as a difference in 
intensity when saturation of the proton is switched on and switched off.  The observed 
hnNOEs are typically negative and become more negative as motion becomes faster 
on a picosecond timescale (Brüschweiler, 2003; Palmer, 2001). hnNOE is determined 
by the equation: hnNOE= (I-I0)/I0, where I is the intensity of the proton saturated 
resonance and I0 is the intensity of the non-saturated resonance (Noggle & Schirmer, 
1971).  If the protein is rigid and tumbles isotropically, the T1, T2 and hnNOE values 
will be similar at each site (Kleckner & Foster, 2011).  Therefore these parameters can 
give a complete picture of the dynamic properties of a protein. 
 
Spectral density can be used to describe T1 and T2. Spectral density describes motion 
that occurs at specific frequencies and is field strength dependent on the NMR 
spectrometer used (Peng & Wagner, 1992a, 1992b) . Following equations define 






































) is the 
permeability of free space. rNH (1.02x10
-10
 m) is the length  of the amide bond, ħ 
(6.63x10
-34

















) is the difference between the perpendicular components of the chemical 
shift tensor (Broadhurst, Hardman, Thomas, & Laue, 1995). 
 
ModelFree analysis (Lipari & Szabo, 1982) is the most commonly used approach for 
the interpretation of  T1, T2 and hnNOE (Fischer, Majumdar, & Zuiderweg, 1998; 
Palmer, 1997). This approach assumes that internal motion is independent and faster 
than molecular rotation (Chen & Tjandra, 2008) and no structural model is required.  
Spectral density function equation (Abragam, 1961; Mcconell, 1987; Wagner, 1993) 
cannot be used to describe individual nuclei in the protein (equation 4.5). To break 
down spectral density functions into different motional properties the ModelFree 
formalism was proposed (Lipari & Szabo, 1982) by adding additional parameters to 







1/T1, 1/T2 and hnNOE are proportional to J(ω). J(ω) is spectral density, S
2 
 is the order 






where τe is 
internal motion correlation time which indicates the timescale of bond vector 
reorientation i.e. internal motion (Andrec, Montelione, & Levy, 2000). The left half 
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inside the brackets represents global motion and right half represents internal motion. 
If the protein is rigid, has no internal motion, the right spectral density expression 
equals 0, causing global motion to dominate. As protein becomes less rigid and S
2
 
reduces from 1.0 to 0.0, influence of internal motion τe, i.e. the influence of the right 
hand side, increases.  S
2
 is a measure of the magnitude of the angular function of a 
chemical bond vector and so it reflects the flexibility of the polypeptide chain at these 
sites (Ishima & Torchia, 2000).  S
2
 can take a value between 0 and 1, where 1 defines 
a rigid system and it decreases as flexibility increases, for example termini typically 
have reduced S
2
 values compared to structured regions. 
 
Global correlation time, τm is the time taken for molecule to rotate through one radian 
(Abragam, 1961). τe is the effective correlation time and gives an indication of fast 
and slow internal motions. τm should be estimated and it can be obtained by 
determining T1/T2. τm is dependent on the size of protein and can be estimated using 
equation 4.7 where N is the number of residues present i.e. the larger the protein the 






The interpretation of T1, T2 and hnNOE can be approached in several ways. Plots of 
T1, T2 and hnNOE vs residue number provide information on the dynamic properties 
of proteins.  T1 vs T2 plots inform on tumbling characteristics of the molecule 
including isotropy/anisotropy or indication of chemical or conformational exchange 
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4.2 Materials and Methods 












dynamics experiments was expressed and purified as described in Chapter 2. To 
concentrate the protein for NMR analysis, it was dialysed into 2 litres of sodium 
phosphate buffer, pH 6.5 containing sodium chloride and freeze-dried. The dried 















sample. The double labelled N-CIRP was 






N-CIRP was prepared in 10% (v/v) D2O. The concentration of the phosphate 
and salt dialysis buffer was prepared so that when the freeze-dried material was 
resuspended, the final concentration would be 20 mM sodium phosphate and 50 mM 
sodium chloride.  The sample was transferred into a 5 mm Shigemi NMR tube BMS-
005B (Goss Scientific) for Bruker spectrometers.  
 
4.2.2 Data Acquisition and Processing 
All spectra were collected at 25°C with the aid of Dr. Michelle Rowe. The data was 
processed using NMRpipe and NMRDraw on Linux PCs and the NMR spectra were 
assigned using CcpNmr Analysis version 2.0. Side chain resonance assignments were 




N labelled N-CIRP sample using HCCH-TOCSY 
experiments (Kay, Xu, Singer, Muhandiram, & Forman-Kay, 1993). Experiments 
were performed with the sample exchanged in D2O.  Each experiment was acquired 
with 2048 points (9014 Hz) in the direct F3 dimension (
1
H) and 64 points (3244 Hz) 
in F2 (
13
C) and 256 points (9014 Hz) in F3 (
1
H) indirect dimensions.  The 
13
C 
dimension was centred on 35.734 ppm with limits at 10.00 and 80.00 ppm such that 
resonances outside these regions were aliased into the spectrum in order to optimise 
resolution.  The HCCH-TOCSY 
13
C mixing period was set to 11.3 ms. The number of 
transients and relaxation delay was set to provide 109 hours experimental time for the 




C-edited NOESY was acquired on a Varian UnityINOVA 800 MHz NMR 
system operating at 18.8 Tesla at the MRC National Institute for Medical Research 
(NIMR), Mill Hill, London.  The 
13
C-edited NOESY used a mixing time of 100 ms 
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was acquired with 2048 points (12000 Hz) in the direct F3 dimension (
1
H) and 128 
points (8000 Hz) in F2 (
13
C) and 360 points (10500 Hz) in F1 (
1
H) indirect 
dimensions.  The 
13
C dimension of this edited NOESY was centred on 41.066 ppm 
with limits at (10.00 and 80.00 ppm) such that resonances outside these regions were 
folded into the spectrum in order to optimise resolution. The number of transients and 
relaxation delay was set to provide 68 hours experimental time. 
 
Carrier points were defined as 4.766 ppm for all 
1
H, 41.109 ppm for 
13
C and 117.436 
ppm for 
15




N TOCSY-HSQC and NOESY-HSQC experiments were run with 2048 points 
(8000 Hz) in the 1H F3 dimension, 192 points (8000 Hz) in the 1H F2 dimension and 
64 points (2150 Hz) in the 
15
N F1 dimension. NOESY experiments had a mixing time 
of 100 ms, and TOCSY experiments a 60 ms mixing time and both experiments were 
collected with 4 transients. 
 
4.2.3 Amino acid sequential backbone resonance walkthrough 
N-CIRP CBCANH and CBCA(CO)NH 3D spectra were previously acquired by Dr. 
Michelle Rowe. The triple resonance experiment CBCANH and CBCA(CO)NH were 
collected with a double labeled 1 mM N-CIRP sample with the N-terminal hexaHis-
tag removed. CBCANH and CBCA(CO)NH experiments were run with 1024 points 
(8000 Hz) in the 1H F2 dimension, 64 points (2150 Hz) in the 13C F1 dimension and 
120 points (2000 Hz) in the 
15
N F3 dimension over 32 transients. 2 X linear prediction 
was used to make 3 X data in 
15
N resonance. These spectra had been partially 
assigned previously by Shu-Ju Hseih. A sequential walkthrough was carried out using 
the spectra to confirm the existing assignments and additional backbone Cα, Cβ and 
amide N and H resonance assignments were made as described further in the results 
section 4.3.1.1.  
 
4.2.4 Amino acid side chain NMR resonance assignments 
The assignments made from the triple resonance spectra were used as starting points 
to make side chain assignments.  HCCH-TOCSY is a 3D experiment with two 
1
H 
axes and a 
13




H with each 
other (section 4.1.1).  As the backbone resonances had already been assigned through 
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the triple resonances experiments, the side chain resonances which correlate with 
these could be identified. The spectrum was acquired using double labelled N-CIRP 
as described above. The spectrum was used to complete the 
13
C side chain 
assignments: it also provided 
1
H side chain information and these were assigned using 
residue specific identifiable patterns of the proton resonances (figure 4.3). This is 
further described in the results section 4.3.1.2.  
 
4.2.5 Secondary Structure Prediction 
Secondary structure prediction was completed using DANGLE (dihedral angles from 
global likelihood estimates) software (Cheung et al., 2010). DANGLE uses Bayesian 
methods to estimate Φ and Ψ backbone dihedral angles for each residue and 
secondary structure using chemical shift measurements and a database of structures 
with known chemical shifts (section 4.1.2). Maximum number of islands was set to 2 
when running DANGLE. 
 
4.2.6 Structure Calculation 
N-CIRP structure calculations were carried out using the automated structure 
determination software ARIA (Ambiguous Restraint for Iterative Assignment) and 
CNS running on a Linux platform. For each round of calculations 9 iterations were 
performed. For the first 8 iterations, 20 structures were calculated and after each step 
the 7 lowest energy structures were used for the calculation of next of 20 structures. 
For the final iteration, 20 structures were calculated and the 10 with the lowest energy 
were analysed. The assignments and peak information imported into the ARIA 
software is described in detail in section 4.2.7. The parameter settings used in ARIA 
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Default settings were used with CNS unless specified otherwise. All setting for CNS 
are described below. 
 
 
Ambiguous and unambiguous restraints Parameter Value 
Force constant high temp 
Initial force constant cool 1 
Final force constant cool 1 
Final constant cool 2 
Flat bottom harmonic well 
Left switch-point high temp 
Right switch point high temp  
Left asymptote high temp 
Right asymptote high temp 
Left switch-point cool 1 
Right switch-point cool 1 
Left switch-point cool 2 
Right switch-point cool 2 
Right asymptote cool 2 
Hydrogen bond restraints 
Use H-bonds starting at iteration 
Force constant high temp 
Initial force constant cool 1 
Initial force constant cool 1 
Force constant cool 2 
Dihedral angle restraints 
Force constant high temp 
Force constant cool 1 



























TAD high temperature 
TAD time-step factor 
Cartesian high 
temperature 
Cartesian first iteration 
Time-step 
Cool1 final temperature 























Table 4.1 Violation analysis and partial assignment settings used in ARIA for structure 
calculation of N-CIRP. 
!
Table 4.2 (a) Annealing parameters used for structure calculation with CNS. (b) Dynamics 
settings used for structure calculation with CNS. 
!
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4.2.7 Analysis and Refinement of Calculated N-CIRP Structures 
 
Structure calculations initially used 
13
C carbon and 
1
H side chain assignments made 
using the HCCH TOCSY spectra described above for preliminary calculation to 
optimise the calculation method. 10 structures were calculated and to determine the 
quality of the resultant structure ensemble, they were viewed using MOLMOL 
(Koradi, Billeter, & Wüthrich, 1996) and RMSD (root mean square deviation) values 
were calculated. Subsequent calculations included 
15
N backbone assignment 
information as well as peak information from a 3D 
15
N NOESY spectrum.  The 
15
N 
NOESY peaks were assigned for the NH backbone resonance and also the side chain 
protons. The NOESY spectrum also provides proton NOE peaks which give inter-
residue information (section 4.1.3.1), this peak data was also included in the 
calculations to help determine the proximity of amino acids to each other. 10 
structures were calculated again and RMSD values calculated.  
 
To improve the calculated structures further, the HCCH TOCSY spectra assignment 
and peak information was replaced by information from a 3D 
13
C NOESY spectra 
which contained all the information that is included in an HCCH-TOCSY spectra but 
it also provides additional inter-residue information like the 
15
N NOESY spectra with 
extra NOE peaks. This is further described in the results sections. The assignments 
made on the HCCH TOCSY spectra were transferred onto the 
13
C NOESY spectra 
and the extra NOE peaks were also picked and included in the calculation along with 
the 
15
N NOESY information and the RMSD values for the ensemble of 10 structures 





spectra and making assignments of the inter-residue NOE peaks to define contacts 
between helices and strand residues and a further 10 structure calculations. 
 
 The final refinement step taken was by analysis of any restraint violations at the end 
of the calculations. Every violation was analysed and if necessary it was corrected by 
reassigning or being removed. A new round of calculations was carried out each time 
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4.2.8 RMSD Value Calculation 
The RMSD values were calculated by opening the PDB structure ensemble of 10 in 
the MOLMOL software (Koradi et al., 1996). Calculation was made by using the 
option “fit!to first”. RMSD was calculated for all atoms of all residues, the backbone 





N NMR Relaxation Experiments 
15
N T1 experiments were run with 1820 data points in the F2 dimension and 256 
points in the F1 dimension. The delay times used were 64, 128, 256, 385, 513, 641 
and 769 ms. 
15
N T2 experiments were run with 2048 data points in the F2 dimension 
and 256 points in the F1 dimension. The delay times used were 20, 40, 60, 80, 100, 




N} NOE experiments were run with 2048 data points in 





N} NOE ON and OFF with a two second saturation. hnNOES were calculated 
using (I-I0)/I0 (section 4.1.4). 
 
All experiments were run with proton centred at 4.766 ppm and nitrogen at 116.579 
ppm at 25°C by Dr Michelle Rowe on a Varian Inova, 600 MHz spectrometer. The 
data was processed using NMRpipe on Linux PCs and the NMR spectra were 
assigned using the software CcpNmr Analysis 2.0. 
15
N T1 and T2 values were 




H peak volume intensities over time. Each 











H peak height intensity at a given time, t, from the start of the 




I= I0exp(-kt) where k is R1 or R2. 
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4.3 Results 
4.3.1 Resonance assignment of N-CIRP 







are listed in appendix B. Percentage assignments are listed in table 4.3 below.  
 
















































4.3.1.1 Conformation and further assignment of backbone resonances 
The majority of the backbone resonance assignments for N-CIRP were achieved by 
Shu-Ju Hseih using a sequential assignment strategy with the triple resonance 









H HSQC spectrum 
(figure 3.2).  To confirm the assignments already made, a sequential walkthrough of 









Cβ resonance of the previous residue 
(i-1). Using these rules further assignments which were absent were completed with 
the aid of the chemical shift pattern for amino acids in random coil conformation used 
a reference (figure 4.2) (Wishart & Sykes, 1994). The assignment process for residues 
49-52 is shown in figure 4.6. For example, if 50 Gly is i, then i-1is for 49 Phe. The 









N resonance of 50 Gly as shown in the left-hand side 50 Gly strip pair in 
figure 4.6. The CBCANH spectrum (right-hand side) shows the 
13
Cα resonance peak 
Table 4.3 Extent of resonance assignments for N-CIRP. 
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of 50 Gly.  The chemical shifts were linked both forward and backward looking at 
these patterns and matching the peaks at the same 
13
C chemical shifts. If these 
matches could not be made, residues which have unique patterns as described earlier 
in the chapter (section 4.1.1) were searched for and used as a starting point to assign 










Cβ resonances assignment were confirmed and were assigned 
to 100% using the CBCANH and CBCA(CO)NH spectra. The chemical shift values 










Figure 4.6 An example of backbone triple resonance assignment of N-CIRP. The 
CBCA(CO)NH strips are shown on the left and the CBCANH strips are shown on the right for 
each residue. The 
15
N chemical shift position is shown at the bottom of each strip. Sequential 
matches are indicated by a dotted line. CBCA(CO)NH peaks are in green, positive Cα CBCANH 
peaks are purple and negative Cβ CBCANH peaks are orange with the exception of Gly Cα peaks 
which is negative. 
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4.3.1.2 Side Chain Assignment 





C side chain resonances. A 3D 
15
N-edited TOCSY experiment 




H backbone to the side chain 
1
H side chain 
resonances was used to begin the assignment process for each residue. Residue 
specific patterns as described in section 4.1.1 were used to aid the process. Figure 4.7 
shows examples of side chain resonances assigned using the 
15
N-edited TOCSY 
spectra. Peak on the diagonal is the chemical shift of the hydrogen which is bonded to 
the nitrogen at the 
15
N chemical shift indicated. The correlated 
1
H resonances are 
found at this 
1









































H strips showing example assignments for 
1
H side 
chain resonance of residues 7, 20, 59 and 81. The 
15
N chemical shift position of each strip is 
indicated above each strip.  
!
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The majority of the side chain assignments were made using the HCCH-TOCSY 
spectrum. The side chain hydrogen resonance assignments made on the 
15
N-edited 
TOCSY spectra aided this process. The reference chemical shift patterns shown in 
figure 4.3 were also used to identify resonances for specific residues. Resonances 
were identified by moving through 
13
C chemical shift planes. The spectrum shows a 
strip of side chain 
1
H resonances which are bonded to the side chain carbons for every 
residue. A separate strip is seen for every carbon in the side chain of the amino acid at 
the chemical shift plane for that carbon. The peak on the diagonal belongs the 
hydrogen which is bonded to the carbon at that that chemical shift plane. For example, 
at the chemical shift plane of Cα, the hydrogen resonance on the diagonal will belong 




























C resonances. The 
13
C chemical shift of each plane is indicated to the right, which 
is the carbon to which the hydrogen on the diagonal is bonded. The assignment and 
1
H chemical 
shift of the hydrogen on the diagonal is indicated on the left. The assignment and the 
1
H chemical 
shift of the side chain hydrogens are indicated on top. 
  








































C resonances. The 
13
C chemical shift of each plane is indicated to the right, which 
is the carbon to which the hydrogen on the diagonal is bonded. The assignment and 
1
H chemical 
shift of the hydrogen on the diagonal is indicated on the left. The assignment and the 
1
H chemical 
shift of the side chain hydrogens are indicated on top. 
  









C resonances. The 
13
C chemical shift of each plane is indicated to the right, 
which is the carbon to which the hydrogen on the diagonal is bonded. The assignment and 
1
H 
chemical shift of the hydrogen on the diagonal is indicated on the left. The assignment and the 
1
H 
chemical shift of the side chain hydrogens are indicated on top. 
  











4.3.2 Secondary Structure Determination 
Several programs are available for predicting protein secondary structure using 






C. DANGLE was used to compare the predicted N-
CIRP secondary structure with the N-CIRP (1X5S) secondary structure available in 






C were provided by 
Shu-Ju Hseih. 
 
Figure 4.12 shows examples of Ramachandran plots for determining secondary 
structures using the DANGLE prediction program. The middle window shows an 
ambiguous result (residues 16 Asp) indicating this residue is placed in a loop region. 









C resonances. The 
13
C chemical shift of each plane is indicated to the right, 
which is the carbon to which the hydrogen on the diagonal is bonded. The assignment and 
1
H 
chemical shift of the hydrogen on the diagonal is indicated on the left. The assignment and the 
1
H 
chemical shift of the side chain hydrogens are indicated on top. 
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The left window shows β-strand prediction (residue 9 Phe). Residue 60Ala in the right 
window shows an α-helix prediction. Ramachandran plots were analyzed for each 


















The comparison between the 1X5S structure and the secondary structure predicted by 
DANGLE is shown in figure 4.13. The predicted secondary structure is largely similar 
to that of the structure 1X5S. The α- helices are especially similar being almost 
identical in length and in the same region of the sequence. The DANGLE prediction 
for α1 being identical to the 1X5S structure between residues 19-29 and α2 was only 
one residue shorter in the DANGLE prediction between amino acids 57-66 instead of 
57-67.  The length of the β-strands are different, generally shorter than the 1X5S 
structure except for β2 being longer. DANGLE predicted β as 3 residues long (8-10) 
whereas the sheet was placed between residues 7-11 in 1X5S. Similarly DANGLE 
prediction for β3 was 3 residues long (51-53) but 49-53 in 1X5S. β2 however was 
predicted to be across 6 residues (34-39) by DANGLE but it was shorter in 1X5S, 
(34-37).  Even though the length of the strands varied between DANGLE and 1X5S, 
they were predicted to be in the same region in both.  β4 shows the most dissimilarity 
being more upstream in the DANGLE prediction (71-80) and also longer than the 
1X5S strand (78-83).  
 
The secondary structure arrangement of N-CIRP was also compared to the RNA 
binding protein hnRNP1A RRM1 whose structure has recently been solved (Barraud 
Figure 4.12 Representative global likelihood estimate (GLE) diagrams of Ramachandran 
space distribution plots from DANGLE for residues 9,16 and 60 of CIRP that were predicted 
to be a section of β-sheet, loop and α-helix). Bins with B-scores below the threshold value are in 
white; other bins are shaded from red (threshold value) to black (Bmax)  
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& Allain, 2013) and this protein displays a typical RNA binding protein fold. It 
possessed two RNA binding domain similar to one another, figure 4.13 is showing the 
RRM1 domain. The secondary structure arrangement of hnRNPA1 RRM1 is similar 
to that of N-CIRP with the exception of an extra strand and each of the secondary 
structure elements being further downstream in the sequence.   β1 and α2 are of a 
similar length as in N-CIRP. β4 and α1 are longer in N-CIRP than in hnRNP1A 
RRM1 and β2 and β3 are shorter in length.  β strand and α sheet information is 
heavily defined by hydrogen bond information. No hydrogen bond data was collected 
















Figure 4.13 Schematic representation of the secondary structure of N-CIRP in the protein 
data bank (1X5S) and predicted secondary structure of N-CIRP using DANGLE. Also shown 
here is the sequence and secondary structure of the RNA binding protein hnRNPA1 RRM1 
(2LYV) which has a similar structure to the human CIRP structure. Sequence numbering is 
indicated above the sequence and prediction is shown below the sequence; α-helices are 
represented by cylinders and β-strands are represented by arrows. 
!
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4.3.3 N-CIRP Structure Calculations 
Many steps were carried out during the process of calculating the structure of N-
CIRP. A summary of the process is shown in the table 4.4 below, where the qualities 
of the structures were assessed by the RMSD value.  
 
 RMSD (Å)- 
Total Backbone 
RMSD (Å)- 
Structured Regions Backbone 
13C NOESY data 3.96 2.23 
13C NOESY and 15N NOESY data 3.45 2.10 
+ Manual Assignments 2.82 2.2 
Violation correction 1 3.75 1.22 
Violation correction 2 2.14 1.16 
Violation correction 3 3.03 1.56 
Violation correction 4 3.51 2.70 
Violation correction 5 4.12 3.32 
Violation correction 6 2.77 1.01 
Violation correction 7 2.17 1.03 








4.3.3.1 NOESY spectra and Manual NOE Assignments 
13
C HCCH-TOCSY and 
15
N-edited TOCSY spectra were useful for the assignment of 
N-CIRP resonances. These spectra provide residue information but do not provide 
inter-residue data. 3D 
13
C NOESY and 
15
N NOESY spectra contain equivalent peaks 
to the TOCSY spectra but also have extra peaks which provide through space inter-
residue information. Having this extra inter-residue information is essential for 
structural calculations. The peak assignments on the HCCH TOCSY spectra were 
transferred to the 
13
C NOESY spectra as well as picking the extra inter-residue NOE 





N NOESY spectra. The chemical shift information of the assigned 
N-CIRP resonances taken from the NOESY spectra and the unassigned NOE peaks 
were used for the structure calculations in ARIA (figure 4.14). 
 
Table 4.4 Summary of the N-CIRP structure calculation and violation analysis process.  For 
the RMSD calculations backbone atoms C, Cα and N were considered and for structured regions, 
secondary structure elements as predicted by DANGLE were used.  
!

















Once the transfer of the assignments were complete and all NOE cross peaks were 
selected, this data was used to run an automated structure calculation of N-CIRP using 
the ARIA software. Initially calculations were carried out using the 13C NOESY 
assignments and peak data only, i.e. without any 15N-1H assignment information. The 
calculated ensemble had a backbone RMSD of 3.96 Å and was showing initial 
formation of the secondary structure elements (figure 4.15).  3 strands could be seen 
out of a total of 4 determined with DANGLE  (section 4.3.2) and out of the two 












Figure 4.14 The process of assignment transfer from HCCH TOCSY spectra to the 
13
C 
NOESY spectra and the identification of the NOE cross peaks which are indicated by circles. 
!





assignment data. The structure ensemble was produced by fitting al 10 structures together by the 
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After this, another calculation was carried out using both 13C NOESY and 15N 
NOESY assignments and peak information. The structure ensemble from this 
calculation had a lower backbone RMSD value 3.45 Å and the regions with the 
secondary structure elements looked more defined and tightly fitted together and one 






To increase structural precision, more data was included in the ARIA structure 
calculation. More data, which gives indication of how the protein is folded in space 
and which, add restraints to calculation. This was achieved by making manual NOE 
assignment using the CcpNmr analysis software. ARIA software makes automated 
ambiguous NOE assignments to calculate the structure of the protein, the addition of 
correct unambiguous manual assignments result in a more accurate structure.  
Parameters reported by Barsukov and Lian (table 4.5) were used to identify NOE 
cross peaks of resonances close in space. These parameters are helpful to define 
secondary structures, and short and medium range interaction between strands. 
 
Some assignments were also made by examining the calculated structure (figure 4.16) 
and identifying potential NOEs between residues, which appeared in close proximity 












assignment data. The structure ensemble was produced by fitting al 10 structures together by the 
secondary structure backbone in MOLMOL. 
!







Approximately 260 cross peaks were identified and assigned, the majority of these 
were made using the 
15
N NOESY spectra (220) (figure 4.18) and the remainder on 
13
C 
NOESY (figure 4.17).  
 
For example, the first 
13
C NOESY strip on figure 4.17 shows that a cross peak on the 
8 Val 
13
Cα strip had been assigned to 52 Hα, this assignment was made through 
examination of the calculated structures and discovering that these two residues on 
strands β1 and β3 respectively are close in space and the presence of the cross peak 
confirmed that these two strands run alongside each other. Also seen on strip 3, the 52 
Val Hα on β3 and 35 Val Hα on β2 are in close distances to each other suggesting that 
strands β3 and β2 are antiparallel to each other. From this we can conclude that the 
strands β1-3 are antiparallel in the order of β1, β3 and β2. The strips 2 and 4 shows 
the dαβ(i, i+3) parameter where 22 and 57 Hα are i and 25 and 60 Hα i+3. This 
suggests that these residues are in an alpha helix formation in the structure. This 
agrees with the DANGLE prediction (section 4.2) from where these residues are 





Parameter α-Helix 310-Helix β-Anti-parallel β-Parallel 
dαN(i, i) 2.6 2.6 2.8 2.8 
dαN(i, i+1) 3.5 3.4 2.2 2.2 
dαN(i, i+2) 4.4 3.8   
dαN(i, i+3) 3.4 3.3   
dαN(i, i+4) 4.2 (>4.5)   
dNN(i, i+1) 2.8 2.6 4.3 4.2 
dNN(i, i+2) 4.2 4.1   
dβN(i, i+1) 2.5-4.1 2.9-4.4 3.2-4.5 3.7-4.7 
dαβ(i, i+1) 2.5-4.4 3.1-5.1   
dαα(i, j)   2.3 4.8 
dαN(i, j)   3.2 3.0 
dNN(i, j)   3.3 4.0 
3
JHN-Hα (<4) (<4) (>9) (>9) 
NH exchange rate slow slow slow slow 
Table 4.5 Parameters that are useful for secondary structure identification; short sequential 




H distances, vicinal coupling constants and amide hydrogen exchange 
rates. The most readily available parameters are highlighted in bold adapted from Barsukov & 
Lian, 1993. 
!


















































Figure 4.17 Example of 
13
C NOESY strips showing cross peak assignments. The 
13
C chemical 
shift position is indicated above each strip. 
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Similar assignments were also made on the 
15
N NOESY spectra (figure 4.18). For 
example residues 40 Asp and 56 Asn shown in strips 2 and 3 correlate with the prior 
amino acids 39 and 55 NOE peaks, suggesting that these residues are in strand 










































Figure 4.18 Example of 
15
N NOESY strips showing cross peak assignments. The 
15
N chemical 
shift position is indicated above each strip.! 
!
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ARIA structure calculation was performed following the addition of the manual NOE 
assignments. The ensemble of the 10 calculated structures had a significantly 
improved backbone RMSD of 2.82 Å.  The structures showed that one of the helices 
and two strands was very well defined, with the second helix and the other two 
strands also formed but not as tightly fitted together (figure 4.19). A higher agreement 
of the loop regions between the structures was also observed.  The structure also 
looked more condensed with the strands and helices in better agreement with each 









4.3.3.2 Structure Refinement 
 
All NOE data from 13C NOESY spectra, 15N NOESY spectra and the manual NOE 
cross peaks assignments were used for all proceeding calculations. To improve the 
structures after each calculation the NOE violation list was analysed. Each violation 
was checked on the appropriate spectra using CcpNmr analysis software and either 
corrected or if necessary removed. An improvement in the RMSD value was observed 
after each calculation and the checking of the violations list. 8 rounds of these 
corrections were performed as summarised in table 4.5. The most improved structure 
is shown in figure 4.20 below. This ensemble had a backbone RMSD value of 1.63 Å 





Figure 4.19 N-CIRP structure ensemble as calculated by ARIA after addition of manual NOE 
assignment data. The structure ensemble was produced by fitting al 10 structures together by the 
secondary structure backbone in MOLMOL. 
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structured regions was 0.89 Å. The 10 calculated structures appeared tightly fitted 
together and in agreement for both the loop and the structured regions. 4 well defined 
strands and 2 helices were easily identifiable with the strands in the order of β4, β1, 
β3, β2. The boundaries for the strands and helices were found to be in agreement with 
the DANGLE secondary structure determination in sections 4.3.2 and also with the 








The figure 4.20 shows the most refined version of the N-CIRP structure calculated 
during this project. A more precise structure can be achieved by the addition of 














Figure 4.20 Final N-CIRP structure ensemble as calculated by ARIA after rounds of violation 
corrections. The fitted ensemble structure was produced by fitting all 10 structures together by the 
secondary structure backbone in MOLMOL. 
!




N T1,T2 and hnNOE Relaxation Experiments  
To study N-CIRP dynamics, relaxation experiments were used. 
15
N HSQC 
experiments were set up with a series of T1 or T2 relaxation delays. T1 and T2 values 
were obtained by measuring peak volumes after a range of relaxation delays (figure 
4.21). T1, T2 and hnNOE values for each residue are listed in appendix C. 
 
Figure 4.21 shows example relaxation decay curves for residues across the N-CIRP 
protein. These were generated in the CcpNmr Analysis software by following peak 
volume changes of each amino acid peak on the HSQC spectra collected with a range 
of relaxation delays. These were then used to produce T1 and T2 values (figure 4.22) 























































































Figure 4.21 Example relaxation decay curves for the calculation of T1 and T2 values. 
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The relaxation times shown by the scatter graphs (figure 4.22) give an indication of 
protein motion. Relaxation times for all 3 parameters (T1, T2, hnNOE) did not change 
significantly across the central regions of the protein. A small increase in the T1 values 
were observed at the N- and C-terminal residues with an average T1 time of 0.64±0.06 
s across the protein.  Similarly the T2 times also showed a small increase at the 
termini residues with an average T2 of 0.15±0.04 s. The hnNOE values were also 
similar across the centre of the protein with a -0.23±0.33 average. The extreme 
residues at the N- and C-termini had values more negative hnNOE compared the rest 







































































































Figure 4.22 Plots of 
15
N T1, T2 and heteronuclear NOE relaxation rates. 
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T1 vs. T2 plot (figure 4.23) shows the T1 and T2 values for all residues of N-CIRP. The 
plot includes dipolar relaxation curves (600 MHz) for the order parameters S
2
 and τm 
provided by Mark Howard. The data points on the plot were packed tightly together in 
the same region, except for the termini residues, which were diffused across the graph 
as labelled on the plot. The average 
15
N T1 value was calculated as 0.63±0.03 s and 
the 
15
N T2 value was 0.14 ± 0.01 s. The average S
2
 value was 0.77 ± 0.08 and the 
























































T1 and T2 of each amide of N-CIRP. Contour lines are shown for S
2 
order 
parameter and τm. 
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4.3.5 ModelFree Calculated Order Parameters 
The T1, T2 and NOE relaxation times were used for ModelFree analysis to better 
understand N-CIRP motion. S
2
 and τe values were calculated for each residue  
(appendix C). S
2
 is an order parameter and describes spacial restriction of internal 
motion, S
2
=1.0 meaning complete rigidity. τe is a measure of the correlation time of 
exchange and has been used to describe timescale of internal motion.  
S
2
 values (figure 4.24) for each residue of N-CIRP revealed that the order parameter 
across the protein is similar for most residues being at around 0.8. This value agrees 
with the average S
2
 calculated from the T1 vs. T2 plot contours (0.77 ± 0.08). S
2
 was 
reduced closer to 0 for the residues at the termini. A similar pattern was observed for 
the τe values across N-CIRP, most being around 0.0 and an increase was seen for the 
termini residues. A small change was seen in the order parameter S
2
 in loops between 




































































Figure 4.24 Plots of Model Free parameters S
2
 and τe%against N-CIRP residue number.  
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4.4 Discussion 
In this chapter N-CIRP structure and dynamics was investigated to help further our 
understanding of this RNA binding domain by looking at mobility solution and its 
fold. The secondary structure prediction using DANGLE confirmed that the protein 
has topology of β1α1β2β3α2β4 (figure 4.1.3) and in agreement with the PDB 
structure (1X5S) and also similar to the RRM1 domain of RNA binding protein 
hnRNPA1 (Barraud & Allain, 2013). For structure calculations, resonance assignment 
of N-CIRP backbone and side chains were sufficient to run automated structure 
calculations.  The backbone resonances 1H and 15N were completely assigned for each 
residue and the other components Cα, Cβ, Hα,Hβ and Hγ were all assigned  for above 
90% of the residues (table 4.3).  All assignments can be found in appendix B. 
 
Following the assignment, N-CIRP structures were calculated using an automated 
procedure. Manual NOE assignment can be a very time consuming process so ARIA 
software was chosen for the calculation process as this makes automated ambiguous 
assignment (Linge et al., 2001). NOE manual assignments were also included at later 
stages (figures 4.17 and 4.18). ARIA was found to operate well, as even after the very 
initial structure calculation only using 13C and 1H data, structured regions and a 
general fold of the protein was visible with an RMSD of 2.23 Å over regions with 
secondary structure. With the addition of extra data from the 15N NOESY spectrum 
and some manual NOE assignments, the RMSD values did not reduce significantly 
specifically over the structured regions (table 4.4.). However, the analysis and 
correction of the violations improved the structure significantly where the final 
RMSD value was 1.63 Å over the whole protein backbone and 0.89 Å for the regions 
in secondary structure. Having an RMSD below 1.0 Å is very good at this stage of 
structure determination before the addition of extra information such as dihedral 
angles and hydrogen bonds which are what really condense and tighten the structure 
(Barsukov & Lian, 1993; Cavanagh et al., 2007).  
 
Due to the large variety of studies carried out during this project to investigate N-
CIRP function, time was not available to complete the structure with the dihedral 
angle and hydrogen bond information, which will have to be done in the future. 
However the final structure achieved here provides information on the topology of the 
protein and enables the RNA binding sites on β1 and β3 to be located (figure 4.25). 
Discussion                      Chapter 4: Structural and Dynamics Analysis of N-CIRP 
! !139!
The two RNA binding motifs are on the strands 1 and 3 as predicted by the secondary 
structure analysis by DANGLE (Cheung, Maguire, Stevens, & Broadhurst, 2010). 
The phenylalanine residues which were reported to be essential for RNA binding by 
Maris et al’s model (figure 1.8) are shown in figure 4.25 (Maris, Dominguez, & 
Allain, 2005). The positions of these agree with the model shown in Chapter 1 ( 
section 1.4.2) where the aromatic rings in position 2 of RNP2 (in this case F9) and in 
position 5 of RNP1 (F51 in this case) are predicted to ring stack. Looking at the 
position and the close proximity of these two residues this is also the case for N-CIRP 
(figure 4.25). The residue F49 which is the position 3 of RNP1 is thought to interact 
with the RNA ribose sugar and phosphate backbone. This agrees with the finding in 
the previous chapter (3) where the mutation of this residue had the largest effect on 
RNA binding of N-CIRP as well as inducing a significant structural change (sections 









Figure 4.25 Ribbon structure of N-CIRP. RNP1 and RNP2 residues on β1 and β3 are shown in 
red.! 
.  
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N-CIRP possesses a fold typical of an RNA binding protein. The solved structure of 
human N-CIRP confirmed this (figure4.26 (b)) and having the typical β1α1β2β3α2β4 
(Sheikh, 1997). The DANGLE software predicted mouse N-CIRP also has this 
topology and the structure determined has a very similar fold to the human protein 
(figure 4.26 (a)). To confirm the RNA binding fold the N-CIRP structure was 
compared to the structure of another typical RNA binding protein hnRNPA1 RRM1 
(Barraud & Allain, 2013) (figure 4.26 (c)).  Both human and mouse N-CIRP have a 
very similar fold to that of hnRNPA1 RRM1 except the absence of a strand, however, 
when looked at closely, mouse N-CIRP has a long β4 strand which curves around 
(figure 4.26 (a)) and hnRNPA1 RRM1 has a β4 strand very closely followed by β5 in 
a similar position to where the mouse N-CIRP β4 curves around. So it may be that 
CIRP also posseses an extra strand here that was not picked by DANGLE or even 























Figure 4.26 Ribbons structures of mouse N-CIRP (the structure closest to the mean) (a), 
human N-CIRP (PDB- 1X5S) (b) and hnRNPA1 RRM1 (PDB- 2LYV) (c).  
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The calculated structure was further analysed by superimposing with human N-CIRP 
as well as the structure of hnRNPA1 RRM1.  This process was carried out using the 
web-based software DaliLite (Holm & Park, 2000).  The superimposition between 
human N-CIRP and mouse N-CIRP gave an RMSD value of 2.6 Å over 75 residues, 
which were picked by the software as equivalent between the two structures. The 
RMSD value between mouse N-CIRP and hnRNPA1 RRM1 was 2.5 Å over 72 
equivalent residues.  The close similarity of the structure to both human N-CIRP and 
hnRNPA1 RRM1 confirms the RNA binding protein fold of the protein and it 
accuracy. The superpositions showed that two proteins aligned well with mouse N-
CIRP on both cases specifically at the secondary structure regions. There is no doubt 
that mouse N-CIRP shares the same fold as human N-CIRP and the RMSD value will 













Figure 4.27 The superimposition of mouse N-CIRP structure with human N-CIRP or 
hnRNPA1 RRM1 achieved using DaliLite software (www.ebi.ac.uk/Tools/structure/dalilite). 
Mouse N-CIRP backbone is shown in green and human N-CIRP and hnRNPA1 RRM1 backbone 
in navy. (a) mouse N-CIRP and human N-CIRP, (b) mouse N-CIRP and hnRNPA1 RRM1. 
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The NMR dynamics data gained from the relaxation experiments revealed that N-
CIRP is rigid except for some flexibility at both termini. If the protein is rigid and 
tumbles isotropically, the T1, T2 and hnNOE values will be the similar at each site 
(Kleckner & Foster, 2011). The data points on the T1 scatter graph revealed that T1 
values were 0.6-0.7 s for most residues (figure 4.22). There were no extreme rises or 
dips except a small increase for the extreme residues at the N- and C-termini. This is 
expected as most proteins have increased motion at the termini (Jacob & Unger, 
2007). The loop regions can be flexible regions of proteins however this was not 
observed here. Variation of the T1 value across protein suggests anisotropy (Palmer, 
2001), but the similarity of values across the protein show that N-CIRP is isotropic. 
The same was found from the T2 data with most of the residues having a T2 value of 
around 0.15 s (figure 4.22). The T2 time parameter also gives and indication of the 
size of protein but also reduction of T2 indicates chemical exchange (Palmer, 1997). 
This further confirms that WT N-CIRP is isotropic and not involved in any chemical 
exchange.  
 
The hnNOE becomes more negative as picosecond motion increases (Brüschweiler, 
2003; Palmer, 2001). hnNOE values across most residues were approximately -0.2, 
this became more negative for residues in the termini (figure 4.22). Termini residues 
are expected to have elevated motion, but the rest of N-CIRP displays little 
picosecond motion.  
 
The isotropic nature of N-CIRP was confirmed from the T1 vs T2 scatter plot that 
provided  concentrated focus of points (figure 4.23). In this plot, the termini residue 
points were more dispersed but this is as expected as it reflects faster motion in these 
regions. Dipolar relaxation contour lines for τm and S
2
 were plotted on the T1 vs. T2 
plot to estimate the S
2 
and τm values for N-CIRP.  As the majority of data points 
concentrate in one region of the plot, this suggests most residues have a similar S
2
 and 
τm values i.e. the protein has a similar motion across all regions. The average S
2 
value 
was estimated to be 0.77 ±0.08 from this plot and indicates that the protein backbone 
is fairly rigid with little internal motion. A value of 6.8±0.21 ns was estimated from 
the plot for the τm, this is a typical tumbling time of a protein of such molecular 
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weight (11.6 kDa), as the estimated value calculated using the Daragon & Mayo 
equation (Daragan et al., 1997) (equation 4.7) was 6.3 ns. 
 
To further describe dynamic motion in N-CIRP, ModelFree analysis was used. This 
uses the T1, T2 and hnNOE times to produce S
2
 order parameters for each residue and 
τe internal motion correlation times without the need of a structural model. T1, T2 and 
hnNOE values were imported into ModelFree to produce S
2
 and τe values, which were 
plotted against residue number (figure 4.24).  The S
2 
values were similar for most 
residues with the exception of the residues at the N- and C-terminus, which have a 
lower order, as they are more flexible. The residues in the loop regions between sheets 
β2 and β3 and also between α2 and β4 showed a small change of 0.05 to 0.1 in the 
order parameter suggesting these regions have some increased motion and are less 
rigid compared to the rest of the protein. The change in S
2
 on the β2-β3 loop is 
interesting as this the region just before the RNP1 sequence including F49. This 
agrees with the findings of Chapter 3 where the mutation of this residue was found to 
have an effect on N-CIRP structure (section 3.3.2). This region appears more dynamic 
on the pico to millisecond time scale compared to the rest of the protein. The 
remaining residues had a value of around 0.8, which agrees with the value calculated 
from the T1 vs. T2 plot suggesting a significant degree of backbone rigidity with little 
motion that is common with a compact structure. τe values for most residues were also 
very small, with some motion in the same loop regions, agreeing with the rest of the 
calculated parameters. N-CIRP is a rigid protein with the exception of some motion at 
the termini. The loop regions are expected to be more flexible and also the RNA 
binding sites of RNP1 and RNP2 at β1 and β3 may have been expected to have more 
motion but this was not observed at the fast timescales that were analysed 
(picoseconds to milliseconds) and this may have been due to the absence of a ligand. 
The mobility of the residues at the termini was as expected as these regions are often 
more flexible in a protein due to fewer structural constraints (Jacob & Unger, 2007).  
 
In conclusion, this chapter gave an insight to the structure and dynamic properties of 
N-CIRP. N-CIRP adopts the expected RNA binding fold as seen in the human 
protein. This structural information can be used to make assumptions as to the RNA 
binding mechanisms that N-CIRP follows by utilising data already known about 
proteins which also possess this typical RNA binding protein structure. In the absence 
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of a ligand, N-CIRP does not display much motion at the picosecond to millisecond 
timescale and is relatively rigid with the exception of the N- and C-terminal residues 
as well as the protein being isotropic and mouse N-CIRP has typical RNA a binding 
protein structure very similar to human N-CIRP. 
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5.1 Introduction 
As described in the introduction chapter of this thesis, expression of CIRP (Cold-
Inducible-RNA-Binding-Protein) is up-regulated in mammalian cells upon perception 
of mild cold-shock  (27-32°C) (Nishiyama, Higashitsuji, et al., 1997). Culturing of 
cells at these temperatures can also result in improved recombinant protein yields, 
improved protein folding and activity (Al-Fageeh, Marchant, Carden, & Smales, 
2005; Masterton, Roobol, Al-Fageeh, Carden, & Smales, 2010). CIRP has also been 
suggested to bind to key proteins involved in the control of mRNA translation 
initiation, potentially acting as a bridge between the mRNA and the protein synthesis 
machinery.  RNA binds to the RNP1 and RNP2 sequence present on the N-terminal 
domain of CIRP as described in Chapter 3 (section 3.3.3).  CIRP also has an 
arginine/glycine rich C-terminal domain, which is natively disordered with an 
unknown function (Shu-Ju Hseih 2010). This chapter describes the generation of 
CIRP constructs to assess the influence of CIRP on recombinant protein production, 
and to investigate whether modulation of CIRP, N-CIRP and C-CIRP influences 
mRNA translation/protein synthesis, and to investigate potential binding partners of 
CIRP. Through such investigations, a better understanding of the function of CIRP 
and its involvement in mechanisms which upon mild hypothermia lead to improved 
recombinant protein production can be achieved. 
  
CIRP has been reported to bind the 3’UTR of particular mRNAs resulting in an 
increase in their translation (Yang & Carrier, 2001; Yang et al., 2010). One of these is 
the 3’UTR of the ATR protein (ataxia telangiectasia mutated and Rad3 related kinase) 
and it has also been shown that overexpression of CIRP leads to increased ATR 
protein levels (Yang et al., 2010).  ATR belongs to a family of protein serine 
threonine kinases and the ATR signalling pathway is associated with cell cycle arrest 
due to compromised DNA replication (Abraham, 2001). This mechanism is described 
in more detail in chapter 1 (section 1.4.3). It is possible that CIRP may play a role in 
this cold induced phenotype by, upon its up-regulation, binding to the 3’UTR mRNA 
of ATR leading to an increase in ATR protein amounts. The cell cycle arrest response 
to cold shock is thought to be a primary cold-shock response that contributes to 
increased protein production at such temperatures in mammalian cells (Kumar, 
Gammell, & Clynes, 2007).  
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It has been suggested that the binding of CIRP to the 3’UTR of specific mRNA 
results in an increase in their translation and is mediated by an interaction between 
CIRP, the mRNA and the translational machinery (Yang, Weber, & Carrier, 2006). 
This mechanism was supported by the studies of Yang et al who reported that CIRP 
binds to the eukaryotic initiation factor 4G (eIF4G).  From these observations it is 
hypothesised that through the interaction with 3’UTRs and eIF4G, CIRP acts as a 
bridge between 3’ and 5’UTRs to increase translation. The translation initiation 
process (figure 1.9) and the role of eIF4G is discussed in detail in chapter 1 (section 
1.4.3). 
 
As described in detail in chapter 1, CIRP consists of a well-characterised N-terminal 
domain and a natively disordered C-terminal domain. A further investigation 
undertaken here was to express each of the two domains on their own in CHO cells to 
determine if either has aspects of CIRP function.  CIRP constructs of full-length, N-
terminal and C-terminal were therefore generated in mammalian cell expression 
vectors to study the interaction of these regions with RNA and protein and their effect 
on recombinant protein production in Chinese hamster ovary (CHO) cells.  
 
5.1.1 CIRP Expression in Mammalian Systems 
To be able to investigate CIRP function and its effect on recombinant protein 
production in mammalian expression systems, the industrially relevant CHO (Chinese 
hamster ovary) cell line was used as a model system. Mammalian cells are used 
extensively for the production of recombinant proteins because of their ability to 
correctly fold and assemble polypeptides and proteins and are able to perform human-
like post translation modifications (Andersen & Krummen, 2002; Baldi, Hacker, 
Adam, & Wurm, 2007; Chu & Robinson, 2001; Pham, Kamen, & Durocher, 2006). 
The dominance of this system is demonstrated by the fact that of the 58 
biopharmaceuticals approved between 2006 and 2010, 32 were expressed in 
mammalian systems (Walsh, 2010). CHO cells are widely used for the production of 
recombinant proteins as they produce high yields rapidly, with good product quality 
and have regulatory authority approval (Ye et al., 2009). Nearly 70% of recombinant 
therapeutic proteins are made in CHO cells and this is expected to be maintained in 
the next decade (Jayapal, Wlaschin, Hu, & Yap, 2007; Yeon-Gu, 2012). The 
advantages of using CHO cells in an industrial setting include human-like post 
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translational modification capacity, low specific productivity can be overcome by 
gene amplification, CHO cells can produce recombinant protein with glycan forms 
that are compatible with, and bioactive in, humans and can be easily adapted to grow 
in the regulatory friendly serum-free suspension conditions for large scale production 
(Kim, Kim, & Lee, 2012). Recently use of temperature reduction from 37°C to 32-
34°C during industrial fermentation to enhance recombinant protein production has 
been popular. As such, a better understanding of how CHO cells respond to reduced 
temperature, and whether CIRP induction can be linked to the use of specific 3’-UTR 
elements to improve recombinant protein production was investigated here. 
 
In order to manipulate the expression of CIRP and the N- and C-terminal domains, the 
gene sequences for these were cloned into the commercially available pcDNA5/FRT 
vector to allow their over-expression in CHO cells. The pcDNA5/FRT mammalian 
expression vector system possesses a human CMV (cytomegalovirus) promoter for 
high level expression of the gene of interest (Andersson, Davis, Dahlbäck, Jörnvall, & 
Russell, 1989; Boshart et al., 1985; Nelson, Reynolds-Kohler, & Smith, 1987). It has 
10 unique restrictions sites for easy cloning of the gene of interest and ampicillin 
resistance. The vector also contains a FLP Recombination Target (FRT) site which 
allows integration of the vectors into a specific site in the FlpIn host cell genome 
allowing for the generation of stable cell lines when transfected together with the Flp 
recombinase expressing pOG44 vector and the hygromycin resistance gene allows for 
the selection of stable cells lines (Gritz & Davies, 1983). The Flp recombinase allows 
a recombination between the FRT sites (Craig, 1988; O’Gorman, Fox, & Wahl, 1991; 
Sauer, 1994).  When the FRT vector is inserted into the genome at the FRT site, the 
SV40 promoter and ATG initiation codon is in frame with the hygromycin resistance 
gene so cells with the FRT vector integrated can be selected (Figure 5.1). This makes 
the FRT plasmid a good expression vector for the expression of CIRP in CHO cells as 
it yields high protein expression through the generation of stable cell lines, or 
conversely, the vector can be used for transient expression whereby the vector is not 


























5.1.2 Protein-Protein Interactions 
To study the interaction between eIF4G and CIRP it is necessary to investigate 
protein-protein interactions. There are various methods of studying protein-protein 
interactions. Co-immunoprecipitation (Co-IP) is one of the most commonly used 
methods to determine protein binding partners. This method uses the specific 
interaction between an antibody and the protein of interest given that the antibody-
protein interaction does not disrupt the protein interactions of interest. It is one of the 
most convincing methods to provide evidence that two or more proteins interact in 
vivo (Monti, Orrù, Pagnozzi, & Pucci, 2005; Ren, Emery, Kaboord, Chang, & 
Qoronfleh, 2003). Co-IP is performed under conditions that preserves protein-protein 
interactions even when cells are lysed and protein solubilised. The antibody specific 
for the protein of interest is incubated with the cell lysate to allow the antibody and 
protein to form a complex. After the antibody is bound to the protein, the complex can 
be isolated from the cell lysate using protein A or protein G, which will bind to the 
!
!
Figure 5.1 Schematic representation of the integration of the commercially available FRT 
expression plasmid into the host cell genome  (Invitrogen Flp-In System Manual).! 
!
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antibody bringing with it any protein that interacts with the target protein (Miernyk & 
Thelen, 2008). When this procedure is carried out with the appropriate controls, 
proteins that specifically interact with the protein of interest can be identified 
successfully. There are many advantages to using this method to study protein 
interactions; it allows high specificity, it is a relatively easy method to carry out and it 
is compatible with a number of subsequent analysis protocols (e.g. SDS-PAGE, 
western blotting) and it allows the study of protein-protein interactions in vivo 
(Miernyk & Thelen, 2008). 
 
 As CIRP binding has only been studied by NMR methods in vitro, this was a suitable 
method to study the interaction of CIRP, N-CIRP and C-CIRP in vivo with other 
proteins. This approach was simplified further here by the addition of a V5 tag to the 
CIRP constructs, as the highly specific V5 antibody could be used to carry out the Co-
IP experiments. Importantly, studies in the laboratory at Kent have shown that the V5 
antibody does not recognise any CHO cell proteins and hence will only result in the 
pull down of recombinant CIRP that is V5 tagged. A potential disadvantage of this 
method is that attaching a tag at the N- or C-terminal end of CIRP, N- and C-CIRP 
may interfere with protein-protein interactions. 
 
5.1.3 The Effect of CIRP on Recombinant Protein Production 
Overexpression of CIRP in mammalian cells has been shown to lead to increased 
recombinant protein expression (Tan, Lee, Yap, & Wang, 2008). Further, reduced 
temperature culturing of mammalian cells results in the up-regulation of CIRP 
expression and this is associated with enhanced recombinant protein production and 
improved protein quality (Al-Fageeh & Smales, 2006). Here, whether over-expression 
of CIRP and its interactions with eIF4G and specific mRNAs can be 
used/manipulated to further enhance recombinant protein production was 
investigated.  
 
In order to determine the effect on recombinant protein production, there are a number 
of approaches to determine the amounts of recombinant protein expressed by the cell. 
This can be done by transfecting the cells with a reporter gene and determining its 
expression levels after the desired manipulation(s) have been made.  Detection of 
protein expression in cells through reporter bioluminescence is a commonly used 
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technology and often utilises recombinant luciferase expression. Luciferases are 
oxidative enzymes that catalyse the oxidation of a substrate, luciferin, to form 
oxyluciferin with the emission of a photon (Thorne, Inglese, & Auld, 2010).  The 
emission of the photon can be measured and quantified which is directly correlated to 
the amount of luciferase protein expressed by the cell. Therefore, this is a good 
method for studying how manipulations to the cellular machinery effect the amount of 
recombinant protein that is expressed, in this case the effect of CIRP manipulation on 
recombinant luciferase expression.  Further advantages of using luciferase are (1) 
measurement of luminescence does not require excitation, which lowers the 
background signal resulting in a sensitive assay unlike other methods such as 
fluorescence (Simeonov et al., 2008), (2) measurement of dynamic changes in 
reporter expression can be determined (Corish & Tyler-Smith, 1999), and (3) the 
detection is simple using commercially available reagents containing the substrate and 
changes in protein expression can be detected by making comparisons to the 
appropriate controls.  
 
Two commonly used luciferase assays are firefly and gaussia luciferase. Firefly is an 
intracellular protein, which requires the lysis of cells before the detection reagent can 
be added and gaussia is a secreted protein and can be detected in the culture media. 
Both these assays were used in this project as described below in the appropriate 
sections.
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5.2 Materials and Methods 
5.2.1 Cloning  
 For the expression of CIRP, N-CIRP and C-CIRP in mammalian systems, the gene 
sequences were cloned into the pcDNA5/FRT plasmid using the pcDNA3.1 plasmid 
as a template. The appropriate gene sequences were initially cloned into the 
pcDNA3.1 plasmid to add the V5 tag onto the gene sequence. The sequences were 
then sub-cloned from the pcDNA3.1 vector into the pcDNA5/FRT vector. The 
template DNA used for the cloning was the pet28a(+) vector containing the CIRP 
gene as described in Chapter 2 (section 2.1.1).  CIRP constructs created in the 







To create the CIRP constructs with an N-terminal V5 tag, the region of the vector 
containing the V5 tag followed by a His6 tag was amplified by polymerase chain 
reaction using the V5HIS Forward and Reverse primers (Table 5.1) and pcDNA3.1 
plasmid DNA as template. The amplification region was from the Xba1 site to the end 
of the His tag but did not include the stop codon. An Nhe1 site and start codon was 
added to the 5’ and a BamH1 site to the 3’ end to aid with ligation into the FRT vector 
(figure 5.3).  The V5+His tag fragment was then cloned into the pcDNA5/FRT at the 
BamH1 and Nhe1 sites making a construct with an N-terminal V5 tag which the CIRP 
genes could be cloned into. 
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Figure 5.2 Schematic diagram of CIRP constructs generated with and without N/C-terminal 
V5 tag.  N-terminal domain is described as amino acids 1-86 and the C-terminal domain 87-172. 
These are shown in figure 2.3 in Chapter 2. 
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For the FRT plasmid containing the CIRP truncation with an N-terminal V5 tag, 
pet28a(+) CIRP vector was used as a template to amplify CIRP, N-CIRP and C-CIRP. 
The primers were designed to add a BamH1 site at 5’ and Xho1 site and a stop codon 
at the 3’ end. The restriction sites added were used to ligate the DNA fragments 
amplified by PCR into the pcDNA5/FRT plasmid with the N-terminal V5 tag 
described above following restriction digest. To make the FRT plasmid construct 
expressing CIRP truncations with no tag, the DNA fragments were ligated into the 
original pcDNA5/FRT plasmid as the primers were designed to add a start codon to 
each fragment. To amplify full length CIRP, CIRP Forward and CIRP Reverse+STOP 
primers were used. For the amplification of N-CIRP, CIRP Forward and N-CIRP 
Reverse+STOP primers were used. C-CIRP was amplified using C-CIRP Forward 
and CIRP Reverse+STOP primers (Table 5.1).  
 
To make the plasmid expressing CIRP truncations with a C–terminal V5 tag, the 
DNA fragments were initially sub cloned into the pcDNA3.1 plasmid. The primers 
used to amplify the CIRP fragments were the same as described above except the 
reverse primers without STOP were used to allow expression of the C-terminal V5 
tag.  The forward primers were also designed to include a Pme1 site at the 5’ end as 
well as the start codon and the BamH1 site. The PCR amplified CIRP, N-CIRP and C-
CIRP fragments were digested and ligated into the pcDNA3.1 plasmid using the 
BamH1 and Xho1 sites.  The ligated fragments were then digested out of the plasmid 
using the Pme1 enzyme removing the V5 and His tag with it.  Finally, the digested 
fragments were ligated into the FRT plasmid using the two Pme1 sites. The 












Primer Name Sequence (5’>3’) Tm 
(°C) 
CIRP Forward TATGGATCCGTTTAAACATGGCTAGCGATGAAGCAAGCTT 71.4 
CIRP Reverse ATACTCGAGCTCTCGTTGTGTGTAGCATAACT 66.9 
CIRP Reverse+STOP ATACTCGAGTTACTCGTTGTGTGTAGCATAACTGT 67.1 
C-CIRP Forward TATGGATCCGTTTAAACATGGACAACCGGTCCCGA 70.6 
N-CIRP Reverse ATACTCGAGCTAGAAGACTTGCCAGCCTGGT 69.5 
N-CIRP Reverse+STOP ATACTCGAGTTAAGAAGACTTGCCAGCCTGGT 68.2 
V5HIS Forward TATGCTAGCAGTCTAGAGGGCCCGCGGTTCGAAATGGGTAAGCCTAT 75.0 





5.2.2 Polymerase Chain Reaction 
The pet28a(+) CIRP template DNA to be used was generated in large quantities by 
transforming into DH5α E.coli cells  and following the QIAGEN midiprep kit 
protocols. For the PCR reactions, Pfu DNA polymerase (Promega, 3U/µl) was used as 
described in Chapter 2 (section 2.2.2). The primer pairs and DNA template used are 
described above (5.2.1).  PCR products were analysed on 2% agarose gels and 
visualised with ethidium bromide to confirm that the correct sized product was 
Figure 5.3 Schematic representations of the pcDNA3.1 and pcDNa5/FRT vector maps and 
multiple cloning sites. (Invitrogen) 
!
Table 5.1 Primer sequences used for the amplification of CIRP and V5 epitope DNA 
fragments for the generation of constructs in the pcDNA5/FRT plasmid.!
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present. PCR products were purified using a PCR clean up (QIAGEN, QIAquick PCR 
Purification Kit) or gel extraction kit (QIAGEN, QIAquick Gel Extraction Kit) 
following the manufacturers protocols. 
 
5.2.3 DNA Gel Electrophoresis 
This was undertaken as described in Chapter 2, section 2.2.3. 
 
5.2.4 Restriction Enzyme Digestion 
To isolate or to give the correct sticky ends to the CIRP, N-CIRP and C-CIRP DNA 
fragments, restriction enzyme digestion was used. PCR products or pcDNA3.1 
plasmid with the correct inserts, were taken forward and the DNA was digested using 
the enzymes described above using the optimal buffer for the two enzymes (section 
5.2.1).  The digest procedure is described in Chapter 2, section 2.2.6. 
 
5.2.5 Ligation of PCR products 
The!PCR!products!and!plasmids!were!digested!with!the!appropriate!enzymes!to!
give! the! correct! sticky! ends! as! described! in! section! 5.2.1.!DNA was quantified 
using a Nanodrop instrument.  Various ratios of insert:vector were tested; 5:1, 2:1, 1:1!
with!50!ng!vector!for!each!ligation!in!10!µl!reaction!volume. The amount of insert 





ng of vector x kb size of insert   x insert: vector molar ratio = ng of insert 
       kb size of vector 
 
 
1 µl of T4 DNA ligase (Promega, 3 U/µl) was added per reaction and 1µl of 10x 
ligase buffer.  The samples were incubated for 1.5-2 h at room temperature. After 
incubation, 3-4 µl of the ligation mix was transformed into competent DH5α cells.  
Negative (no insert) and positive (1 µl of plasmid DNA) controls were also included. 
100 µl of transformed cells were spread on LB agar plates containing 100 µg/ml 
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ampicillin and incubated overnight at 37°C. Colonies were checked by PCR screening 
or restriction enzyme digest before being sent for sequencing.  
 




Were prepared as described in Chapter 2, section 2.2.8. 
 
5.2.8 Transformation 
For DNA purification, competent DH5α cells were transformed with pcDNA3.1 or 
pcDNA5/FRT vectors with or without the CIRP genes cloned in. For the 
transformation, 30 µl aliquots of competent cells in microfuge tubes were thawed on 
ice and the transformation procedure is described in Chapter, section 2.2.9 followed 
with the exception that transformed cells were spread on to LB agar plates containing 
100 µg/ml ampicillin (Sigma). 
 
5.2.9 Creating Stable CHOK1 Cell Lines Expressing Recombinant Mouse CIRP, 
N-CIRP and C-CIRP With the Invitrogen Flp-In System 
Adherent Flp-In CHOK1 cells were maintained in Ham’s F12 media (Invitrogen) 
containing 10% FBS and 1/1000 Zeocin selection agent (Invitrogen) at 37°C. 24 
hours before transfection, 5x10
5 
cells were seeded into T25 flasks in 6.25 ml of 
medium without Zeocin.  To transfect the cells, 9 µg of pOG44 Flp-Recombinase 
expression vector  (Invitrogen) plus 1 µg of pcDNA5/FRT vector containing the gene 
of interest were diluted in 625 µl Opti-mem media (Invitrogen). 30 µl of 
Lipofectamine 2000 reagent (Invitrogen) was also diluted in 625 µl Opti-mem. The 
two mixes were incubated for 5 min and then mixed together. After a 20 min 
incubation of the mix, this was added to the cells in the T25 flask seeded with cells 
the previous day.  The cells and transfection reagent were then incubated for five and 
a half hours at 37°C before the cells were washed with PBS. The media was then 
replaced with fresh medium without Zeocin for 24 hours. 24 hours after transfection 
the cells were washed again with PBS and the media changed. 48 hours after 
transfection, cells were washed with PBS and trypsinised with 200 µl trypsin-EDTA 
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(Invitrogen, 0.05%). The detached cells were taken up in 20 ml Ham’s F12 (10% 
FBS) medium containing 500 µg/ml hygromycin B (Invitrogen). Cells were then 
plated out in 6 well plates with 2 ml of cell suspension per-well. Media containing 
hygromycin was then used for the remainder of the process. Medium in the wells was 
changed every third day. 
 
After 7 to 10 days, colonies of cells were visible and clonal selection was carried out 
once clones were visible by eye (10-12 days). Clonal selection was achieved by 
removing the medium and PBS washing the cells. A cloning tube was then firmly 
pressed down around the clones to be removed and 50 µl of trypsin-EDTA added. 
After a 3 min incubation at 37°C, the detached cells were removed by aspirating up 
and down with a Gilson pipette and transferred into a 6 well plate containing 2 ml of 
medium. 3 clones were selected for each cell line alongside generation of a polyclonal 
population. The media in the wells containing clones was changed every third day 
until there were sufficient numbers of cells to be transferred to a T25 flask. Once 70% 
confluent, the cells were harvested and frozen stocks and lysates were made for 
further analysis. 
 
5.2.10 Growth Curve Profiles of Stably Expressing CIRP FRT CHO Cells 
Growth curves were established for the stable FRT CHO cell lines generated as 
described above (section 5.2.1). To record growth over time an xCELLigence system 
(RTCA DP, Acea) connected to a PC with the RTCA control software was used 
which allows real time cell based assays. The instrument was placed in an incubator, 
and the automated system recorded cell index readings at given intervals.  To record 
growth, 5000 viable cells were seeded per well in a total volume of 200 µl in 16 well 
plates (E-Plate 16, Acea). The instrument was programmed to take readings every 30 
min. Cell index readings were collected until the decline during the death phase 
plateaued. Growth data for each cell line was collected at both 37°C and 32°C. 
 
5.2.11 Transient Transfection and Expression of CIRP in CHO Cells 
For transient transfection of cells in 24 well plates, 6x10
4
 viable cells were seeded per 
well in 500 µl of media and incubated at 37°C for 24 hours before transfecting. The 
commercially available transfection reagent Lipofectamine 2000 was used for all 
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transfections. For 1 transfection (i.e. 1 well), in a 24 well plate, 500 ng of DNA was 
diluted in 50 µl of Opti-mem and 2 µl of Lipofectamine reagent was diluted in 50 µl 
of Opti-mem. The two tubes were incubated for 5 min before mixing the two together 
and incubating for 20 min at room temperature. During the incubation time, the cells 
to be transfected were PBS washed and fresh media was added to each well. The 100 
µl transfection mix was then added to each well drop-wise. For co-transfections with 
more than one plasmid the same method was followed except 400 ng of each plasmid 
DNA was used. For transfection in 6 well plates, cells were seeded at 4x10
5
 viable 
cells per well in 2 ml of media and incubated at 37°C for 24 hours before transfecting.  
For each well 2.5 µg of DNA was diluted in 150 µl and 5 µl of Lipofectamine 2000 
reagent was diluted in 150 µl of Opti-mem. The 300 µl transfection mix was added to 
each well drop-wise. For co-transfections the same method was followed except 2 µg 
of each DNA was added to the transfection mix. Transfection of HEK cells was as for 
CHO cells. The plasmid expressing 3’ATR-UTR-luciferase and all eIF4G constructs 
were kindly provided by Jo Roobol.  
 
5.2.12 Collection and Lysis of CHO and HEK Cells 
Cells were harvested by removing the media and PBS washing the cells briefly.  Once 
the PBS was removed, ice-cold lysis buffer (20 mM HEPES-NaOH pH 7.2, 10 mM 
NaCl, 10 mM Na β glycerophosphate, 0.5 % TX100) was added. Immediately before 
using the lysis buffer 50 µl/ml of 1 M NaF and 5 µl/ml of 200 mM activated Na3VO4 
was added to the lysis buffer to inhibit protein phosphatases. At the same time, 2 
µl/ml of 5 mg/ml leupeptin, 2 µl/ml of 1 mg/ml pepstatin and 2 µl/ml of 100 mM 
PMSF were added to the lysis buffer before use as protease inhibitors. The volume of 
lysis buffer used to harvest cells was experiment dependent as specified in sections 
5.2.15 and 5.2.18. After the addition of the lysis buffer with inhibitors, cells were 
removed by scraping on ice.   
 
5.2.13 Determination of Protein Concentration in Cell Lysates 
The concentration of protein in cell lysates was determined using the method of 
Bradford (Hammond & Kruger, 1988). Samples were prepared by diluting 5 µl of cell 
lysate in 50 µl of water.  To this, 1 ml of Bradford reagent (0.01% Coomasie Blue 
G250, 15% ethanol, 10% phosphoric acid) was added, mixed and incubated at room 
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temperature for 10 min. The absorbance of samples was then read at 595 nm using 
water as blank and a standard curve was generated using known concentrations of 
BSA. Unknown protein concentrations were then calculated from the standard curve. 
 
5.2.14 Immunostaining of CHO Cells 
For immunostaining experiments, cells were seeded into 24 well plates containing 13 
mm glass coverslips. Cells were incubated at 37°C for 48 hours or at 32°C for 48 
hours or at 37°C for 24 hours followed by 32°C for 24 hours after transfection. CHO 
cells stably and transiently expressing CIRP were subjected to immunostaining for 
CIRP expression. For transient expressing cells, 4x10
4
 viable cells were seeded 24 
hours before transfection. Transient transfection was then undertaken as described in 
section 5.2.11. For stable expression, 3x10
4 
viable cells were seeded for incubation at 
37°C for 48 hours whilst 5x10
4
 viable cells were seeded for incubation at 37°C for 24 
hours after seeding followed by a shift to 32°C for 24 hours. At the end of the 
incubation period, the media was aspirated off and cells were rinsed with 2 ml/well of 
PBS at 37°C. Cells were then fixed and permeabilised with 1 ml/well of methanol at -
20°C for 5 min. The permeabilising agent was then aspirated off and cells rinsed for 5 
min in PBS (2 ml/well). A 3% BSA in PBS blocking solution was then added for 30 
min at room temperature.  
 
Droplets of primary antibody (20 µl) were prepared by diluting the antibody in 3% 
BSA in PBS on Nescofilm in a moist box.  The primary antibodies used were a 
monoclonal anti-CIRP antibody produced in rabbit (Protein-Tech Group) (1 in 100 
dilution) and a monoclonal anti-V5 antibody produced in mouse (1 in 500 dilution) 
(Sigma V8012).  The coverslips were removed from the wells using forceps and 
placed on the antibody droplets cell side down. The coverslips were then incubated 
overnight at 4°C and then rinsed on 5 successive drops of 0.1% Tween PBS. The 
coverslips were then placed on 30 µl of secondary antibody droplets diluted 1 in 100 
in 3% BSA in PBS and incubated in the dark at room temperature for 2 hours. The 
secondary antibodies used were anti-rabbit IgG, TRITC (Sigma, T2526) and anti-
mouse IgG, FITC (Sigma, F2012). The coverslips were then rinsed on 5 successive 
drops of 0.1% Tween PBS.  To stain nuclei, coverslips were incubated on 30 µl 
droplets of DAPI for 1 min and then rinsed on 5 successive drops of 0.1% Tween 
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PBS. Finally, coverslips were mounted onto microscope slides by placing cell side 
down onto 10 µl Mowiol+antifade reagent (1,4-phenylenediamine dihydrochloride, 
Sigma) and left to cure overnight at 4°C in the dark. Once set, the sides of the 
coverslips were sealed with clear nail varnish and tops of the coverslips were cleaned 
with a Q-tip dipped in water before visualizing. 
 
5.2.15 Co-Immunoprecipitation Experiments 
For co-immunoprecipitation experiments from CHO/HEK cells grown in 6-well 
plates, cells were harvested by adding 100 µl of lysis buffer (section 5.2.12) into each 
well and scraped on ice. Lysates were then centrifuged at 13000 rpm for 10 min in a 
bench top centrifuge at 4°C.  The supernatants were then used for IP experiments. To 
ensure that the binding capacity of the beads were not exceeded, Bradford assays were 
carried out on each sample to ensure the protein concentration was in the 0.4-10 
mg/ml range.  
 
For immunoprecipitation, 2-3 µg of the appropriate antibody (specified in the results 
section 5.3.3) was added into the lysates and incubated for 3-4 hours at 4°C on a 
rocking platform. 40 µl of a 1 in 4 suspension of Protein A Sepharose beads (Sigma) 
(i.e. 10 µl packed beads diluted in 40 µl) was added to each sample and incubated 
overnight at 4°C on a rocking platform. The beads were then pelleted by centrifuging 
for 1 min at 13000 rpm on a bench top microfuge at room temperature and the 
supernatant removed. The beads were then washed 3 times by adding 100 µl lysis 
buffer and centrifuging at 13000 rpm for 1 min before removing the supernatant. 
After the last wash, 20 µl of 2xSDS PAGE sample buffer  (section 2.2.19) was added 
to the beads and boiled for 3 min to disassociate the protein from the beads. The beads 
were then sedimented by centrifuging for 1 min at 13000 rpm and the sample loaded 
on to, and run on, a 12.5% SDS-PAGE gel as described in section 2.2.19. Gels were 
then transferred onto nitrocellulose membranes for western blot analysis (section 
5.2.16). 
 
5.2.16 Western Blot Analysis 
Cell lysate samples generated from harvest samples or after immunoprecipation were 
run on SDS-PAGE gels as described in section 2.2.19. Proteins were then transferred 
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onto nitrocellulose membranes for detection using antibodies (specified in section 
5.3.2 and 5.3.3). All components for transfer were pre-soaked in transfer buffer (100 
mM Tris, 12.5 mM glycine, 0.1% SDS) prior to assembly. The gels were then 
transferred for 1 hour at 750 milliamps at 4°C. Blots were removed from the transfer 
tank and placed in a staining box with the protein side up. The blots were washed for 
5 min in TBS buffer (10 mM Tris, 140 mM sodium chloride, pH 7.5) and then placed 
in block solution (25 ml 5% marvel in TBS per blot) for 30 min at room temperature 
on a rocking platform. The block solution was then discarded, blots briefly washed in 
TBS and placed in 8 ml of the appropriate 1° antibody dilution (specified in result 
sections 5.3.2 and 5.3.3) in 3% BSA (bovine serum albumin) in TBS. Blots were then 
incubated on a rocking platform at 4°C overnight. The 1° antibody was then removed 
and all subsequent washes carried out at room temperature.  Blots were washed under 
stringent wash conditions of high salt (500 mM NaCl in 0.1% Tween-TBS) for 10 
min, followed by three 10 min washes in 0.1% Tween-TBS. The blots were then 
placed in 8 ml of horseradish peroxidase conjugated secondary antibody against the 
species which the 1° antibody was raised in, diluted 1/1000 in block solution. Blots 
were incubated in secondary antibody solution for 1 hour on a rocking platform. 
Finally, blots were washed in stringent wash for 10 min, followed by 4x5 min washes 
in 0.1% Tween-TBS.  Peroxidase activity of the bound secondary antibody was then 
detected by ECL (enhanced chemiluminescense). ECL reagent (1 ml) was added to 
each blot and incubated for 5 min. ECL signal was detected by exposing the blot to 
film for up to 10 min in an x-ray film cassette in the dark and developing the film in 
an automated film developer. 
 
5.2.17 Luciferase Assays 
For detecting firefly luciferase activity, cells were initially washed with PBS after 
removing the media. For cell lysis, two 20x buffers were used (A- 348 mM Na2HPO4, 
70 mM NaH2PO4, pH 7.68; B- 18 mM CaCl2, 70 mM KCl, 18 mM MgCl2, 2740 mM 
NaCl), each containing protease inhibitors as described in section 5.2.11 whilst 0.1% 
triton was added to the lysis buffer immediately before harvest. Lysis buffer (100 µl) 
was added to each well and the cells scraped on ice. Luciferase activity was 
determined by mixing 75 µl of lysate and 75 µl of the steadylite plus reporter gene 
assay system (Perkin Elmer) reagent in the wells of a 96 well white opaque microplate 
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(OptiPlate). Each sample was mixed by pipetting up and down and incubated for 10 
min before analysis on a luminometer.  For the gaussia luciferase assay, the media 
was removed from the 24 well plates and centrifuged at 13000 rpm to remove any cell 
debris. In a 96 well white opaque microplate, 25 µl of the cell media was mixed with 
25 µl of the Biolux gaussia luciferase assay reagent (New England BioLabs) and 
mixed by pipetting. Analysis of light was then undertaken on a luminometer 
immediately. Bradford assays were performed on all samples and used to normalise 











































5.3.1 Generation of CIRP, N-CIRP and C-CIRP (± V5 tag) constructs  
PCR reactions were carried out with the appropriate primers and templates as 
described in sections 5.2.1 and 5.2.2 to generate CIRP/ N-CIRP/ C-CIRP with and 
without a V5 tag at the 5’ and 3’ end of the gene sequence. The analysis of the 








The V5 epitope sequence is a short sequence consisting of only 42 bases. Such a short 
stretch would be difficult to clone and therefore a longer stretch of DNA upstream 
from the V5 sequence including the 3’ His tag sequence downstream was amplified to 
generate a fragment with an expected size of 109 bases (figure 5.4, lane 2). Following 
digestion with the appropriate restriction enzymes, this was successfully ligated into 
the FRT plasmid between the Nhe1 and BamH1 restriction sites.  This plasmid was 
then used to ligate CIRP fragments downstream of the V5 tag to generate an N-
terminal V5 tag.  The expected fragment size of the N-CIRP, C-CIRP and full-length 
CIRP PCR products were 286, 283 and 544 respectively. PCR products of the correct 
sizes were observed on the DNA gels (figure 5.4, (a)).  The CIRP fragments with 
STOP codons were successfully ligated into the empty FRT vector or into the FRT 
vector with N-terminal V5 tag.  The CIRP fragments without the STOP codon were 
sub-cloned into the pcDNA 3.1 vector to generate a C-terminal V5 tag and this 
100 













Figure 5.4 2% agarose gel analysis of PCR products (a) PCR products amplified from pcDNA 
3.1 plasmid and pet28a(+) plasmid containing the full length CIRP sequence for cloning into the 
pcDNA FRT plasmid. Lane 1: 100 bp ladder, Lane 2: DNA fragment containing the V5 and His 
Tag sequences, Lane 3: N-CIRP DNA fragment, Lane 4: C-CIRP DNA fragment, Lane 5: Full-
length CIRP DNA fragment. (b) PCR colony screen of DNA from ligation of PCR products in to 
pcDNA 3.1 plasmid, Lane 1: 100 bp ladder, Lanes 2-5: C-CIRP, Lanes 6-11: Full-length CIRP. 
Red tick marks indicate correct inserts.  
!
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fragment was then subsequently digested from this donor vector and ligated into the 
FRT plasmid. Ligation colonies containing the correct inserts throughout the cloning 
process were identified by PCR colony screen (figure 5.4, (b)). DNA of colonies with 
the correct insert were sent for sequencing and all sequences confirmed as correct.   
 
5.3.2 Transient Expression of CIRP, N-CIRP and C-CIRP (± V5 tag) Constructs 
in the FLP-In CHO Host Cell Line 
The CIRP constructs generated with a V5 tag were transiently tranfected into CHO 
FlpIn cells to test for the expression of each protein whilst an empty FRT vector was 
transfected as a control. Cells lysates were generated 24 h post-transfection and the 
expression of the target protein determined by western blot analysis of transfected cell 
lysates and immuno staining of the transfected cells using the anti-V5 antibody.  
 
Initial Western blot analysis for the expression of the CIRP constructs with a V5 tag 
showed that only bands for full-length CIRP and CIRP with an N-terminal V5 tag 
were present 24 h post-transfection (figure 5.5, (a)). No bands were observed for N-
CIRP or C-CIRP with an N- or C-terminal V5 tag. An increased amount of protein 
was observed for the full- length CIRP sample that was incubated at 32°C for 18 
hours showing the up-regulation of the protein at mild hypothermic temperatures. 
This is interesting as the vector construct does not contain the CHO 3’ or 5’-UTRs 
and therefore the normal control of CIRP expression via both transcriptional 
activation and via the 5’-UTR of CIRP (Al-Fageeh & Smales, 2009) are not present. 
This may reflect the greater stability of proteins at 32
°
C compared to 37
°
C. Although 
it would be expected that endogenous CIRP would be up-regulated at 32
°
C, this 
would not be detected by the anti-V5 antibody.  
 
The initial cell lysates were collected from a 24 well plate where 500 ng of DNA was 
transfected per well and 20 µg of total protein was loaded on to the subsequent SDS-
PAGE gel (figure 5.5 (a)). A further blot where the lysate was taken from a 6 well 
plate where 2.5 µg of DNA was transfected and 30 µg of total protein loaded on to the 
gel revealed a band for N-CIRP with an N-terminal V5 tag at the expected size (figure 
5.5 (b)).  These analyses allowed transient expression of CIRP and N-CIRP with an 
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N-terminal V5 tag to be confirmed but expression of the other constructs, including 

















To further characterise expression, the CHO FlpIn cells transiently expressing full-
length CIRP with an N-terminal V5 tag were subjected to immunostaining. For 
controls, cells were transfected with blank FRT plasmid. Cells were probed with 1° 
CIRP or V5 antibodies. For the V5 antibody, fluorescent conjugated FITC (red) and 









































































































Figure 5.5 Western blot analysis of CHO FlpIn cells transiently transfected with CIRP/N-
CIRP/C-CIRP constructs containing a V5 tag on either the N- or C-terminal.  Blots were 
probed with a V5 antibody. (a) Lanes 1-6: cells incubated at 37°C for 24 hours post transfection, 
lanes 7-12: cells incubated at 37°C for 6 hours, followed by an 18 hour incubation at 32°C post 
transfection. (b) Cells incubated at 37°C. 
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The control cells transfected with empty FRT plasmid did not show any FITC signal 
but a small amount of TRITC staining was seen on the cells due to the presence of 



















Figure 5.6 Immunofluorescense images collected following immunostaining of CHO FlpIn 
cells transiently expressing control FRT vector or FRT vector containing full length CIRP 
with an N-terminal V5 tag incubated at 37 or 32°C following transfection as shown above. (a) 
Cells expressing control vector (b) Cells expressing full length CIRP with V5 tag.  
!
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was very low (figure 5.6 (a)). The DAPI staining confirmed the presence of many 
cells, which had been fixed on to the slide.  Cells which had been transfected with 
CIRP showed a signal for both CIRP and V5 staining.  Only 1-2 cells per slide 
showed signal for both CIRP and V5 (figure 5.6, (b)). As the presence of many cells 
on the slide was confirmed by the DAPI staining, this suggests that the transfection 
efficiency was low or there was low protein expression in most cells. The reason why 
expression is observed in so few cells is most likely to be a combination of both these. 
Cells which had been at 32°C showed higher protein levels compared to the cells 
incubated at 37°C in the transfected cells.   
Another interesting observation made was that if the cells had been incubated only at 
32°C following transfection they expressed less protein than if they were first 
incubated at 37°C followed by temperature shift to 32°C. The temperature shift causes 
the most up-regulation of CIRP rather than culturing only at colder temperature, this 














Figure 5.7 Analysis of CIRP localisation in CHO FlpIn cell transiently expressing FRT vector 
containing full length CIRP with an N-terminal V5 tag incubated at 37 or 32°C following 
transfection as shown above (figure 5.6) by overlay of immunofluorescence images.  
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To determine where CIRP was localised in the cell, the DAPI stained images showing 
the cell nucleus were overlaid with images of the cells showing the CIRP and V5 
signal (figure 5.7). These showed that in the cells incubated at 37°C for 48 hours and 
32°C for 48 hours the CIRP appeared to be localised to the nucleus as the images 
overlaid with the nucleus boundaries on the DAPI images. However, some signal for 
CIRP and V5 was present outside the nucleus in the cytoplasm in the cells that had 
been subjected to temperature shift from 37°C to 32°C.  Therefore, it appears that the 
temperature shift results in the translocation of CIRP to the cytoplasm from the 
nucleus as well as leading to an up-regulation in expression, this agrees with the 
findings of Leeuw et al (2007) who presented that CIRP migrates from nucleus to the 
cytoplasm upon cell stress by a methylation dependent mechanism (De Leeuw et al., 
2007). 
 
5.3.3 Investigating the Potential Interaction between CIRP and eIF4G  
Potential interactions between CIRP and the eIF4G protein was investigated by co-
immunoprecipation experiments using a V5 primary antibody.  eIF4G protein with an 
N-terminal V5 tag was pulled down with a V5 antibody to determine if CIRP was 
bound to it (figure 5.8, (a)) and vice versa full-length CIRP protein with an N-terminal 
V5 tag was pulled down with a V5 antibody to determine if eIF4G was bound (figure 
5.8, (b)). Two truncations (kindly provided by Miss Joanne Roobol, University of 
Kent) of the eIF4G protein termed 642 and 1078 were also investigated (figure 5.18), 
and these also possessed an N–terminal V5 tag. 
 
The immunoprecipitation experiments to investigate protein-protein interactions 
between eIF4G and full length CIRP confirmed the presence of an interaction 
between the two proteins (Figure 5.8). CIRP bands were observed on the blot where 
eIF4G protein was pulled down in both HEK and CHO cells (figure 5.8, (a)). A strong 
band was also observed for the eIF4G 642 and 1078 truncations confirming that large 
amounts of these proteins were pulled down with the anti-V5 antibody and protein A 
beads. A band for full-length eIF4G could not be observed on this blot due to the 
large size of this protein. CIRP was therefore shown to be present in 
immunoprecipitation samples of full-length eIF4G and both eIF4G truncations. The 
CIRP band intensity was greater when immunoprecipitating eIF4G in HEK cells 
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compared to CHO cells (see Figure 5.8). The intensity of the CIRP band was greatest 
when immunoprecipitating the eIF4G 642 truncation in HEK cells suggesting that the 
strongest interaction is between CIRP and this truncated version of eIF4G. When the 
interaction between eIF4G and CIRP was investigated by immunoprecipitation of 
recombinant CIRP with a V5 tag, large amounts of CIRP were observed on the blots 
and eIF4G protein was present in samples for both CHO and HEK cells (figure 5.8 
(b)).  
 
A much stronger eIF4G band was present in the sample from HEK cells compared to 
CHO cells agreeing with the eIF4G immunoprecipitation results again suggesting that 
a stronger interaction takes place between mouse CIRP and eIF4G in HEK cells than 
in CHO cells. Interestingly, the CIRP bands seen on the blots appeared as a double 
band, (figures 5.5 (b), 5.8 (b), 5.9), this may be due to the methylation event that 
CIRP undergoes before being translocated to the cytoplasm.  Therefore the two bands 
observed here are potenitially one for the up-regulated methylated CIRP located in the 
















The interaction between N-CIRP and eIF4G was also confirmed by pull down of N-
CIRP with an N-terminal V5 tag whereby bands for N-CIRP were observed in the 
resulting blot (figure 5.9). The band intensity of N-CIRP was stronger in the HEK 
cells. eIF4G was present in both CHO and HEK cell samples containing recombinant 
(b)!(a)!
Figure 5.8 Western blot analysis of immunoprecipitation experiments to study the interaction 
of recombinant CIRP with eIF4G. (a) Immunoprecipitation of the NV5 full-length eIF4G and 
truncations 642 and 1078 for the interaction with CIRP in CHO and HEK cells. (b) 
Immunoprecipitation of the NV5 full-length CIRP for the interaction with eIF4G in CHO and HEK 
cells. All samples were incubated at 37°C for 48 h post transfection before collection and lysis. 
!
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V5 N-CIRP. Once again, a stronger eIF4G band was observed for HEK cell samples. 
These data collectively suggest that expression of mouse CIRP in HEK cells is higher 
than in CHO cells, both full-length CIRP and N-CIRP interact with eIF4G and a 
stronger interaction is present between mouse CIRP and eIF4G in HEK cells although 
this may simply reflect the relative expression of the recombinant CIRP between the 
















5.3.4 Investigating The Effect of the Presence of the ATR 3’UTR on Luciferase 
mRNA when Over-Expressing CIRP and eIF4G on Transient Firefly Luciferase 
Expression 
The data in section 5.3.3 confirmed that CIRP interacts with eIF4G and others have 
previously shown that CIRP also binds to the 3’UTR of the ATR mRNA. To 
determine if CIRP acts to increase specific mRNA translation upon mild cold shock 
by binding to both mRNA and eIF4G, CHO cells were transfected with either all 3 or 
a combination of ATR-3’UTR-luciferase, luciferase alone, NV5 CIRP and NV5 
eIF4G and the subsequent effect on luciferase expression investigated. As well as full-
length eIF4G and CIRP, the eIF4G 642 truncation and N-CIRP was also transfected 
into cells. Following transfection in 24 well plates, cells were incubated at 37°C for 














































Figure 5.9 Western blot analyses of immunoprecipitation experiments to study the 
interaction of recombinant N-CIRP with eIF4G. Immunoprecipitation of the NV5 N-CIRP for 
the interaction with full-length eIF4G in CHO and HEK cells. All samples were incubated at 37°C 
for 48 h post transfection before collection and lysis. 
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or eIF4G was then confirmed by western blot analysis and the luciferase activity 
determined as described in section 5.2.17. The resulting luciferase expression results 
are shown in Figure 5.10 below. 
 
Full-length CIRP was transiently expressed in CHO cells with eIF4G and luciferase 
containing the 3’UTR-ATR, the highest luciferase activity was observed when both 
CIRP and full length eIF4G and the ATR 3’UTR containing luciferase were all 
present (figure 5.10). Removing the ATR 3’UTR from luciferase or the eIF4G 
plasmid from transfection experiments resulted in a reduction in the luciferase activity 
observed. The eIF4G 642 truncation did not have the same effect as the full-length 
eIF4G suggesting that full-length eIF4G is required to elicit an effect as the presence 
of the truncation showed reduced luciferase activity (see Figure 5.10). The sample 
transfected with luciferase without the ATR 3’UTR and the 642 eIF4G truncation had 
relatively low luciferase activity. The same findings were observed at both 37 and 
32°C.  The statistical ANOVA test was performed on each data set. A p value of 
0.0669 was calculated for the assays carried out at 37°C with full-length CIRP, this 
suggests that the means in each group tested at 37°C do not significantly differ from 
each other. However at 32°C the p value was 0.008, which suggest that there may be a 
significant difference between the groups tested. To further identify which groups in 
the data set differ from each other, Tukey’s test was performed. With this test it was 
identified that there was a significant difference between the sample transfected with 
ATR3’UTR-luciferase, eIF4G and CIRP and the sample transfected with luciferase 
mRNA, 642 eIF4G and CIRP as well as the sample transfected with ATR 3’UTR-
luciferase and 642 eIF4G. 
 
When N-CIRP was transiently expressed in CHO cells with the different luciferase 
and eIF4G combinations, the highest luciferase activity was observed with N-CIRP 
and full-length eIF4G and luciferase without the ATR 3’-UTR at both 37°C and 32°C 
(Figure 5.10).  It is also noted that in general, luciferase readings were lower for the 
N-CIRP samples.  The ANOVA calculations gave a p value of 0.0011 at 37°C for N-
CIRP data sets suggesting a possible significant difference between the groups. The 
Tukey‘s test revealed that the samples; +ATR,+N-CIRP,+eIF4G and –ATR,+N-
CIRP,+eIF4G are different; +ATR, +N-CIRP, +642 eIF4G and –ATR, +N-CIRP, 
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+eIF4G are different; –ATR, +N-CIRP, +eIF4G  and –ATR, +N-CIRP, +642 eIF4G 
are different; –ATR, +N-CIRP, +eIF4G  and +ATR, -NCIRP,+642 eIF4G are 
different. However the ANOVA test for the assays carried out at 32°C had a p value 








The western blot analysis showed that N-CIRP expression was very low compared to 
full-length CIRP, especially at 37°C where no N-CIRP bands were observed (Figure 
5.11). This was also true for the expression of eIF4G i.e. lower expression of the 
protein was observed on blots when expressed with N-CIRP compared to when 
expressed with full-length CIRP.   
 
The western blot analysis of the luciferase assay samples showed that of the eIF4G 
proteins, the 642 truncation showed the highest expression levels (figure 5.11). 
p!=0.008!p!=0.067!
p!=0.001! p!=0.070!
Figure 5.10 Recombinant firefly luciferase protein production in CHO cells transiently 
expressing CIRP/N-CIRP protein, full-length/642 eIF4G protein and +/-3’ATR-UTR-
luciferase at 37 or 32°C.  The top graph shows data for full length CIRP and bottom graph shows 
N-CIRP luciferase readings. The error bars represent standard deviation errors where n=3. The p 
values shown are from one-way ANOVA test. 
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Although this protein was expressed at higher levels by the cells, it is the transient 
over-expression of the full-length eIF4G protein that leads to the higher luciferase 
levels. Interestingly, in the absence of CIRP, full-length and 642 eIF4G levels were 
reduced and these samples also show low luciferase activity when compared to 
samples which contained full-length CIRP. The full-length CIRP western blots also 
showed that when luciferase was co-transfected without ATR 3’-UTR, the CIRP and 
642 eIF4G sample showed the lowest CIRP expression levels, which also showed the 
lowest luciferase levels. The luciferase activity and western blot data shows that 
expression of CIRP, eIF4G and 3’ ATR UTR-luciferase leads to maximal expression 
of all three components. Luciferase activity was highest when luciferase contained the 


















Following the initial preliminary experiment described above, a second targeted 
experiment was undertaken investigating the ATR-3’UTR-luciferase with full-length 
CIRP and full-length eIF4G as the combinations of these constructs showed the 
highest recombinant luciferase expression in the preliminary studies.  The samples 
were tested in 6 replicates instead of 3 to give greater confidence to the data and the 
results are reported in figure 5.12 below.  
(b)!(a)!
Figure 5.11 Western blot analysis of CHO FlpIn cells transiently transfected with NV5 
CIRP/N-CIRP, 3’UTR-ATR-luciferase, NV5 eIF4G/642.  Blots were probed with a V5 1° 
antibody, top blots show samples with full-length CIRP and bottom blots show N-CIRP samples. 
(a) Cells incubated at 37°C for 48 hours post transfection (b) cells incubated at 37°C for 6 hours, 
followed by an 42 hour incubation at 32°C post transfection.  
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In agreement with the preliminary data, the highest luciferase expression was 
observed when the luciferase containing the ATR 3’UTR and CIRP and eIF4G 
proteins were present at 37
o
C (figure 5.12). The luciferase activity was much higher, 
approximately 21 times, at 37 °C compared to cells transfected with luciferase lacking 
the ATR 3’-UTR and in the absence of recombinant CIRP and eIF4G. The data also 
show that removing the ATR 3’UTR from the luciferase gave a greater reduction in 
luciferase activity compared to when eIF4G was removed, suggesting the presence of 
the ATR 3’-UTR leads to a greater effect than the presence of additional exogenous 
eIF4G. Indeed, at 32
o
C, there was no increase in the observed luciferase activity when 
p!=7.52x10-7!
p!=7.37x10-8!
Figure 5.12 Recombinant firefly luciferase protein production in CHO cells transiently 
expressing CIRP protein, full-length eIF4G protein and 3’ATR-UTR-luciferase at 37 or 
32°C. The error bars represent standard deviation errors where n=6. The p values shown are 
calculated from one way ANOVA test. 
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eIF4G was over-expressed alongside CIRP in the presence of the ATR 3’-UTR 
containing luciferase construct suggesting that the presence of additional eIF4G at 
32
o
C does not result in any additional increase in recombinant protein expression 
(Figure 5.12).  The ANOVA test calculated a very small p value of  7.51x10
-7
 for the 
groups at 37°C and 7.37x10
-8
 for the 32°C data set. These value confirm that there is a 
significant difference between the groups tested here. The Tukey’s test revealed that 
each group differs from one another except the groups:  +ATR,+CIRP, -eIF4G and -
ATR,+CIRP, +eIF4G at 37°C;  +ATR,+CIRP, +eIF4G and +ATR,+CIRP, -eIF4G at 
32°C.  
 
5.3.5 The Effect of Over-Expression of Recombinant CIRP and eIF4G on Stable 
Firefly and Gaussia Luciferase Expression 
The results presented in section 5.3.4 showed that transient firefly luciferase 
expression can be enhanced via the addition of the ATR 3’-UTR to luciferase and the 
over-expression of CIRP and eIF4G at 37
o
C and of CIRP at 32
o
C. To determine if a 
similar effect could be generated in stably expressing cells, CHO cells stably 
expressing firefly luciferase and gaussia luciferase were used to study the effect of 
CIRP protein and a combination of CIRP and eIF4G on the recombinant protein 
expression levels. Cells were incubated at 37°C for 24 or 48 hours following 
transfection with CIRP or eIF4G constructs or for 6 hours at 37°C before moving to 
32°C for the remainder of the incubation. The resulting luciferase activity is reported 
in figures 5.13 and 5.14 below. 
 
Cells incubated for 24 hours at 37°C did not show any appreciable differences in 
luciferase activity compared to control cells transfected with blank FRT vector (figure 
5.13) except for when cells were transfected with C-CIRP and eIF4G, where there 
was a reduction in luciferase activity. At 32°C approximately twice as much 
luciferase activity was observed and as in the 37°C samples, the majority produced 
similar amounts of luciferase including the C-CIRP and eIF4G sample. The data 
collected for cells incubated for 48 hours showed the same trend (figure 5.13). Some 
samples such as FRT+4G and CIRP+4G showed large differences at 32°C but these 
had large error bars. The ANOVA test calculations gave p values which were above 
Results                       Chapter 5: Functional Studies of CIRP in Mammalian Cells 
!176!
0.05 for all data sets suggesting that there is no significant differences between the 
























When investigating the effect of over-expression of CIRP or eIF4G on stable, secreted 
Gaussia luciferase production similar results to the firefly protein expression were 
observed (figure 5.14). Interestingly, an up-regulation of the amount of secreted 
protein at 32°C was not observed (figure 5.14) suggesting that the secretory capacity 
of the cell may be limited at the reduced temperature. As observed with the 
intracellular firefly data, addition of eIF4G led to an improvement of gaussia 
luciferase production in most samples, although this was not seen for the CIRP+4G 
sample at 37°C for both the 24 and 48 hour samples.  In general, although a large 




Figure 5.13 Recombinant firefly luciferase protein production in CHO cells stably expressing 
firefly luciferase and transiently transfected with CIRP/N-CIRP protein, eIF4G protein or 
both at 37 or 32°C for 24 or 48 hours. As a control in place of CIRP/N-CIRP empty FRT 
plasmid was transfected. Errors bars represent standard deviation errors where n=3.  p values 
shown were calculated using the one way ANOVA test. 
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expressing CIRP, the overall trend was that the largest influence on stable 
recombinant protein expression was observed when both CIRP and eIF4G were both 
over-expressed at 32°C. This was further confirmed by carrying out the ANOVA test 
which calculated p vales above 0.05 i.e. no significant differences between the groups 


































Figure 5.14 Recombinant gaussia luciferase protein production in CHO cells stably 
expressing gaussia luciferase and transiently expressing CIRP protein, eIF4G protein or both 
at 37 or 32°C for 24 or 48 hours. Error bars represent standard deviation errors where n=3. p 
values shown were calculated using the one way ANOVA test. 
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5.3.6 Generation of CHO FlpIn Cell Lines Stably Expressing CIRP 
CHO FlpIn cells stably expressing full-length CIRP, N-CIRP and C-CIRP with an 
N/C-terminal V5 tag or no tag were generated as described in section 5.2.1 and 5.2.9. 
For characterisation of these cells lines, growth curves were obtained at 37°C and at 
32°C. Immunofluorescence was also undertaken to confirm protein expression and 
localisation. The resulting data is presented in figures 5.15 below.  
 
The growth profiles at 37°C showed that cell lines expressing CIRP and variations, 
apart from the C-CIRP cell line, all grew faster compared to the control (figure 5.15 
(a)) whilst the C-CIRP cell line growth was similar to that of the FRT control cell 
line. Specifically, cells stably expressing full-length CIRP without a tag showed the 
largest difference in growth, being the cell line with fastest growth rate and reaching 
the highest cell concentration of all cell lines. The differences in the growth curves 
suggests that the expression of CIRP leads to faster cell growth at 37°C with the 
exception of C-CIRP which grew at the same rate as the control. This may be due to a 
lack of expression of the natively disordered C-CIRP in CHO cell as previously 
observed when transiently attempting to express C-CIRP (see section 5.3.2).  The 
unstructured nature of this domain may lead to its degradation and no or very low 
expression.  
 
The growth profiles of the stable cell lines at 32°C did not show large difference 
between growth rates of the control cell line and CIRP cell lines. Cell lines stably 
expressing full-length CIRP and N-CIRP with N-terminal V5 tag reached the highest 
cell concentration/density. The growth profile clearly shows the influence of 32°C 
culturing on growth and cell viability being extended (note the extended time on the x 
axis on figure 5.15b). These data suggest that whilst CIRP over-expression results in 
more rapid growth of CHO cells at 37
o
C, this effect is not observed when culturing 










































FRT! N-CIRP! C-CIRP! FL-CIRP! V5!N-CIRP!


















FRT! N-CIRP! C-CIRP! FL-CIRP!
V5!N-CIRP! V5!C-CIRP! V5!FL-CIRP! N-CIRP!V5!
(a)!
(b)!
Figure 5.15 Growth curves generated using the xCELLigence instrument for the CHO Flp In 
cell lines stably expressing full length CIRP and CIRP truncations with and without the V5 
tag. (a) Cells incubated at 37°C (b) Cells incubated at 32°C. Note the larger x-axis bar on panel b. 
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In order to confirm that the cell lines generated were indeed expressing the desired 
proteins, the stable cell lines expressing full-length CIRP with an N-terminal V5 tag 
and the control FRT cell line were immunostained using CIRP and V5 antibodies. 
After seeding, cells were either incubated at 37°C for 48 hours or at 37°C for 6 hours 
followed by incubation at 32°C for 42 hours before fixing and immunofluorescence as 
described in section 5.2.14. Resulting representative images are shown in figures 5.16 
and 5.17 below. 
 
The immunostaining of the cells expressing full-length CIRP with an N-terminal V5 
tag confirmed the expression of CIRP in these cells (Figure 5.16).  Some background 
signal was observed in the control samples for TRITC (CIRP) and FITC (V5) (figure 
5.16, (a)) but this was due to the long exposure time and a much higher signal was 
observed for the CIRP expressing cells confirming that recombinant CIRP is 
expressed in these cells (figure 5.16, (b)) and it is expressed with a V5 tag as signal 
for both V5 and CIRP were observed in these samples. Localisation appears cytosolic 















































































Figure 5.16 Immunofluorescense images collected following immunostaining of CHO FlpIn 
cells stably expressing control FRT vector or FRT vector containing full length CIRP with an 
N-terminal V5 tag incubated at 37 or 32°C following transfection as shown above. (a) Cells 
expressing control vector (b) Cells expressing full length CIRP with V5 tag. 
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To determine which region of the cell CIRP localises to in these cells, images of cells 
showing CIRP and V5 staining were overlaid with images of the cells showing the 
nucleus DAPI staining (figure 5.17).  These showed that at 37°C CIRP is present in 
both the nucleus and cytoplasm but at 32°C the amount of CIRP in the cytoplasm was 
much higher compared to what was observed at 37°C even though CIRP was still also 
localised to the nucleus. This result agrees with the immunostained cells transiently 
expressing CIRP (section 5.3.2), at mild cold temperatures (32°C) CIRP translocates 


































Figure 5.17 Analysis of CIRP localisation in stably expressing cells by overlay of 
immunofluorescence images. 
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5.4 Discussion 
This chapter describes investigations that were undertaken to further probe the 
function of CIRP in the cell and how the expression of CIRP relates to recombinant 
protein expression. To enable the investigation of the roles of the N- and C-terminal 
domains of CIRP on their own as well as the full-length protein, FRT plasmids 
expressing N-CIRP, C-CIRP or full-length CIRP were successfully generated by 
PCR, restriction digest and ligation of the fragments. For the co-immunoprecipitation 
experiments to study CIRP interactions, each construct was also generated with a V5 
tag at either the N-terminal or the C-terminal. All constructs were successfully 
generated and sequences were confirmed by DNA sequencing.  
 
The plasmids were tested for expression by transiently transfecting into CHO cells 
and cell lysates collected and analysed by western blotting. Full-length CIRP with an 
N-terminal V5 tag was successfully expressed transiently in CHO cells. The 
expression of N-CIRP was more difficult to observe by western blot analysis, a higher 
concentration of total protein had to be analysed to be able to see the N-CIRP bands 
on the blots. The protein that had been subjected to storage by freezing was much 
more difficult to see in samples. This was not found for the full-length protein. N-
CIRP is not expressed by the cells as well as the full-length protein and is presumably 
degraded much more quickly. This might be expected as the cells may recognise that 
this is not the full-length protein and the missing C-terminal region could make the 
protein more prone to degradation.  In a study by Zhang et al (2007) it was found that 
C-terminal cleavage of -crystallin protein which has a chaperone function and 
supressing protein aggregation or promoting protein folding, significantly reduced its 
stability and increased its susceptibility to degradation by the ubiquitin proteasome 
pathway (Zhang et al., 2007). It is also noted that the full-length endogenous protein 
is still made in the N-CIRP cells and it has been previously suggested that both the N-
terminal and C- terminal are required for maximum function of the CIRP (Yang et al., 
2006).  
 
The western blot analysis suggested that the C-terminal domain on its own was not 
expressed at all or that it was degraded too quickly to be observed. The western blot 
analysis also confirmed that CIRP is up-regulated under mildly hypothermic 
conditions as also shown by previous studies (Nishiyama, Itoh, et al., 1997). As this 
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domain is natively unstructured, it is not surprising that it would be a target for 
degradation or not expressed at all. The C-terminal region of CIRP was also found to 
be prone to degradation in experiments described in Chapter 2 (section 2.3.3). Studies 
have shown that unstructured regions of protein are highly susceptible to degradation 
especially in vitro and in the absence of ligands (Mittag, Kay, & Forman-Kay, 2010; 
Tompa, Prilusky, Silman, & Sussman, 2008).  
 
The successful expression of full-length CIRP with an N-terminal V5 tag was further 
confirmed by immunostaining of cells transiently transfected with the protein. Only 
one or two cells on each slide showed expression of CIRP suggesting low expression 
levels or poor transfection efficiency. As expected, higher CIRP expression was 
observed at the lower temperature of 32°C. Exposing the cells to hypothermia without 
first incubating at 37°C did not increase protein expression but shifting the 
temperature of the cells from being incubated at 37°C to 32°C showed an increase in 
CIRP levels in the cells. This suggests that it is the temperature shift that activates 
mechanisms associated with cold shock but exposing them to cold temperatures 
without the shift most likely activates other stress mechanisms in the cell. The up-
regulation of CIRP due to the temperature shift was also confirmed as it was the 
temperature shift condition that lead to the translocation of CIRP to the cytoplasm and 
CIRP is predicted to translocate to the cytoplasm from the nucleus under mild 
hypothermia to be functional (De Leeuw et al., 2007). This is not the case for cells 
that do not experience the recovery at 37°C before the temperature shift but are only 
incubated at 32°C, as well as the up regulation of CIRP being absence in these cells, it 
was not present in the cytoplasm suggesting that mechanisms activated by cold shock 
and involving CIRP were not activated.  
 
The interaction of CIRP with the eIF4G protein was confirmed through co-
immunoprecipitation experiments. eIF4G interacted with both full-length CIRP and 
the N-terminal domain of CIRP alone. This suggests that the C-terminal of CIRP is 
not required for the interaction between CIRP and eIF4G. It has been suggested that 
the N- and C-terminal regions of CIRP interact individually with RNAs but that both 
are required for maximal binding (Yang et al., 2006). As C-CIRP expression could 
not be achieved, co-immunoprecipitation experiments could not be carried out to test 
Discussion                  Chapter 5: Functional Studies of CIRP in Mammalian Cells 
!185!
the interaction of this domain with eIF4G. Truncations of eIF4G were kindly provided 
by Jo Roobol, these truncations of eIF4G were made of the C-terminal, removing 







As described above, the data reported here shows that eIF4G interacts with the N-
terminal domain of CIRP. To help determine the binding region for CIRP on eIF4G, 
the truncations in figure 5.18 were used. The binding was significantly reduced or 
non-existent when testing the 1078 truncation of eIF4G (figure 5.8), therefore the 
binding site for CIRP must be between residues 642 and 1078 on eIF4G between the 
eIF4E and eIF3 binding sites.  It was also noticed that higher expression of eIF4G and 
the truncations was observed in HEK cells compared to CHO, previous studies have 
shown that in comparison to HEK, CHO is more challenging for transient transfection 
producing lower yields (Ye et al., 2009). 
 
With the constructs available here, we were to then investigate the hypothesis that 
through the interaction of CIRP and eIF4G and the interaction of CIRP with the 
3’UTR of specific mRNA such as ATR, CIRP acts as a bridge between the 3’ and 
5’UTR of mRNA through its interaction with eIF4G and circularise the RNA, 
enhancing the translation of such an mRNA. Luciferase reporter assays were therefore 
undertaken to investigate the effect of CIRP on recombinant protein production as 
well as to further investigate the interaction between CIRP, eIF4G and a specific 3’-
UTR sequence, that from the ATR 3’UTR mRNA that has previously been shown to 
bind to CIRP (Yang et al., 2010). In order to investigate this, a luciferase construct 






Figure 5.18 Schematic figure of the eIF4G initiation factor, with the binding domains 
indicated. The truncations tested for binding to CIRP are shown as blue rectangles.  Figure adapted 
from Yángüez & Nieto, 2011.  
!
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The luciferase assays revealed that the highest expression of recombinant protein 
(luciferase) was observed when CHO cells were transfected with CIRP, eIF4G and 
luciferase containing the ATR 3’UTR both at 37°C and 32°C, although generally the 
luciferase activity was much higher at 32°C (figure 5.12).  This may be due to the up-
regulation of CIRP at 32°C and is likely to have been enhanced by the up-regulation 
of endogenous CIRP as well as the recombinant transfected CIRP. The highest 
luciferase expression was observed for the CIRP, eIF4G and luciferase containing 
ATR 3’UTR mRNA combination when full-length eIF4G protein was used and not 
with the 642 truncation. The significance of the differences between the samples was 
further confirmed by ANOVA and Tukey’s tests. This further supports the theory that 
CIRP interacts with RNAs and the translational machinery to improve protein 
production (Yang et al., 2006). For translation to take place the full eIF4G protein 
would be necessary as it is a scaffold protein with many binding sites for other 
initiation factors (Hinton, Coldwell, Carpenter, Morley, & Pain, 2007). The removal 
of eIF4G over-expression resulted in a reduction of the luciferase activity. This is 
presumably because at reduced temperature protein synthesis rates drop so there may 
be more ‘available’ eIF4G (e.g. less translation so more free eIF4G available and 
hence over-expression of this has no effect as not limiting) so this is not a limitation 
but the presence of CIRP and ATR 3’-UTR allows more efficient translation at this 
temperature. 
 
Removal of the ATR 3’-UTR from luciferase also led to a reduction of luciferase 
expression. Presumably when this 3’UTR is present, CIRP can bind to the ATR 3’-
UTR on luciferase and to eIF4G and enhance the translation of the luciferase mRNA 
to give increased protein production.  It has also been shown previously that the 
interaction of CIRP with eIF4G can lead to increased translation (Yang et al., 2006). 
The same results were not observed when CIRP was replaced by N-CIRP, in fact 
lower luciferase expression was observed across all N-CIRP samples. This is in 
agreement with previous findings that both the N- and C-terminal domains are 
required for maximum function of CIRP (Yang et al., 2006) although N-CIRP alone 
binds to RNAs (as described in chapter 3,section 3.3.3) and to eIF4G. The C-terminal 
domain must contribute to the function of the protein; this maybe by a change in 
conformation upon ligand binding which could be further studied by in cell NMR in 
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future experiments (Sakakibara et al., 2009; Tochio, 2012). The binding affinity of the 
N-terminal to RNA was found to be weak in chapter 3. Disordered regions of proteins 
can enable recognition of a spectrum of ligands and conformational rearrangement for 
these (Mittag et al., 2010), this may be true for CIRP as it can bind several RNA 
ligands and the C-terminal may strengthen the binding which is weak for the N-
terminal domain alone. Another point the consider is that it has been suggested that 
the translocation of CIRP from cytoplasm into the nucleus is dependent on the 
methylation of the arginine residues found on the C-terminal domain (Aoki, Ishii, 
Matsumoto, & Tsujimoto, 2002; De Leeuw et al., 2007). Without the methylation of 
these residues at the C-terminal, N-CIRP may be remaining in the nucleus and unable 
interact with the translational machinery and mRNAs, leaving only endogenous 
protein available in the cell to do this.  
 
Increased eIF4G levels were observed when CIRP was overexpressed compared to 
when CIRP was not, as shown by western blots (figure 5.11). This suggests that over 
expression of CIRP leads to the general up-regulation of protein expression in the 
cells which has also been reported in other studies (Tan et al., 2008). These findings 
all provide evidence that eIF4G, and CIRP act together to enhance protein production 
in cells by binding to the 3’UTR of mRNAs specifically the 3’UTR of ATR in this 
case. It was also noticed that removing the ATR 3’UTR from luciferase lead to lower 
luciferase levels than if exogenous eIF4G was removed. This was probably because 
when recombinant eIF4G was removed, endogenous eIF4G levels were still sufficient 
enough to carry out translation of the ATR 3’UTR luciferase mRNA but removing the 
ATR 3’UTR means that the translation of the luciferase mRNA may not be CIRP 
mediated and hence not up-regulated as CIRP only binds specific mRNAs for 
example 3’UTR ATR. The significance of these results were confirmed using the 
statistical ANOVA and Tukey’s tests. 
 
With transient transfection, there can be variables such as the transfection efficiency, 
which means not every cell is expressing the gene of interest and also the transfected 
plasmid dilutes through generations of the cells and every cell will have not have the 
same number of copies of the gene, hence will not make the same amount of protein, 
which can lead to inconsistency between samples. Recombinant protein production 
levels were therefore also studied using cells that stably express secreted gaussia or 
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intracellular firefly luciferase (section 5.3.5). As the desired gene is integrated into 
genome of the host cell in stably expressing cell lines, every cell expresses the gene of 
interest; therefore there is less variability in expression. However, there can still be 
variability in terms of the cells expressing the exogenous CIRP or eIF4G. Neither of 
the luciferase mRNAs in these stable cell lines contain the ATR 3’UTR either. Most 
samples showed that the addition of eIF4G increased the luciferase levels observed 
marginally at best. The ANOVA tests showed that there was no significant 
differences between the groups in each data set with p values higher than 0.05. The 
reason that differences were small may have been due to the fact that the cells had a 
different production load on them, meaning for example the control cell lines had only 
the load of producing the luciferase protein where as the cells transfected with CIRP 
and eIF4G were generating two exogenous proteins as well as luciferase. This means 
that control cells with the empty plasmid may be able to make much higher levels of 
luciferase as it is the only protein being overexpressed by the cell whereas the cell 
transfected with CIRP or both CIRP and eIF4G have to make all 3 proteins, which 
may compromise luciferase expression. This may simply be a competition effect 
whereby the resources of the cell have to be shared across multiple exogenous genes 
or just one in the case of luciferase on its own. This may also be the reason why little 
increase in luciferase readings was observed when CIRP and EIF4G were both 
exogenously expressed compared to when only CIRP was being expressed. As such 
one could question whether the luciferase comparisons of these samples are a realistic 
comparison to each other.  
 
Growth profiles of all cell lines stably expressing CIRP, N-CIRP and C-CIRP at 37°C 
had clear differences compared to the control showing that over expression of CIRP 
affect cell growth (figure 5.15). The exception was the C-CIRP construct without the 
V5 tag, this cell line had the same growth profile as the FRT control cell line. This 
suggests that this domain was not being expressed by the cell at all, in agreement with 
the western blot analysis of the transiently expressed cells.  The cell line expressing 
full-length CIRP without the V5 tag showed the largest difference being the cell line 
that grew the fastest compared to tagged full length CIRP, N-CIRP and C-CIRP. The 
same result was not observed at 32°C, all cell lines had a similar growth profile 
except full-length CIRP and N-CIRP with N-terminal V5 tag reached higher cell 
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densities but all cell lines had similar growth rates. This is most likely due to natural 
up regulation of endogenous CIRP at 32°C. The profiles suggest that overexpression 
of full-length CIRP increases the growth rates of the cells.  This finding is 
contradictory to the reports in the literature which suggest that up-regulation of CIRP 
leads to activation of mechanisms which lead to cell cycle arrest hence supressing cell 
growth (Tan, Lee, Yap, & Wang, 2008). This effect may have been observed here as 
the growth profiles were effected at 37°C and mechanisms which lead to cell cycle 
arrest may not be activated at this temperature, but CIRP could still be having its 
mRNA stabilising and up-regulating effect leading to increased protein synthesis and 
hence an increased metabolism. 
 
Expression of CIRP and V5 tag in the stable cell lines and their up-regulation at 32°C 
was also confirmed through immunostaning of the cells (figure 5.16). Analysis of the 
localisation of CIRP in these cells showed that it localises to both the nucleus and 
cytoplasm at 37°C, the ratio of nucleus to cytoplasm being skewed toward the nucleus 
but at 32°C even though protein is present in the nucleus the ratio was now skewed to 
more CIRP being present in the cytoplasm. This agrees with the results seen for the 
cells transiently expressing CIRP and supports the theory that CIRP interacts with the 
translational machinery under mild hypothermia as translation takes place in the 
cytoplasm. It has been previously reported that CIRP translocate from nucleus to 
cytoplasm under stress conditions (De Leeuw et al., 2007). This translocation would 
be necessary for CIRP to be able to interact with eIF4G and act as a bridge to aid 
mRNA circularisation under cold stress conditions. 
 
The data reported in this chapter supports the idea that CIRP is up-regulated under 
mild hypothermic conditions and is involved in cold shock mechanisms which lead to 
increased protein expression in the cell. It does this by translocation to the cytoplasm 
under cold conditions and direct involvement in the translation process, specifically 
through interactions with the eIF4G protein and mRNA 3’UTRs. These conclusions 
are also supported by the cold shock response model reported suggested by Al-Fageeh 
& Smales (2006). It has also previously been suggested that RNA constructs 
containing the 3’UTR CIRP-binding region displayed enhanced resistance to 
degradation by RNases and that CIRP enhances translation of its target RNA species 
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through stabilization of the mRNA (Sonna, Fujita, Gaffin, & Lilly, 2002) which is 
supported by the findings here. From!the!findings!reported!in!this!chapter!we!can!
hypothesise!a!mechanistic!method!by!which!CIRP!interacts!with!specific!mRNAs!
and!the!translational!machinery!via!an!interaction!with!eIF4G!and!the!3’RUTRs!of!



































Figure 5.19 Schematic showing the proposed mechanism of how CIRP interacts with 
translational machinery and specific mRNA to enhance the translation of these. 
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6.1 Overview 
The objectives of this project were to: (1) to create RNA binding motif mutants of the 
N- terminal domain of the cold-shock induced protein CIRP to identify the essential 
residues for RNA binding and use this information to generate inactive version of the 
CIRP RNA binding domain to help further elucidate the function of the 
arginine/glycine rich C-terminal domain, (2) express and purify full-length CIRP to 
produce a soluble protein sample for RNA binding studies, (3) study the RNA binding 
properties of full-length CIRP, N-CIRP and N-CIRP mutants by EMSA and NMR, 
(4) solve the 3-dimensional structure and investigate the dynamic properties of N-
CIRP in solution by NMR, and (5)  undertake studies aimed at furthering our 
understanding of the molecular mechanisms by which CIRP can influence the rate of 
recombinant protein production in mammalian cells under normal (37°C) and reduced 
(32°C) culture temperatures. These objectives were largely achieved and the findings 
are discussed in detail in the previous chapters of this thesis. 
 
N-CIRP RNA binding mutants were successfully generated, expressed and purified in 
chapter 2 and in the following chapter (chapter 3) it was shown that these mutated 
residues (F9 and F49) are essential for CIRP binding to RNA and therefore an 
inactive RNA binding form of the domain was achieved.  Further importance of these 
residues was confirmed by the NMR dynamics studies where the region (β2-β3 loop) 
just before the RNP1 sequence including F49 was found to have increased motion 
compared to the rest of the protein (chapter 4). The three dimensional structure 
determination of N-CIRP was achieved by first completing the heteronuclear 
assignments of the backbone and side chain resonances for each amino acid as 
described in Chapter 4. Even though the structure requires further refinement, the 
identification of the backbone topology of N-CIRP was accomplished. Finally in 
Chapter 5, data was presented to support the hypothesis that CIRP interacts with 
specific mRNAs and the translational machinery via an interaction with eIF4G and 
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6.2 Conclusions 
RNA chaperones have been shown to stabilise mRNA molecules, prevent the 
formation of secondary structures and prevent or reverse aggregation (Herschlag, 
1995; Russell, 2008; Tompa & Csermely, 2004). This study set out to further 
elucidate the structure and function of CIRP, a cold inducible RNA chaperone and the 
mechanism(s) by which it is able to enhance mRNA translation and increase protein 
expression of specific transcripts. This project further confirmed the identity of 
residues in CIRP essential for the binding of RNA ligands and the importance of these 
to the function and conformational rigidity of CIRP. The phenylalanine residues 9 and 
49 in the amino acid sequence in positions 2 and 3 of RNP2 and RNP1 respectively 
were confirmed as important for binding RNA as their mutagenesis to Ala prevented 
RNA binding to N-CIRP(figure 3.7).  Although the mutation of these essential 
residues did not have an effect on the expression of the protein in E.coli, their 
substitution to Ala did result in some conformational change in the structure of the 
domain as observed by HSQC-NMR, particularly for the F49 residue in RNP1 (figure 
3.3). The mutation of one of the phenylalanine residues affected the chemical shift of 
the other confirming their proximity in space. Even though there is little information 
on the sequence specificity of the RNAs that CIRP binds, this study has increased the 
knowledge of how CIRP binds to its RNA ligands. 
 
Proteins which function as RNA chaperones, together with cell signaling and cancer 
associated proteins, have been reported to often have disordered domains 
(Iakoucheva, Brown, Lawson, Obradović, & Dunker, 2002; Tompa & Csermely, 
2004). Various hnRNP proteins are thought to have disordered regions, for example 
hnRNPA1, hnRNPC1/C2 and hnRNPU. The protein Hsp12 is induced upon a 
reduction in temperature (Murata et al., 2006) and it is a natively unfolded protein, 
which adopts a helical structure in the presence of its ligands (Welker et al., 2010). A 
study by Tantos et al (2009) has found that disordered proteins have a higher 
resistance to cold treatment in terms of retaining activity under cold conditions where 
as the globular proteins showed a drop in activity due to cold denaturation. As a result 
of this study, Tantos et al suggested that protein disorder is one of the key factors in 
cold stress (Tantos, Friedrich, & Tompa, 2009).  The difficulty with producing a 
soluble purified full-length CIRP sample during this project limited the experiments 
that could be carried out to study the function of the C-terminal domain. The data that 
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was collected suggests that the C-terminal domain contributes to the function of 
CIRP. It has also been previously shown that both the N- and the C-terminal domain 
of CIRP are required for maximal RNA binding (Yang, Weber, & Carrier, 2006). The 
insolubility of the protein when expressed with the C-terminal region suggests that it 
requires a cellular environment and/or to be in the presence of a ligand to prevent 
aggregation. The EMSA results in chapter 3 of this work confirmed that both domains 
are required for maximal RNA binding as at the concentrations investigated only the 
full-length protein showed binding activity (section 3.3.4). As suggested by Tantos et 
al (2009), the disordered region may have a function towards resistance to cold stress 
helping the protein to retain their activity under low temperature conditions. As well 
as the N-terminal binding to RNA ligands in the absence of the C-terminal, this study 
has shown that the C-terminal domain is not required for the interaction of CIRP with 
eIF4G (figure 5.9). Further, the full length-protein lead to the highest increase in 
luciferase levels compared to N-CIRP when expressed in CHO cells and also cell 
lines stably expressing full-length CIRP showed an increased growth rate confirming 
that the C-terminal is necessary for maximal function of CIRP (section 5.3.4 and 
5.3.6). When all data is considered together, this suggests that the arginine/glycine 
rich C-terminal domain plays an important role towards ligand specificity that may 
provide more stringent recognition or tighter binding after the N-terminal domain has 
initially recognized RNA binding partners. The low affinity of the N-terminal domain 
for RNA ligands suggest this may act as an initial binding partner with fast on/off 
rates whilst the C-terminal region may act to facilitate tighter binding to ‘correct’ 
binding partners. Whether this hypothesis is correct or not could be examined in 
future studies.  
 
Previous studies have shown that CIRP migrates from the nucleus to the cytoplasm 
under stress conditions such as UV exposure, hypoxia and mild hypothermia (De 
Leeuw et al., 2007). This translocation has been shown to be regulated by the 
methylation of C-terminal RGG motifs that CIRP possess in its disordered C-terminal 
domain. In this project, immunofluorescence data has also shown an increase in the 
amount of CIRP located in the cytoplasm of cells exposed to cold stress at 32°C and 
higher concentrations of CIRP located in the nucleus in control cells cultured at 37°C 
(figures 5.7 and 5.17).  This finding supports the function of CIRP acting as a bridge 
between mRNAs and the translational machinery to enhance the stability and 
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translation of specific mRNAs under hypothermic conditions, as a cytoplasmic 
location would be required for this function.  This is an interesting point, because as 
mentioned above, over-expression of the full-length protein lead to a greater increase 
in luciferase levels compared to expression of N-CIRP (although N-CIRP expression 
itself was lower than full-length CIRP) and cell lines stably expressing full-length 
CIRP showed an increased growth rate. Even though the C-terminal is not required 
for RNA ligand binding of the protein, it is required for CIRP to translocate into the 
cytoplasm to be able to perform the suggested role its plays in the translation of 
mRNAs. 
 
Luciferase experiments showed that the overexpression of CIRP in cells transfected 
with luciferase containing the ATR 3’UTR in its mRNA lead to an increased 
expression of luciferase protein i.e. the enhanced translation of this mRNA and also 
the interaction of CIRP with eIF4G (section 5.3.4).  This is evidence that CIRP can 
bind specific mRNAs and enhances their expression through its interaction with the 
translation machinery leading to increased protein levels. It was possible to up-
regulate the expression of luciferase protein by the addition of the ATR 3’UTR 
sequence, which has been identified as a RNA ligand for CIRP (Yang et al., 2010). 
These findings provide an opportunity to develop strategies to enhance the level of 
recombinant protein production in mammalian cells. The data also shows that CIRP 
binds both proteins via the N-terminal domain and RNA, although exactly where 
protein binding occurs on the N-terminal domain is not currently known. Presumably 
this cannot be on the face that interacts with RNA as mapped in the NMR studies if 
this domain binds RNA and protein simultaneously. For such a small domain to bind 
a large RNA molecule and a large translation factor at the same time must involve 
some steric constraints and further work to investigate the binding mode to eIF4G 
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6.3 Main Findings and Future Work 
As described in chapter 1, there have been many reports on the cellular response and 
biotechnological application of sub physiological temperatures for improved protein 
production. Many have investigated how the induction of CIRP at these temperatures 
contributes to these responses through its role as an RNA chaperone. Several reports 
have suggested a number of functions for CIRP, for example, in the reduction of 
testicular damage induced by cryptorchidism (Zhou, Zheng, Yang, Zhang, & Chen, 
2009) and in the contribution to human HuR and cyclin E1 deregulation in breast 
cancer (Guo, Wu, & Hartley, 2010). In this study, we have focused on the effect of 
CIRP on cells which leads to improved recombinant protein production through 
investigating the binding of the N-terminal domain of CIRP to RNA ligands and the 
function of the C-terminal domain as well as gaining a structural understanding.  
Using this information as well as the investigations described into the function of 
CIRP in mammalian cells such as its interaction with the translational machinery and 
its effect on levels of recombinant protein production through these interaction, the 
work reported here has shown how CIRP can be used to develop new strategies for 
enhanced recombinant protein expression from mammalian cells grown at mildly 
hypothermic temperatures. 
 
In conclusion, the work carried out in this project has provided us with data showing 
that the RNA binding of CIRP is mainly through the phenylalanine residues in 
position 3 of RNP1 and position 2 of RNP2. These residues are close in space and 
structurally significant, specifically the phenylalanine in the RNP1 motif. Mouse N-
CIRP possesses a typical RNA binding protein structure, which is also highly similar 
to the human protein and displays little motion in the absence of a ligand.  The N-
terminal domain of CIRP as well the full-length protein binds to the translation 
initiation factor eIF4G and does so by translocating from nucleus to the cytoplasm 
upon cold stress. Full-length CIRP binds to RNA ligands and increases recombinant 
protein production levels more than N-CIRP when overexpressed, suggesting that the 
C-terminal may have a role towards ligand specificity rather than binding as N-CIRP 
binds the ligands tested in this project alone.  The final and key finding of this project 
was that the recombinant protein production from CHO cells can be improved by 
overexpression of CIRP in cells through it interaction with eIF4G and ATR 3’UTR 
mRNA.   
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To further support the conclusions made from this project, further binding 
experiments should be carried out to identify RNA or protein ligands for CIRP, which 
will provide more knowledge on the mechanisms CIRP is involved in. As an inactive 
form of the RNA binding domain was generated in chapter 2, this could be used to 
build a full length CIRP construct where the N-terminal domain is unable to bind 
RNA, which would help to investigate the function of the C-terminal domain. As 
soluble well-behaved recombinant full-length protein could not be produced, it could 
be studied instead by in-cell NMR (Sakakibara et al., 2009; Tochio, 2012), which 
would potentially enable the study of the structure and dynamics of the full-length 
protein and possibly identify an interaction with a ligand. It would also be useful to 
develop a method to achieve a soluble purified form of the full-length protein to be 
able to investigate CIRP function and binding as whole in more detail. The dynamics 
studies of N-CIRP showed little motion in the absence of a ligand and it would be 
interesting to study the dynamics with a bound ligand present to see which regions, if 
any, are affected. Studying the dynamic properties of the mutants forms of N-CIRP 
generated in this project will give further insight as to how these mutations affect the 
protein structurally and to understand how these affect the stability of the protein 
some denaturation assays should be carried out. Using further NMR experiments, 
dihedral angle and hydrogen bonding data should be collected to refine the structure 
of mouse N-CIRP to a point where it can be deposited in the protein data bank. 
Finally, this project has uncovered some key points contributing to how CIRP 
functions in the cells to improve recombinant protein synthesis through interactions 
with the translational machinery and mRNA. To further understand the mechanism, 
the interactions between eIF4G and CIRP can be interrogated further by using NMR 
binding experiments similar to the ones shown in this thesis to identify the binding 
regions for CIRP on eIF4G and vice versa.  A summary of the proposed mechanism 



























































Figure 6.1 Summary of CIRP mechanism in mammalian cells’ response to cold-shock based 




Abragam, A. (1961). The principles of nuclear magnetism. Oxford:Clarendon. 
Abraham, R. T. (2001). Cell cycle checkpoint signaling through the ATM and ATR 
kinases. Genes & Development, 15(17), 2177–96. 
Ahmed, H., (2004). Principles and Reactions of Protein Extraction, Purification, and 
Characterization - CRC Press Book. 
Aiyar, A., Xiang, Y. & Leis, J., (1996). Site-directed mutagenesis using overlap 
extension PCR. Methods in molecular biology, 57, 177–91.  
Alekhina, O. M., & Vassilenko, K. S. (2012). Translation initiation in eukaryotes: 
versatility of the scanning model. Biochemistry. Biokhimii͡ a, 77(13), 1465–77.  
Al-Fageeh, M. B., Marchant, R. J., Carden, M. J., & Smales, C. M. (2005). The Cold-
Shock Response in Cultured Mammalian Cells!: Harnessing the Response for the 
Improvement of Recombinant Protein Production. Biotechnology and Bioengineering, 
93 (5), 829-35. 
Al-Fageeh, M. B., & Smales, C. M. (2006). Control and regulation of the cellular 
responses to cold shock: the responses in yeast and mammalian systems. The 
Biochemical Journal, 397(2), 247–59.  
Al-Fageeh, M. B., & Smales, C. M. (2009). Cold-inducible RNA binding protein ( 
CIRP) expression is modulated by alternative mRNAs. RNA, 15(6), 1164–1176.  
Al-Fageeh, M. B., & Smales, C. M. (2013). Alternative promoters regulate cold 
inducible RNA-binding (CIRP) gene expression and enhance transgene expression in 
mammalian cells. Molecular Biotechnology, 54(2), 238–49. 
Andersen, D. C., & Krummen, L. (2002). Recombinant protein expression for 
therapeutic applications. Current Opinion in Biotechnology, 13(2), 117–123. 
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989). 
Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-
hydroxylase, a bile acid biosynthetic enzyme. The Journal of Biological Chemistry, 
264(14), 8222–9.  
Andrec, M., Montelione, G. T., & Levy, R. M. (2000). Lipari-Szabo mapping: A 
graphical approach to Lipari-Szabo analysis of NMR relaxation data using reduced 
spectral density mapping. Journal of Biomolecular NMR, 18(2), 83–100.  
Aoki, K., Ishii, Y., Matsumoto, K., & Tsujimoto, M. (2002). Methylation of Xenopus 
CIRP2 regulates its arginine- and glycine-rich region-mediated nucleocytoplasmic 
distribution. Nucleic Acids Research, 30(23), 5182–92. 
Arakawa, T. et al., (2007). Biotechnology applications of amino acids in protein 
purification and formulations. Amino acids, 33(4), 587–605. 
References 
!200!
Baldi, L., Hacker, D. L., Adam, M., & Wurm, F. M. (2007). Recombinant protein 
production by large-scale transient gene expression in mammalian cells: state of the 
art and future perspectives. Biotechnology Letters, 29(5), 677–84.  
Bae, W., Jones, P. G., & Inouye, M. (1997). CspA, the major cold shock protein of 
Escherichia coli, negatively regulates its own gene expression. Journal of 
Bacteriology, 179(22), 7081–8.  
Baghdoyan, S., Dubreuil, P., Eberlé, F., & Gomez, S. (2000). Capture of cytokine-
responsive genes (NACA and RBM3) using a gene trap approach. Blood, 95(12), 
3750–7.  
Baldi, A., Battista, T., De Luca, A., Santini, D., Rossiello, L., Baldi, F., Paggi, M. G. 
(2003). Identification of genes down-regulated during melanoma progression: a 
cDNA array study. Experimental Dermatology, 12(2), 213–8.  
Baneyx, F., (1999). Recombinant protein expression in Escherichia coli. Current 
opinion in biotechnology, 10(5), 411–21.  
Baranick, B. T., Lemp, N. A., Nagashima, J., Hiraoka, K., Kasahara, N., & Logg, C. 
R. (2008). Splicing mediates the activity of four putative cellular internal ribosome 
entry sites. Proceedings of the National Academy of Sciences of the United States of 
America, 105(12), 4733–8.  
Barraud, P., & Allain, F. H.-T. (2013). Solution structure of the two RNA recognition 
motifs of hnRNP A1 using segmental isotope labeling: how the relative orientation 
between RRMs influences the nucleic acid binding topology. Journal of Biomolecular 
NMR, 55(1), 119–38.  
Barron, N., Kumar, N., Sanchez, N., Doolan, P., Clarke, C., Meleady, P.,Clynes, M. 
(2011). Engineering CHO cell growth and recombinant protein productivity by 
overexpression of miR-7. Journal of Biotechnology, 151(2), 204–11.  
Barsukov, I. L., & Lian, L. (1993). Structure Determination from NMR data I: 
Analysis of NMR data in Roberts, G. C. K. (Ed.) NMR of Macromolecules!: A 
practial approach. Oxford, OUP. 
Basu, A., Li, X. & Leong, S.S.J., (2011). Refolding of proteins from inclusion bodies: 
rational design and recipes. Applied microbiology and biotechnology, 92(2), 241–51.  
Bax, A., Kontaxis, G., & Tjandra, N. (2001). Dipolar couplings in macromolecular 
structure determination. Methods in Enzymology, 339, 127–74.  




H Correlation via Isotropic Mixing of 13C a New 
Three-Dimensional Approach for Assigning lH and 13C Spectra of 13C-Enriched 
Proteins. Journal of Magnetic Resonance, 88, 425–431 
Becerra, S., Berrios, J., Osses, N., & Altamirano, C. (2012). Exploring the effect of 




Bedford, M. T. (2007). Arginine methylation at a glance. Journal of Cell Science, 
120(Pt 24), 4243–6.  
Beer, C., Buhr, P., Hahn, H., Laubner, D., & Wirth, M. (2003). Gene expression 
analysis of murine cells producing amphotropic mouse leukaemia virus at a 
cultivation temperature of 32 and 37 degrees C. The Journal of General Virology, 
84(Pt 7), 1677–86.  
Berjanskii, M. V, Neal, S., & Wishart, D. S. (2006). PREDITOR: a web server for 
predicting protein torsion angle restraints. Nucleic Acids Research, 34, 63–9.  
Bloch, F., Hansen, W., & Packard, M. (1946). The Nuclear Induction Experiment. 
Physical Review, 70(7-8), 474–485.  
Bloembergen, N., Purcell, E. M., & Pound, R. V. (1947). Nuclear magnetic 
relaxation. Nature, 160(4066), 475.  
Boehr, D. D., Nussinov, R., & Wright, P. E. (2009). The role of dynamic 
conformational ensembles in biomolecular recognition. Nature Chemical Biology, 5, 
789–796.  
Borys, M. C., Dalal, N. G., Abu-Absi, N. R., Khattak, S. F., Jing, Y., Xing, Z., & Li, 
Z. J. (2010). Effects of culture conditions on N-glycolylneuraminic acid (Neu5Gc) 
content of a recombinant fusion protein produced in CHO cells. Biotechnology and 
Bioengineering, 105(6), 1048–57.  
Boshart, M., Weber, F., Jahn, G., Dorsch-Häsler, K., Fleckenstein, B., & Schaffner, 
W. (1985). A very strong enhancer is located upstream of an immediate early gene of 
human cytomegalovirus. Cell, 41(2), 521–30.  
Broadhurst, R. W., Hardman, C. H., Thomas, J. O., & Laue, E. D. (1995). Backbone 
dynamics of the A-domain of HMG1 as studied by 15N NMR spectroscopy. 
Biochemistry, 34, 16608–16617. 
Brüschweiler, R. (2003). New approaches to the dynamic interpretation and 
prediction of NMR relaxation data from proteins. Current Opinion in Structural 
Biology, 13(2), 175–83.  
Burgess, R.R., (2009). Refolding solubilized inclusion body proteins. Methods in 
enzymology, 463, 259–82.  
Cavanagh, J., Fairbrother, W. J., Palmer, A. G., Skelton, N. J., & Rance, M. (2007). 
Protein NMR Spectroscopy: Principles and Practice. Academic Press.  
Chaikam, V., & Karlson, D. T. (2010). Comparison of structure, function and 
regulation of plant cold shock domain proteins to bacterial and animal cold shock 
domain proteins. BMB Reports, 43(1), 1–8.  
Chappell, S. A., Owens, G. C., & Mauro, V. P. (2001). A 5’ Leader of Rbm3, a Cold 
Stress-induced mRNA, Mediates Internal Initiation of Translation with Increased 
References 
!202!
Efficiency under Conditions of Mild Hypothermia. The Journal of Biological 
Chemistry, 276(40), 36917–22.  
Chen, K., & Tjandra, N. (2008). Extended model free approach to analyze correlation 
functions of multidomain proteins in the presence of motional coupling. Journal of 
the American Chemical Society, 130(38), 12745–51. 
Cheung, Maguire, M. L., Stevens, T. J., & Broadhurst, R. W. (2010). DANGLE: A 
Bayesian inferential method for predicting protein backbone dihedral angles and 
secondary structure. Journal of Magnetic Resonance, 202(2), 223–33.  
Chu, L., & Robinson, D. K. (2001). Industrial choices for protein production by large-
scale cell culture. Current Opinion in Biotechnology, 12(2), 180–187.  
Clarkson, J., & Campbell, I. D. (2003). Studies of protein-ligand interactions by 
NMR. Biochemical Society Transactions, 31, 1006–1009. 
Coles, M., Heller, M., & Kessler, H. (2003). NMR-based screening technologies. 
Drug Discovery Today, 8(17), 803–10.  
Cok, S. J., Acton, S. J., Sexton, A. E., & Morrison, A. R. (2004). Identification of 
RNA-binding proteins in RAW 264.7 cells that recognize a lipopolysaccharide-
responsive element in the 3-untranslated region of the murine cyclooxygenase-2 
mRNA. The Journal of Biological Chemistry, 279(9), 8196–205.  
Corish, P., & Tyler-Smith, C. (1999). Attenuation of green fluorescent protein half-
life in mammalian cells. Protein Engineering Design and Selection, 12(12), 1035–
1040.  
Cornilescu, G., Delaglio, F., & Bax, A. (1999). Protein backbone angle restraints from 
searching a database for chemical shift and sequence homology. Journal of 
Biomolecular NMR, 13(3), 289–302.  
Craig, N. L. (1988). The mechanism of conservative site-specific recombination. 
Annual Review of Genetics, 22, 77–105.  
Danno, S., Nishiyama, H., Higashitsuji, H., Yokoi, H., Xue, J. H., Itoh, K., Fujita, J. 
(1997). Increased transcript level of RBM3, a member of the glycine-rich RNA-
binding protein family, in human cells in response to cold stress. Biochemical and 
Biophysical Research Communications, 236(3), 804–7.  
Danno, S., Itoh, K., Matsuda, T., & Fujita, J. (2000). Decreased expression of mouse 
Rbm3, a cold-shock protein, in Sertoli cells of cryptorchid testis. The American 
Journal of Pathology, 156(5), 1685–92. 
Daragan, V. A., Ilyina, E. E., Fields, C. G., Fields, G. B., & Mayo, K. H. (1997). 
Backbone and side-chain dynamics of residues in a partially folded beta-sheet peptide 
from platelet factor-4. Protein Science, 6(2), 355–63.  
References 
!203!
De Leeuw, F., Zhang, T., Wauquier, C., Huez, G., Kruys, V., & Gueydan, C. (2007). 
The cold-inducible RNA-binding protein migrates from the nucleus to cytoplasmic 
stress granules by a methylation-dependent mechanism and acts as a translational 
repressor. Experimental Cell Research, 313(20), 4130–44.  
Derry, J. M., Kerns, J. A., & Francke, U. (1995). RBM3, a novel human gene in 
Xp11.23 with a putative RNA-binding domain. Human Molecular Genetics, 4(12), 
2307–11.  
Doray, B., Chen, C.D. & Kemper, B., (2001). N-terminal deletions and His-tag 
fusions dramatically affect expression of cytochrome p450 2C2 in bacteria. Archives 
of biochemistry and biophysics, 393(1), 143–53.  
Dresios, J., Aschrafi, A., Owens, G. C., Vanderklish, P. W., Edelman, G. M., & 
Mauro, V. P. (2005). Cold stress-induced protein Rbm3 binds 60S ribosomal 
subunits, alters microRNA levels, and enhances global protein synthesis. Proceedings 
of the National Academy of Sciences of the United States of America, 102(6), 1865–
70.  
Dreyfuss, G., Matunis, M. J., Piñol-Roma, S., & Burd, C. G. (1993). hnRNP proteins 
and the biogenesis of mRNA. Annual Review of Biochemistry, 62, 289–321.  
Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., 
Obradovic, Z. (2001). Intrinsically disordered protein. Journal of Molecular Graphics 
& Modelling, 19(1), 26–59.  
Eliseeva, I. A., Kim, E. R., Guryanov, S. G., Ovchinnikov, L. P., & Lyabin, D. N. 
(2011). Y-box-binding protein 1 (YB-1) and its functions. Biochemistry, 76(13), 
1402–33. 
Ermolenko, D. N., & Makhatadze, G. I. (2002). Bacterial cold-shock proteins. 
Cellular and Molecular Life Sciences, 59(11), 1902–13.  
Evdokimova, V. M., Kovrigina, E. A., Nashchekin, D. V, Davydova, E. K., Hershey, 
J. W., & Ovchinnikov, L. P. (1998). The major core protein of messenger 
ribonucleoprotein particles (p50) promotes initiation of protein biosynthesis in vitro. 
The Journal of Biological Chemistry, 273(6), 3574–81.  
Evdokimova, V. M., & Ovchinnikov, L. P. (1999). Translational regulation by Y-box 
transcription factor: involvement of the major mRNA-associated protein, p50. The 
International Journal of Biochemistry & Cell Biology, 31(1), 139–49. 
Fischer, M. W. F., Majumdar, A., & Zuiderweg, E. R. P. (1998). Protein NMR 
relaxation: theory, applications and outlook. Progress in Nuclear Magnetic 
Resonance Spectroscopy, 33(3), 207–272.  
Fogolín, M. B., Wagner, R., Etcheverrigaray, M., & Kratje, R. (2004). Impact of 
temperature reduction and expression of yeast pyruvate carboxylase on hGM-CSF-
producing CHO cells. Journal of Biotechnology, 109(1-2), 179–91.  
References 
!204!
Follis, A. V., Galea, C. A., & Kriwacki, R. W. (2012). Intrinsic protein flexibility in 
regulation of cell proliferation: advantages for signaling and opportunities for novel 
therapeutics. Advances in Experimental Medicine and Biology, 725, 27–49.  
Fornace, A. J., Alamo, I., & Hollander, M. C. (1988). DNA damage-inducible 
transcripts in mammalian cells. Proceedings of the National Academy of Sciences of 
the United States of America, 85(23), 8800–4.  
Fox, S. R., Patel, U. A., Yap, M. G. S., & Wang, D. I. C. (2004). Maximizing 
interferon-gamma production by Chinese hamster ovary cells through temperature 
shift optimization: experimental and modeling. Biotechnology and Bioengineering, 
85(2), 177–84.  
Fox, S. R., Tan, H. K., Tan, M. C., Wong, S. C. N. C., Yap, M. G. S., & Wang, D. I. 
C. (2005). A detailed understanding of the enhanced hypothermic productivity of 
interferon-gamma by Chinese-hamster ovary cells. Biotechnology and Applied 
Biochemistry, 41(Pt 3), 255–64.  
Fujita, J. (1999). Cold shock response in mammalian cells. Journal of Molecular 
Microbiology and Biotechnology, 1(2), 243–55.  
Fussenegger, M. (2001). The impact of mammalian gene regulation concepts on 
functional genomic research, metabolic engineering, and advanced gene therapies. 
Biotechnology Progress, 17(1), 1–51. 
Galea, C. A., Nourse, A., Wang, Y., Sivakolundu, S. G., Heller, W. T., & Kriwacki, 
R. W. (2008). Role of intrinsic flexibility in signal transduction mediated by the cell 
cycle regulator, p27 Kip1. Journal of Molecular Biology, 376(3), 827–38.  
Geoghegan, K.F. et al., (1999). Spontaneous alpha-N-6-phosphogluconoylation of a 
“His tag” in Escherichia coli: the cause of extra mass of 258 or 178 Da in fusion 
proteins. Analytical biochemistry, 267(1), 169–84.  
Gammell, P., Barron, N., Kumar, N., & Clynes, M. (2007). Initial identification of 
low temperature and culture stage induction of miRNA expression in suspension 
CHO-K1 cells. Journal of Biotechnology, 130(3), 213–8.  
Gaudreault, I., Guay, D., & Lebel, M. (2004). YB-1 promotes strand separation in 
vitro of duplex DNA containing either mispaired bases or cisplatin modifications, 
exhibits endonucleolytic activities and binds several DNA repair proteins. Nucleic 
Acids Research, 32(1), 316–27.  
Ginzinger, S. W., & Coles, M. (2009). SimShiftDB; local conformational restraints 
derived from chemical shift similarity searches on a large synthetic database. Journal 
of Biomolecular NMR, 43(3), 179–85.  
Giuliodori, A. M., Brandi, A., Gualerzi, C. O., & Pon, C. L. (2004). Preferential 
translation of cold-shock mRNAs during cold adaptation. RNA, 10(2), 265–76.  
References 
!205!
Givalos, N., Gakiopoulou, H., Skliri, M., Bousboukea, K., Konstantinidou, A. E., 
Korkolopoulou, P., Karatzas, G. (2007). Replication protein A is an independent 
prognostic indicator with potential therapeutic implications in colon cancer. Modern 
Pathology, 20(2), 159–66.  
Golovanov, A.P. et al., (2004). A simple method for improving protein solubility and 
long-term stability. Journal of the American Chemical Society, 126(29), 8933–9.  
Goswami, J., Sinskey, A. J., Steller, H., Stephanopoulos, G. N., & Wang, D. I. (1999). 
Apoptosis in batch cultures of Chinese hamster ovary cells. Biotechnology and 
Bioengineering, 62(6), 632–40.  
Gräslund, S. et al., (2008). Protein production and purification. Nature methods, 5(2), 
135–46. 
Griesinger, C., & Sattler, M. (1999). Heteronuclear multidimensional NMR 
experiments for the structure determination of proteins in solution employing pulsed 
field gradients. Progress in Nuclear Magnetic Resonance Spectroscopy, 34, 93–158. 
Grishaev, A., & Llinás, M. (2005). Protein structure elucidation from minimal NMR 
data: the CLOUDS approach. Methods in Enzymology, 394, 261–95.  
Gritz, L., & Davies, J. (1983). Plasmid-encoded hygromycin B resistance: the 
sequence of hygromycin B phosphotransferase gene and its expression in Escherichia 
coli and Saccharomyces cerevisiae. Gene, 25(2-3), 179–88. 
Gronwald, W., Brunner, K., Kirchhöfer, R., Nasser, A., Trenner, J., Ganslmeier, 
B.,Kalbitzer, H. (2004). AUREMOL, a New Program for the Automated Structure 
Elucidation of Biological Macromolecules. Bruker Rep., 154/155, 11 – 14. 
Grzesiekt, S., & Bax, A. (1992a). An efficient experiment for sequential backbone 
assignment of medium-sized isotopically enriched proteins. Journal of Magnetic 
Resonance (1969), 99(1), 201–207.  
Grzesiekt, S., & Bax, A. (1992b). Correlating Backbone Amide and Side Chain 
Resonances in Larger Proteins by Multiple Relayed Triple Resonance NMR. Journal 
of the American Chemical Society, 114(16), 6291–6293. 
Gualerzi, C. O., Maria Giuliodori, A., & Pon, C. L. (2003). Transcriptional and Post-
transcriptional Control of Cold-shock Genes. Journal of Molecular Biology, 331(3), 
527–539.  
Guntert, P. (1997). Calculating Protein Structures from NMR data in Reid, D. G. (Ed.) 
Protein NMR techniques. Totowa, NJ., Humana Press. 
Guntert, P. (2003). Automated NMR protein structure calculation. Progress in 
Nuclear Magnetic Resonance Spectroscopy, 43(3-4), 105–125. 
Guntert, P. (2004). Automated NMR structure calculation with CYANA. Methods in 
Molecular Biology , 278, 353–78.  
References 
!206!
Guo, X., Wu, Y., & Hartley, R. S. (2010). Cold-inducible RNA-binding protein 
contributes to human antigen R and cyclin E1 deregulation in breast cancer. 
Molecular Carcinogenesis, 49(2), 130–40. 
Hammond, J. B., & Kruger, N. J. (1988). The bradford method for protein 
quantitation. Methods in Molecular Biology, 3, 25–32.  
Harris, A. L. (2002). Hypoxia--a key regulatory factor in tumour growth. Nature 
Reviews. Cancer, 2(1), 38–47.  
Henzler-Wildman, K., & Kern, D. (2007). Dynamic personalities of proteins. Nature, 
450, 964–972. 
Herschlag, D. (1995). RNA chaperones and the RNA folding problem. The Journal of 
Biological Chemistry, 270(36), 20871–4. 
Hinton, T. M., Coldwell, M. J., Carpenter, G. a, Morley, S. J., & Pain, V. M. (2007). 
Functional analysis of individual binding activities of the scaffold protein eIF4G. The 
Journal of Biological Chemistry, 282(3), 1695–708.  
Ho, S.N. et al., (1989). Site-directed mutagenesis by overlap extension using the 
polymerase chain reaction. Gene, 77(1), 51–59.  
Hofmann, S., Cherkasova, V., Bankhead, P., Bukau, B., & Stoecklin, G. (2012). 
Translation suppression promotes stress granule formation and cell survival in 
response to cold shock. Molecular Biology of the Cell, 23(19), 3786–800.  
Holcik, M., & Sonenberg, N. (2005). Translational control in stress and apoptosis. 
Nature Reviews. Molecular Cell Biology, 6(4), 318–27.  
Holcik, M., & Pestova, T. V. (2007). Translation mechanism and regulation: old 
players, new concepts. Meeting on translational control and non-coding RNA. EMBO 
Reports, 8(7), 639–43. 
Holm, L., & Park, J. (2000). DaliLite workbench for protein structure comparison. 
Bioinformatics, 16(6), 566–567.  
Horn, G., Hofweber, R., Kremer, W., & Kalbitzer, H. R. (2007). Structure and 
function of bacterial cold shock proteins. Cellular and Molecular Life Sciences, 
64(12), 1457–70. 
Hsieh, S., (2010). Structural and functional characterization of the    mammalian cold 
shock protein CIRP. PhD Thesis. 
 
Huang, Y.-M., Hu, W., Rustandi, E., Chang, K., Yusuf-Makagiansar, H., & Ryll, T. 
(2010). Maximizing productivity of CHO cell-based fed-batch culture using 
chemically defined media conditions and typical manufacturing equipment. 
Biotechnology Progress, 26(5), 1400–10. 
References 
!207!
Hughes, T. A. (2006). Regulation of gene expression by alternative untranslated 
regions. Trends in Genetics, 22(3), 119–22.  
Hwang, S.-J., Yoon, S. K., Koh, G. Y., & Lee, G. M. (2011). Effects of culture 
temperature and pH on flag-tagged COMP angiopoietin-1 (FCA1) production from 
recombinant CHO cells: FCA1 aggregation. Applied Microbiology and 
Biotechnology, 91(2), 305–15.  
Idicula-Thomas, S. & Balaji, P. V, (2005). Understanding the relationship between 
the primary structure of proteins and its propensity to be soluble on overexpression in 
Escherichia coli. Protein science, 14(3), 582–92.  
Igumenova, T. I., Frederick, K. K., & Wand, A. J. (2006). Characterization of the fast 
dynamics of protein amino acid side chains using NMR relaxation in solution. 
Chemical Reviews, 106(5), 1672–99.  
Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradović, Z., & Dunker, A. K. 
(2002). Intrinsic disorder in cell-signaling and cancer-associated proteins. Journal of 
Molecular Biology, 323(3), 573–84. 
Ise, T., Nagatani, G., Imamura, T., Kato, K., Takano, H., Nomoto, M., … Kohno, K. 
(1999). Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-
modified DNA and interacts with proliferating cell nuclear antigen. Cancer Research, 
59(2), 342–6. 
Ishima, R., & Torchia, D. a. (2000). Protein dynamics from NMR. Nature Structural 
Biology, 7(9), 740–3.  
Jacob, E., & Unger, R. (2007). A tale of two tails: why are terminal residues of 
proteins exposed? Bioinformatics, 23(2), e225–30. 
Jacobsen, N. E. (2007). NMR Spectroscopy Explained: Simplified Theory, 
Applications and Examples for Organic Chemistry and Structural Biology. 
Quadrature (p. 643). 
Jana, S. & Deb, J.K., (2005). Strategies for efficient production of heterologous 
proteins in Escherichia coli. Applied microbiology and biotechnology, 67(3), 289–98.  
Janson & Ryden, (1998). Protein purification: Principles, high-resolution methods, 
and applications.  
Jarymowycz, V. A., & Stone, M. J. (2006). Fast time scale dynamics of protein 
backbones: NMR relaxation methods, applications, and functional consequences. 
Chemical Reviews, 106(5), 1624–71.  
Jayapal, K. P., Wlaschin, K. F., Hu, W.-S. H., & Yap, M. G. S. (2007). Recombinant 




Jenkins, N., & Hovey, A. (1993). Temperature control of growth and productivity in 
mutant Chinese hamster ovary cells synthesizing a recombinant protein. 
Biotechnology and Bioengineering, 42(9), 1029–36.  
Ji, Z., Lee, J. Y., Pan, Z., Jiang, B., & Tian, B. (2009). Progressive lengthening of 3’ 
untranslated regions of mRNAs by alternative polyadenylation during mouse 
embryonic development. Proceedings of the National Academy of Sciences of the 
United States of America, 106(17), 7028–33. 
Jiang, W., Hou, Y., & Inouye, M. (1997). CspA, the major cold-shock protein of 
Escherichia coli, is an RNA chaperone. The Journal of Biological Chemistry, 272(1), 
196–202.  
Joshi, M., Kulkarni, A., & Pal, J. K. (2013). Small molecule modulators of eukaryotic 
initiation factor 2α kinases, the key regulators of protein synthesis. Biochimie, 95(11), 
1980–90. 
Jungbauer, A. & Kaar, W., (2007). Current status of technical protein refolding. 
Journal of biotechnology, 128(3), 587–96. 
Kay, L. E. (2005). NMR studies of protein structure and dynamics. Journal of 
Magnetic Resonance, 173(2), 193–207.  
Kay, L. E., Xu, G. Y., Singer, A. U., Muhandiram, D. R., & Forman-Kay, J. D. 
(1993). A Gradient-Enhanced HCCH-TOCSY Experiment for Recording Side-Chain 
1H and 13C Correlations in H2O Samples of Proteins. Journal of Magnetic 
Resonance, Series B, 101(3), 333–337.  
Keeler, J. (2005). Understanding NMR Spectroscopy. Chichester, John Wiley. 
Keiper, B. D., Gan, W., & Rhoads, R. E. (1999). Protein synthesis initiation factor 
4G. The International Journal of Biochemistry & Cell Biology, 31(1), 37–41.  
Kempf, J. G., & Loria, J. P. (2003). Protein dynamics from solution NMR: theory and 
applications. Cell Biochemistry and Biophysics, 37(3), 187–211.  
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012). CHO cells in biotechnology for 
production of recombinant proteins: current state and further potential. Applied 
Microbiology and Biotechnology, 93(3), 917–30. 
Kim, S., Merrill, B. M., Rajpurohit, R., Kumar, A., Stone, K. L., Papov, V. V, 
Williams, K. R. (1997). Identification of N(G)-methylarginine residues in human 
heterogeneous RNP protein A1: Phe/Gly-Gly-Gly-Arg-Gly-Gly-Gly/Phe is a 
preferred recognition motif. Biochemistry, 36(17), 5185–92.  
Kita, H. (2002). Modulation of polyglutamine-induced cell death by genes identified 
by expression profiling. Human Molecular Genetics, 11(19), 2279–2287.  
Klann, E., & Dever, T. E. (2004). Biochemical mechanisms for translational 
regulation in synaptic plasticity. Nature Reviews. Neuroscience, 5(12), 931–42.  
References 
!209!
Kleckner, I. R., & Foster, M. P. (2011). An introduction to NMR-based approaches 
for measuring protein dynamics. Biochimica et Biophysica Acta, 1814(8), 942–68.  
Koradi, R., Billeter, M., & Wüthrich, K. (1996). MOLMOL: a program for display 
and analysis of macromolecular structures. Journal of Molecular Graphics, 14(1), 51–
5, 29–32.  
Korneeva, N. L., Lamphear, B. J., Hennigan, F. L., & Rhoads, R. E. (2000). Mutually 
cooperative binding of eukaryotic translation initiation factor (eIF) 3 and eIF4A to 
human eIF4G-1. The Journal of Biological Chemistry, 275(52), 41369–76.  
Kou, T.-C., Fan, L., Zhou, Y., Ye, Z.-Y., Liu, X.-P., Zhao, L., & Tan, W.-S. (2011). 
Detailed understanding of enhanced specific productivity in Chinese hamster ovary 
cells at low culture temperature. Journal of Bioscience and Bioengineering, 111(3), 
365–9.  
Krieg, P. A., & Melton, D. A. (1984). Functional messenger RNAs are produced by 
SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Research, 12, 7057–7070.  
Kriwacki, R. W., Hengst, L., Tennant, L., Reed, S. I., & Wright, P. E. (1996). 
Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: 
conformational disorder mediates binding diversity. Proceedings of the National 
Academy of Sciences of the United States of America, 93(21), 11504–9.  
Kumar, N., Gammell, P., & Clynes, M. (2007). Proliferation control strategies to 
improve productivity and survival during CHO based production culture!: A summary 
of recent methods employed and the effects of proliferation control in product 
secreting CHO cell lines. Cytotechnology, 53(1-3), 33–46.  
Kumar, N., Gammell, P., Meleady, P., Henry, M., & Clynes, M. (2008). Differential 
protein expression following low temperature culture of suspension CHO-K1 cells. 
BMC Biotechnology, 8, 42.  
Lamphear, B. J., Kirchweger, R., Skern, T., & Rhoads, R. E. (1995). Mapping of 
Functional Domains in Eukaryotic Protein Synthesis Initiation Factor 4G (eIF4G) 
with Picornaviral Proteases: Implications for cap-dependent and cap-independent 
translational initiation. Journal of Biological Chemistry, 270(37), 21975–21983.  
Lee, A. L., Volkman, B. F., Robertson, S. A., Rudner, D. Z., Barbash, D. A., Cline, T. 
W.,Wemmer, D. E. (1997). Chemical shift mapping of the RNA-binding interface of 
the multiple-RBD protein sex-lethal. Biochemistry, 36, 14306–14317. 
Li, Z., & Srivastava, P. (2004). Heat-shock proteins. Current Protocols in 
Immunology. 
Lim, Y., Wong, N. S. C., Lee, Y. Y., Ku, S. C. Y., Wong, D. C. F., & Yap, M. G. S. 
(2010). Engineering mammalian cells in bioprocessing - current achievements and 
future perspectives. Biotechnology and Applied Biochemistry, 55(4), 175–89.  
References 
!210!
Ling, M.M. & Robinson, B.H., (1997). Approaches to DNA mutagenesis: an 
overview. Analytical biochemistry, 254(2), 157–78.  
Linge, J. P., O’Donoghue, S. I., & Nilges, M. (2001). Automated assignment of 
ambiguous nuclear overhauser effects with ARIA. Methods in Enzymology, 339, 71–
90.  
Lipari, G., & Szabo, A. (1982). Model-Free Approach to the Interpretation of Nuclear 
Magnetic Resonance Relaxation in Macromolecules. Journal of the American 
Chemical Society, 104, 4546–4559. 
Liu, Q., & Dreyfuss, G. (1995). In vivo and in vitro arginine methylation of RNA-
binding proteins. Molecular and Cellular Biology, 15(5), 2800–8.  
Liu, Y., Hu, W., Murakawa, Y., Yin, J., Wang, G., Landthaler, M., & Yan, J. (2013). 
Cold-induced RNA-binding proteins regulate circadian gene expression by controlling 
alternative polyadenylation. Scientific Reports, 3, 2054. 
Lleonart, M. E. (2010). A new generation of proto-oncogenes: cold-inducible RNA 
binding proteins. Biochimica et Biophysica Acta, 1805(1), 43–52.  
López-Méndez, B., & Güntert, P. (2006). Automated protein structure determination 
from NMR spectra. Journal of the American Chemical Society, 128, 13112–13122.  
Los, D. A., & Murata, N. (2004). Membrane fluidity and its roles in the perception of 
environmental signals. Biochimica et Biophysica Acta, 1666(1-2), 142–57. 
Luan, C.-H. et al., (2004). High-throughput expression of C. elegans proteins. 
Genome research, 14(10B), 2102–10.  
Manival, X., Ghisolfi-Nieto, L., Joseph, G., Bouvet, P., & Erard, M. (2001). RNA-
binding strategies common to cold-shock domain- and RNA recognition motif-
containing proteins. Nucleic Acids Research, 29(11), 2223–33. 
Mantovani, R. (1998). A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids 
Research, 26(5), 1135–43.  
Maquat, L. E., Tarn, W.-Y., & Isken, O. (2010). The pioneer round of translation: 
features and functions. Cell, 142(3), 368–74. 
Marchant, R. J., Al-Fageeh, M. B., Underhill, M. F., Racher, A. J., & Smales, C. M. 
(2008). Metabolic rates, growth phase, and mRNA levels influence cell-specific 
antibody production levels from in vitro-cultured mammalian cells at sub-
physiological temperatures. Molecular Biotechnology, 39(1), 69–77.  
Maris, C., Dominguez, C. & Allain, F.H.-T., (2005). The RNA recognition motif, a 
plastic RNA-binding platform to regulate post-transcriptional gene expression. The 
FEBS journal, 272(9), 2118–31.  
References 
!211!
Marston, F.A.O. & Hartley, D.L., (1990). Solubilisation of Protein Aggregates. 
Methods in Enzymology, 182, 264-276. 
Masterton, R. J., Roobol, A., Al-Fageeh, M. B., Carden, M. J., & Smales, C. M. 
(2010). Post-translational events of a model reporter protein proceed with higher 
fidelity and accuracy upon mild hypothermic culturing of Chinese hamster ovary 
cells. Biotechnology and Bioengineering, 105(1), 215–20. 
Masterton, R., & Smales, C. M. (2014). The impact of process temperature on 
mammalian cell lines and the implications for the production of recombinant proteins 
in CHO cells, 2, 49–61. 
Masuda, T., Itoh, K., Higashitsuji, H., Higashitsuji, H., Nakazawa, N., Sakurai, T., 
Fujita, J. (2012). Cold-inducible RNA-binding protein (Cirp) interacts with 
Dyrk1b/Mirk and promotes proliferation of immature male germ cells in mice. 
Proceedings of the National Academy of Sciences of the United States of America, 
109(27), 10885–90.  
Maurer, T. (2005). NMR studies of protein-ligand interactions. Methods in Molecular 
Biology, 305, 197–214.  
Maxwell, K.L. et al., (2003). Refolding out of guanidine hydrochloride is an effective 
approach for high-throughput structural studies of small proteins. Protein science!: a 
publication of the Protein Society, 12(9), 2073–80.  
Mayr, C., & Bartel, D. P. (2009). Widespread shortening of 3’UTRs by alternative 
cleavage and polyadenylation activates oncogenes in cancer cells. Cell, 138(4), 673–
84.  
McBride, A. E., & Silver, P. A. (2001). State of the arg: protein methylation at 
arginine comes of age. Cell, 106(1), 5–8.  
Mcconell, J. (1987). The theory of nuclear magnetic resonance in liquids. 
Cambridge,Cambridge University Press. 
McIntosh, L. P., & Dahlquist, F. W. (1990). Biosynthetic incorporation of 15N and 
13C for assignment and interpretation of nuclear magnetic resonance spectra of 
proteins. Quarterly Reviews of Biophysics, 23(1), 1–38. 
Middelberg, A.P., (2002). Preparative protein refolding. Trends in Biotechnology, 
20(10), 437–443.  
Mielke, S. P., & Krishnan, V. V. (2009). Characterization of protein secondary 
structure from NMR chemical shifts. Progress in Nuclear Magnetic Resonance 
Spectroscopy, 54(3-4), 141–165.  
Miernyk, J. a, & Thelen, J. J. (2008). Biochemical approaches for discovering protein-




Mihailovich, M., Militti, C., Gabaldón, T., & Gebauer, F. (2010). Eukaryotic cold 
shock domain proteins: highly versatile regulators of gene expression. BioEssays!: 
News and Reviews in Molecular, Cellular and Developmental Biology, 32(2), 109–18.  
Millner, P., (1999). High Resolution Chromatography. Oxford University Press.  
Mittag, T., Kay, L.E. & Forman-Kay, J.D., (2010). Protein dynamics and 
conformational disorder in molecular recognition. Journal of molecular recognition, 
23(2), 105–16.  
Mittermaier, A. K., & Kay, L. E. (2009). Observing biological dynamics at atomic 
resolution using NMR. Trends in Biochemical Sciences, 34(12), 601–11.  
Monti, M., Orrù, S., Pagnozzi, D., & Pucci, P. (2005). Interaction proteomics. 
Bioscience Reports, 25(1-2), 45–56.  
Murata, Y., Homma, T., Kitagawa, E., Momose, Y., Sato, M. S., Odani, M., Iwahashi, 
H. (2006). Genome-wide expression analysis of yeast response during exposure to 4 
degrees C. Extremophiles!: Life under Extreme Conditions, 10(2), 117–28. 
Müller, F., Demény, M. A., & Tora, L. (2007). New problems in RNA polymerase II 
transcription initiation: matching the diversity of core promoters with a variety of 
promoter recognition factors. The Journal of Biological Chemistry, 282(20), 14685–9.  
Myers, J.K. & Pace, C.N., (1996). Hydrogen bonding stabilizes globular proteins. 
Biophysical journal, 71(4), 2033–9.  
Nekrasov, M. P., Ivshina, M. P., Chernov, K. G., Kovrigina, E. A., Evdokimova, V. 
M., Thomas, A. A. M., Ovchinnikov, L. P. (2003). The mRNA-binding protein YB-1 
(p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and 
inhibits protein synthesis at the initiation stage. The Journal of Biological Chemistry, 
278(16), 13936–43. 
Nelson, J. A., Reynolds-Kohler, C., & Smith, B. A. (1987). Negative and positive 
regulation by a short segment in the 5’-flanking region of the human cytomegalovirus 
major immediate-early gene. Molecular and Cellular Biology, 7(11), 4125–9.  
Neudecker, P., Lundstrom, P., & Kay, L. E. (2009). Relaxation Dispersion NMR 
Spectroscopy as a Tool for Detailed Studies of Protein Folding. Biophysical Journal, 
96, 2045–2054.  
Nilges, M. (1995). Calculation of protein structures with ambiguous distance 
restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide 
connectivities. Journal of Molecular Biology, 245(5), 645–60.  
Nishiyama, H., Higashitsuji, H., Yokoi, H., Itoh, K., Danno, S., Matsuda, T., & Fujita, 
J. (1997). Cloning and characterization of human CIRP (cold-inducible RNA-binding 
protein) cDNA and chromosomal assignment of the gene. Gene, 204(1-2), 115–20.  
References 
!213!
Nishiyama, H., Itoh, K., Kaneko, Y., Kishishita, M., Yoshida, O., & Fujita, J. (1997). 
A glycine-rich RNA-binding protein mediating cold-inducible suppression of 
mammalian cell growth. The Journal of Cell Biology, 137(4), 899–908.  
Nishiyama, H. et al., (1998). Decreased expression of cold-inducible RNA-binding 
protein (CIRP) in male germ cells at elevated temperature. The American journal of 
pathology, 152(1), 289–96.  
Noggle, & Schirmer, R. E. (1971). The Nuclear Overhauser Effect. Academic 
Press:New York.  
Noike, T., Miwa, S., Soeda, J., Kobayashi, A., & Miyagawa, S. (2008). Increased 
expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is 
associated with poor prognosis in patients with liver metastasis from colorectal 
cancer. Human Pathology, 39(2), 201–8.  
Oezguen, N., Adamian, L., Xu, Y., Rajarathnam, K., & Braun, W. (2002). Automated 
assignment and 3D structure calculations using combinations of 2D homonuclear and 
3D heteronuclear NOESY spectra. Journal of Biomolecular NMR, 22(3), 249–63. 
O’Gorman, S., Fox, D. T., & Wahl, G. M. (1991). Recombinase-mediated gene 
activation and site-specific integration in mammalian cells. Science, 251(4999), 1351–
5.   
Ohsaka, Y., Ohgiya, S., Hoshino, T., & Ishizaki, K. (2002). Phosphorylation of c-Jun 
N-terminal kinase in human hepatoblastoma cells is transiently increased by cold 
exposure and further enhanced by subsequent warm incubation of the cells. Cellular 
Physiology and Biochemistry!, 12(2-3), 111–8.  
Oldfield, C. J., & Dunker, A. K. (2014). Intrinsically disordered proteins and 
intrinsically disordered protein regions. Annual Review of Biochemistry, 83, 553–84.  
Oswald, T. et al., (1994). Comparison of N-terminal affinity fusion domains: effect on 
expression level and product heterogeneity of recombinant restriction endonuclease 
EcoRV. Applied microbiology and biotechnology, 42(1), 73–7.  
Pace, C.N. et al., (1996). Forces contributing to the conformational stability of 
proteins. FASEB journal, 10(1), 75–83.  
Palmer, A. G. (1997). Probing molecular motion by NMR. Current Opinion in 
Structural Biology, 7(5), 732–7.  
Palmer, A. G. (2001). Nmr probes of molecular dynamics: overview and comparison 
with other techniques. Annual Review of Biophysics and Biomolecular Structure, 30, 
129–55.  
Panadero, J., Pallotti, C., Rodríguez-Vargas, S., Randez-Gil, F., & Prieto, J. A. 
(2006). A downshift in temperature activates the high osmolarity glycerol (HOG) 
pathway, which determines freeze tolerance in Saccharomyces cerevisiae. The 
Journal of Biological Chemistry, 281(8), 4638–45. 
References 
!214!
Pancsa, R. & Fuxreiter, M., (2012). Interactions via intrinsically disordered regions: 
what kind of motifs? IUBMB life, 64(6), 513–20.  
Peng, & Wagner, G. (1992a). Mapping of spectral density functions using 
heteronuclear NMR relaxation measurements. Journal of Magnetic Resonance (1969), 
332, 308–332.  
Peng, & Wagner, G. (1992b). Mapping of the spectral densities of N-H bond motions 
in eglin c using heteronuclear relaxation experiments. Biochemistry, 31(36), 8571–86. 
Phadtare, S., & Severinov, K. (2005). Nucleic acid melting by Escherichia coli CspE. 
Nucleic Acids Research, 33(17), 5583–90.  
Pham, P. L., Kamen, A., & Durocher, Y. (2006). Large-scale transfection of 
mammalian cells for the fast production of recombinant protein. Molecular 
Biotechnology, 34(2), 225–37.  
Pilotte, J., Cunningham, B. A., Edelman, G. M., & Vanderklish, P. W. (2009). 
Developmentally regulated expression of the cold-inducible RNA-binding motif 
protein 3 in euthermic rat brain. Brain Research, 1258, 12–24.  
Piotto, M., Saudek, V., & Sklen, V. (1992). Gradient-tailored excitation for single-
quantum NMR spectroscopy of aqueous solutions. Journal of Biomolecular NMR, 2, 
661–665. 
Qiang, X., Yang, W.-L., Wu, R., Zhou, M., Jacob, A., Dong, W., Wang, P. (2013). 
Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in 
hemorrhagic shock and sepsis. Nature Medicine, 19(11), 1489–95.  
Rajagopal, P., Waygood, E. B., Reizer, J., Saier, M. H., & Klevit, R. E. (1997). 
Demonstration of protein-protein interaction specificity by NMR chemical shift 
mapping. Protein Science, 6, 2624–2627.  
Ramón, A., Señorale-Pose, M. & Marín, M., (2014). Inclusion bodies: not that bad…. 
Frontiers in microbiology, 5, 56. 
Rao, P. N., & Engelberg, J. (1965). HELA Cells: Effects of Temperature on the Life 
Cycle. Science, 148(3673), 1092–4.  
Ren, L., Emery, D., Kaboord, B., Chang, E., & Qoronfleh, M. W. (2003). Improved 
immunomatrix methods to detect protein:protein interactions. Journal of Biochemical 
and Biophysical Methods, 57(2), 143–157.   
Rezaei, M., Zarkesh-Esfahani, S. H., & Gharagozloo, M. (2013). The effect of 
different media composition and temperatures on the production of recombinant 
human growth hormone by CHO cells. Research in Pharmaceutical Sciences, 8(3), 
211–7.  
Rio, D. C. (2014). Electrophoretic mobility shift assays for RNA-protein complexes. 
Cold Spring Harbor Protocols, 2014(4), 435–40.  
References 
!215!
Rollin, B. V, & Hatton, J. (1947). Nuclear magnetic resonance at low temperatures. 
Nature, 159(4032), 201. 
Roobol, A., Carden, M. J., Newsam, R. J., & Smales, C. M. (2009). Biochemical 
insights into the mechanisms central to the response of mammalian cells to cold stress 
and subsequent rewarming. The FEBS Journal, 276(1), 286–302.  
Roobol, A., Roobol, J., Carden, M. J., Bastide, A., Willis, A. E., Dunn, W. B.,Smales, 
C. M. (2011). ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is 
activated by mild hypothermia in mammalian cells and subsequently activates p53. 
The Biochemical Journal, 435(2), 499–508.  
Rosenberg, A.H. et al., (1987). Vectors for selective expression of cloned DNAs by 
T7 RNA polymerase. Gene, 56(1), 125–35.  
Russell, R. (2008). RNA misfolding and the action of chaperones. Frontiers in 
Bioscience!: A Journal and Virtual Library, 13, 1–20. 
Ryan, B.J., (2011). Avoiding proteolysis during protein chromatography. Methods in 
molecular biology, 681, 61–71.  
Sahara, T., Goda, T., & Ohgiya, S. (2002). Comprehensive expression analysis of 
time-dependent genetic responses in yeast cells to low temperature. The Journal of 
Biological Chemistry, 277(51), 50015–21.  
Sakakibara, D., Sasaki, A., Ikeya, T., Hamatsu, J., Hanashima, T., Mishima, M., Ito, 
Y. (2009). Protein structure determination in living cells by in-cell NMR 
spectroscopy. Nature, 458(7234), 102–5.  
Sakurai, T., Itoh, K., Higashitsuji, H., Nonoguchi, K., Liu, Y., Watanabe, H., Fujita, J. 
(2006). Cirp protects against tumor necrosis factor-alpha-induced apoptosis via 
activation of extracellular signal-regulated kinase. Biochimica et Biophysica Acta, 
1763(3), 290–5.  
Sati, S.P. et al., (2002). Extra terminal residues have a profound effect on the folding 
and solubility of a Plasmodium falciparum sexual stage-specific protein over-
expressed in Escherichia coli. European Journal of Biochemistry, 269(21), 5259–
5263.  
Sauer, B. (1994). Site-specific recombination: developments and applications. 
Current Opinion in Biotechnology, 5(5), 521–7.  
Sawicka, K., Bushell, M., Spriggs, K. A., & Willis, A. E. (2008). Polypyrimidine-
tract-binding protein: a multifunctional RNA-binding protein. Biochemical Society 
Transactions, 36, 641–7.  
Schatz, S. M., Kerschbaumer, R. J., Gerstenbauer, G., Kral, M., Dorner, F., & 
Scheiflinger, F. (2003). Higher expression of Fab antibody fragments in a CHO cell 
line at reduced temperature. Biotechnology and Bioengineering, 84(4), 433–8.  
References 
!216!
Schenborn, E. T., & Mierendorf, R. C. (1985). A novel transcription property of SP6 
and T7 RNA polymerases: Dependence on template structure. Nucleic Acids 
Research, 13, 6223–6236.  
Schlitz, H., (1984). Protein Purification: Principles and Practice. Biochemical 
Education, 12(3), 143.  
Shammas, S. L., Travis, A. J., & Clarke, J. (2013). Remarkably fast coupled folding 
and binding of the intrinsically disordered transactivation domain of cMyb to CBP 
KIX. The Journal of Physical Chemistry. 117(42), 13346–56.  
Sheikh, M.S., (1997). Identification of Several Human Homologs of Hamster DNA 
Damage-inducible Transcripts. Cloning and Characterization of a Novel UV-
inducible cDNA that codes for a putative RNA-Binding Protein. Journal of Biological 
Chemistry, 272(42), 26720–26726.  
Shen, Y., Delaglio, F., Cornilescu, G., & Bax, A. (2009). TALOS+: a hybrid method 
for predicting protein backbone torsion angles from NMR chemical shifts. Journal of 
Biomolecular NMR, 44(4), 213–23.  
Shukla, D. & Trout, B.L., (2011). Understanding the synergistic effect of arginine and 
glutamic acid mixtures on protein solubility. The journal of physical chemistry, 
115(41), 11831–9.  
Simeonov, A., Jadhav, A., Thomas, C. J., Wang, Y., Huang, R., Southall, N. T., 
Inglese, J. (2008). Fluorescence Spectroscopic Profiling of Compound Libraries. 
Journal of Medicinal Chemistry, 51(8), 2363-71. 
Simpson, R.J., (2009). Basic Methods in Protein Purification and Analysis: A 
Laboratory Manual. Cold Spring Harbor Labaratory Press. 
Singh, S.M. & Panda, A.K., (2005). Solubilization and refolding of bacterial inclusion 
body proteins. Journal of bioscience and bioengineering, 99(4), 303–10.  
Smart, F., Aschrafi, A., Atkins, A., Owens, G. C., Pilotte, J., Cunningham, B. A., & 
Vanderklish, P. W. (2007). Two isoforms of the cold-inducible mRNA-binding 
protein RBM3 localize to dendrites and promote translation. Journal of 
Neurochemistry, 101(5), 1367–79.  
Smith, H.E., (2007). The transcriptional response of Escherichia coli to recombinant 
protein insolubility. Journal of structural and functional genomics, 8(1), 27–35.  
Smock, R. G., & Gierasch, L. M. (2009). Sending signals dynamically. Science, 324, 
198–203. 
Sonna, L. a, Fujita, J., Gaffin, S. L., & Lilly, C. M. (2002). Invited review: Effects of 
heat and cold stress on mammalian gene expression. Journal of Applied Physiology, 
92(4), 1725–42.  
References 
!217!
Sorensen, H.P. & Mortensen, K.K., (2005a). Advanced genetic strategies for 
recombinant protein expression in Escherichia coli. Journal of biotechnology, 115(2), 
113–28.  
Sorensen, H.P. & Mortensen, K.K., (2005b). Soluble expression of recombinant 
proteins in the cytoplasm of Escherichia coli. Microbial cell factories, 4(1), 1.  
Spronk, C. a. E. M., Nabuurs, S. B., Krieger, E., Vriend, G., & Vuister, G. W. (2004). 
Validation of protein structures derived by NMR spectroscopy. Progress in Nuclear 
Magnetic Resonance Spectroscopy, 45(3-4), 315–337.  
Studier, F.W. et al., (1990). Use of T7 RNA polymerase to direct expression of cloned 
genes. Methods in enzymology, 185, 60–89.  
Studier, F.W. & Moffatt, B.A., (1986). Use of bacteriophage T7 RNA polymerase to 
direct selective high-level expression of cloned genes. Journal of molecular biology, 
189(1), 113–30.  
Sumitomo, Y., Higashitsuji, H., Higashitsuji, H., Liu, Y., Fujita, T., Sakurai, T., 
Fujita, J. (2012). Identification of a novel enhancer that binds Sp1 and contributes to 
induction of cold-inducible RNA-binding protein (cirp) expression in mammalian 
cells. BMC Biotechnology, 12, 72.  
Sunley, K., Tharmalingam, T., & Butler, M. (2008). CHO cells adapted to 
hypothermic growth produce high yields of recombinant beta-interferon. 
Biotechnology Progress, 24(4), 898–906.  
Sureban, S. M., Ramalingam, S., Natarajan, G., May, R., Subramaniam, D., 
Bishnupuri, K. S., Anant, S. (2008). Translation regulatory factor RBM3 is a proto-
oncogene that prevents mitotic catastrophe. Oncogene, 27(33), 4544–56. 
Sutcliffe, M. (1993). Structure determination from NMR data II: computational 
approaches. in Roberts, G. C. K. (Ed.) NMR of Macromolecules: A Practical 
Approach. Oxford, Oxford University Press.  
Takaya, M., Nomura, Y., & Kato, I. (2002). Cold-inducable expression vector USA: 
Takara Shuzo Co. Ltd. 
Takeuchi, K., & Wagner, G. (2006). NMR studies of protein interactions. Current 
Opinion in Structural Biology, 16(1), 109–17.  
Tan, J. S., Mohandas, N., & Conboy, J. G. (2006). High frequency of alternative first 
exons in erythroid genes suggests a critical role in regulating gene function. Blood, 
107(6), 2557–61.  
Tan, H. K., Lee, M. M., Yap, M. G. S., & Wang, D. I. C. (2008). Overexpression of 
cold-inducible RNA-binding protein increases interferon-gamma production in 




Tang, J., Frankel, A., Cook, R. J., Kim, S., Paik, W. K., Williams, K. R., Herschman, 
H. R. (2000). PRMT1 is the predominant type I protein arginine methyltransferase in 
mammalian cells. The Journal of Biological Chemistry, 275(11), 7723–30.  
Tantos, A., Friedrich, P., & Tompa, P. (2009). Cold stability of intrinsically 
disordered proteins. FEBS Letters, 583(2), 465–9. 
Thorne, N., Inglese, J., & Auld, D. S. (2010). Illuminating insights into firefly 
luciferase and other bioluminescent reporters used in chemical biology. Chemistry & 
Biology, 17(6), 646–57.  
Tochio, H. (2012). Watching protein structure at work in living cells using NMR 
spectroscopy. Current Opinion in Chemical Biology, 16(5-6), 609–13.  
Tompa, P., Prilusky, J., Silman, I., & Sussman, J. L. (2008). Structural disorder serves 
as a weak signal for intracellular protein degradation. Proteins, 71(2), 903–9.  
Tompa, P., & Csermely, P. (2004). The role of structural disorder in the function of 
RNA and protein chaperones. FASEB Journal, 18(11), 1169–75.  
Tsumoto, K. et al., (2010). Non-denaturing solubilization of inclusion bodies. Current 
pharmaceutical biotechnology, 11(3), 309–12.  
Vasina, J.A. & Baneyx, F., (1996). Recombinant protein expression at low 
temperatures under the transcriptional control of the major Escherichia coli cold 
shock promoter cspA. Applied and environmental microbiology, 62, 1444–1447. 
Vergara, M., Becerra, S., Berrios, J., Osses, N., Reyes, J., Rodríguez-Moyá, M., 
Altamirano, C. (2014). Differential effect of culture temperature and specific growth 
rate on CHO cell behavior in chemostat culture. PloS One, 9(4), 93865.  
Wagner, G. (1993). Prospects for NMR of large proteins. Journal of Biomolecular 
NMR, 3(4), 375-85.  
Wagstaff, J. L., Masterton, R. J., Povey, J. F., Smales, C. M., & Howard, M. J. 
(2013). 
1
H NMR spectroscopy profiling of metabolic reprogramming of Chinese 
hamster ovary cells upon a temperature shift during culture. PloS One, 8(10), 77195. 
Walsh, G. (2010). Biopharmaceutical benchmarks 2010. Nature Biotechnology, 28(9), 
917–24.  
Welker, S., Rudolph, B., Frenzel, E., Hagn, F., Liebisch, G., Schmitz, G., Buchner, J. 
(2010). Hsp12 is an intrinsically unstructured stress protein that folds upon membrane 
association and modulates membrane function. Molecular Cell, 39(4), 507–20. 
Wellmann, S., Bührer, C., Moderegger, E., Zelmer, A., Kirschner, R., Koehne, P., 
Seeger, K. (2004). Oxygen-regulated expression of the RNA-binding proteins RBM3 




White-Grindley, E., & Si, K. (2006). RISC-y Memories. Cell, 124(1), 23–6.  
Whitehead, B., Craven, C. J., & Waltho, J. P. (1997). Double and triple resonance 
NMR methods for protein assignment. Methods in Molecular Biology , 60, 29–52.  
Wishart, Bigam, C., Holm, A., Hodges, R., & Sykes, B. (1995). 1H, 13C and 15N 
random coil NMR chemical shifts of the common amino acids. I. Investigations of 
nearest-neighbor effects. Journal of Biomolecular NMR, 5(5), 67–81.  
Wishart, D. (2005). NMR spectroscopy and protein structure determination: 
applications to drug discovery and development. Current Pharmaceutical 
Biotechnology, 6(2), 105–20.  
Wishart, D. S., & Nip, A. M. (1998). Protein chemical shift analysis: a practical 
guide. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire, 76(2-3), 
153–63.  
Wishart, D. S., & Sykes, B. D. (1994). Chemical shifts as a tool for structure 
determination. Methods in Enzymology, 239, 363–92.  
Wishart, Sykes, B. D., & Richards, F. M. (1992). The chemical shift index: a fast and 
simple method for the assignment of protein secondary structure through NMR 
spectroscopy. Biochemistry, 31(6), 1647–51.  
Wolffe, A. P. (1994). Structural and functional properties of the evolutionarily ancient 
Y-box family of nucleic acid binding proteins. BioEssays!: News and Reviews in 
Molecular, Cellular and Developmental Biology, 16(4), 245–51. 
Wright, C. F., Oswald, B. W., & Dellis, S. (2001). Vaccinia virus late transcription is 
activated in vitro by cellular heterogeneous nuclear ribonucleoproteins. The Journal 
of Biological Chemistry, 276(44), 40680–6.  
Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids. Wiley.  
Yang, C. & Carrier, F., (2001). The UV-inducible RNA-binding protein A18 (A18 
hnRNP) plays a protective role in the genotoxic stress response. The Journal of 
biological chemistry, 276(50), 47277–84.  
Yang, R., Weber, D.J. & Carrier, F., (2006). Post-transcriptional regulation of 
thioredoxin by the stress inducible heterogenous ribonucleoprotein A18. Nucleic acids 
research, 34(4), 1224–36.  
Yang, R., Zhan, M., Nalabothula, N. R., Yang, Q., Indig, F. E., & Carrier, F. (2010). 
Functional significance for a heterogenous ribonucleoprotein A18 signature RNA 
motif in the 3’-untranslated region of ataxia telangiectasia mutated and Rad3-related 
(ATR) transcript. The Journal of Biological Chemistry, 285(12), 8887–93.  
Yángüez, E., & Nieto, A. (2011). So similar, yet so different: selective translation of 
capped and polyadenylated viral mRNAs in the influenza virus infected cell. Virus 
Research, 156(1-2), 1–12.  
References 
!220!
Ye, J., Kober, V., Tellers, M., Naji, Z., Salmon, P., & Markusen, J. F. (2009). High-
level protein expression in scalable CHO transient transfection. Biotechnology and 
Bioengineering, 103(3), 542–51.  
Yeon-Gu, K. (2012). Omics-Based CHO Cell Engineering – Entrance into Post-
Genomic Era. Advances in Genetic Engineering & Biotechnology, 1,1. 
Yoon, S. K., Kim, S. H., & Lee, G. M. (2003). Effect of low culture temperature on 
specific productivity and transcription level of anti-4-1BB antibody in recombinant 
Chinese hamster ovary cells. Biotechnology Progress, 19(4), 1383–6.  
Yoon, S. K., Song, J. Y., & Lee, G. M. (2003). Effect of low culture temperature on 
specific productivity, transcription level, and heterogeneity of erythropoietin in 
Chinese hamster ovary cells. Biotechnology and Bioengineering, 82(3), 289–98.  
Yoon, S. K., Kim, S. H., Song, J. Y., & Lee, G. M. (2006). Biphasic culture strategy 
for enhancing volumetric erythropoietin productivity of Chinese hamster ovary cells. 
Enzyme and Microbial Technology, 39(3), 362–365.  
Yuan, X., Davydova, N., Conte, M. R., Curry, S., & Matthews, S. (2002). Chemical 
shift mapping of RNA interactions with the polypyrimidine tract binding protein. 
Nucleic Acids Research, 30(2), 456–62.  
Zeng, Y., Kulkarni, P., Inoue, T., & Getzenberg, R. H. (2009). Down-regulating cold 
shock protein genes impairs cancer cell survival and enhances chemosensitivity. 
Journal of Cellular Biochemistry, 107(1), 179–88.  
Zhang, Y. et al., (1998). Expression of eukaryotic proteins in soluble form in 
Escherichia coli. Protein expression and purification, 12(2), 159–65.  
Zhang, X., Dudek, E. J., Liu, B., Ding, L., Fernandes, A. F., Liang, J. J., Shang, F. 
(2007). Degradation of C-terminal truncated alpha A-crystallins by the ubiquitin-
proteasome pathway. Investigative Ophthalmology & Visual Science, 48(9), 4200–8.  
Zhang, X. H., Zhao, C., & Ma, Z. A. (2007). The increase of cell-membranous 
phosphatidylcholines containing polyunsaturated fatty acid residues induces 
phosphorylation of p53 through activation of ATR. Journal of Cell Science, 120(23), 
4134–43. 
Zhou, K.-W., Zheng, X.-M., Yang, Z.-W., Zhang, L., & Chen, H.-D. (2009). 
Overexpression of CIRP may reduce testicular damage induced by cryptorchidism. 






















KH2PO4 3 g/l 
 
Sodium Chloride 0.5 g/l 
 
Na2SO4 0.3 mM 
 
EDTA 0.05 mM 
 
MnCl2 160 mM 
 






































Glucose 4 g/l (
12




Appendix B: Resonance Assignments of CIRP                                                                                                                                      Appendices  
! 222!
!
Appendix B: Resonance Assignments of N-CIRP                                                                                                                                  Appendices 
! 223!
24' Gln' 117.49' 8.08' 59.14' 28.29' 33.99' >' >' 4.03' 2.19,2.25' 2.43,2.55' >' >'
25' Val' 115.4' 7.58' 64.83' 32.34' 21.81,21.45' >' >' 3.99' 2.19' 1.10,0.78' >' >'
26' Phe' 115.85' 8.25' 62.29' 39.63' >' >' >' 4.63' 2.96,3.40' >' >' >'
27' Ser' 115.62' 8.51' 61.35' 63.08' >' >' >' 4.57' 4.18,4.08' >' >' >'
28' Lys' 119.61' 7.14' 57.59' 31.46' 23.51' 28.47' 41.54' 3.98' 1.48,1.28' 0.74,0.95' 1.44,1.49' 2.85'
29' Tyr' 115.66' 7.68' 59.47' 38.93' >' >' >' 4.25' 3.27,2.91' >' >' >'
30' Gly' 104.98' 7.37' 44.24' >' >' >' >' 3.83,4.89' >' >' >' >'
31' Gln' 116.07' 8.27' 56.81' 28.99' 33.67' >' >' 4.22' 2.00,2.09' 2.28,2.37' >' >'
32' Ile' 129.3' 8.78' 60.4' 39.82' 18.06,27.84' 14' >' 4.03' 1.59' 0.03,1.47,0.51' 0.39' >'
33' Ser' 122.46' 9.08' 58.81' 64.2' >' >' >' 4.53' 3.62' >' >' >'
34' Glu' 120.11' 7.27' 56.58' 33.44' 37.13' >' >' 4.47' 1.79,1.98' 1.97,2.14' >' >'
35' Val' 124.36' 8.43' 61.37' 34.74' 22.4,22.27' >' >' 4.73' 1.9' 0.89,0.87' >' >'
36' Val' 124.68' 8.78' 60.76' 36.86' 21.24' >' >' 4.55' 1.93' 0.91' >' >'
37' Val' 126.12' 8.46' 62.52' 33.18' 21.88,20.87' >' >' 3.98' 1.71' 0.56,0.76' >' >'
38' Val' 130.09' 8.37' 64.6' 30.33' 21.69,22.79' >' >' 3.59' 0.84' 0.91,0.79' >' >'
39' Lys' 124.72' 8.18' >' 35.51' 24.66' 28.78' 41.95' 4.78' 1.40,1.28' 1.06,1.40' 1.59,1.44' 2.98'
40' Asp' 123.16' 8.63' 54.22' 42.8' >' >' >' 4.47' 2.50,2.93' >' >' >'
41' Arg' 127.14' 8.91' 58.91' 30.01' 27.12' 43.09' >' 3.96' 1.9' 1.69' 3.24' >'
42' Glu' 117.29' 8.59' 58.63' 30.22' 36.7' >' >' 4.27' 2.16,2.12' 2.24,2.30' >' >'
43' Thr' 107.44' 8.17' 61.83' 70.74' 21.03' >' >' 4.33' 4.31' 1.2' >' >'
44' Gln' 114.34' 8.14' 57.41' 25.95' 33.91' >' >' 3.87' 2.35,2.28' 2.19,2.30' >' >'
45' Arg' 118.31' 7.65' 55.31' 31.55' 27.23' 43.2' >' 4.36' 1.59,1.78' 1.64' 3.1' >'
46' Ser' 116.73' 8.75' >' >' >' >' >' >' >' >' >' >'
47' Arg' 122.9' 9.05' 55.99' 30.9' 27.83' 43.42' >' 4.39' 2.28,1.05' 1.61' 3.05,3.23' >'
48' Gly' 108.41' 9.61' 45.63' >' >' >' >' 4.18,3.26' >' >' >' >'
49' Phe' 112.34' 7.11' 54.82' 41.58' >' >' >' 5.21' 2.98,3.27' >' >' >'
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50' Gly' 106.2' 8.84' >' >' >' >' >' >' >' >' >' >'
51' Phe' 114.11' 9' 55.9' 44.12' >' >' >' 5.89' 2.59,2.86' >' >' >'
52' Val' 122.12' 8.78' 60.97' 35.07' 20.68,21.65' >' >' 4.42' 1.34' 0.27,0.27' >' >'
53' Thr' 123.23' 8.98' 61.44' 69.34' 22.11' >' >' 5.05' 3.9' 1.02' >' >'
54' Phe' 127.45' 8.83' 58.11' 40.42' >' >' >' 4.68' 2.81,3.69' >' >' >'
55' Glu' 120.11' 7.92' 58.84' 30.25' 36.22' >' >' 4.03' 1.90,2.06' 2.17' >' >'
56' Asn' 116.37' 9.29' 51.41' 40.2' >' >' >' 5.12' 2.98,2.79' >' >' >'
57' Ile' 124.58' 8.73' 64.89' 38.16' 17.71,28.26' 14.05' >' 3.68' 1.79' 0.94,1.13,1,53' 0.9' >'
58' Asp' 121.29' 8.38' 57.62' 39.91' >' >' >' 4.35' 2.75,2.57' >' >' >'
59' Asp' 121.25' 7.31' 56.94' 40.06' >' >' >' 4.22' 2.65,2.89' >' >' >'
60' Ala' 120.13' 6.93' 54.48' 18' >' >' >' 3.27' 1.52' >' >' >'
61' Lys' 117.45' 7.75' 59.91' 31.66' 25.33' 29.15' 41.93' 3.86' 1.93' 1.40,1.63' 1.7' 2.95'
62' Asp' 120.1' 7.67' 57.16' 40.54' >' >' >' 4.27' 2.93,2.66' >' >' >'
63' Ala' 122.46' 8.11' 54.44' 20.07' >' >' >' 2.58' 1.19' >' >' >'
64' Met' 117.66' 8.35' 59.64' 32.93' 31.08' >' >' 3.74' 2.02,2.29' 2.40,2.37' >' >'
65' Met' 115.74' 7.77' 57.39' 31.93' 32.01' >' >' 4.22' 2.16,2.11' 2.68,2.76' >' >'
66' Ala' 119.53' 7.71' 54.03' 20.21' >' >' >' 4.18' 1.26' >' >' >'
67' Met' 111.2' 8.01' >' 31.63' >' >' >' 4.76' 1.77,2.03' >' >' >'
68' Asn' 117.19' 7.67' 56.77' 38.52' >' >' >' 4.37' 2.95,3.16' >' >' >'
69' Gly' 116.44' 8.66' 45.86' >' >' >' >' 3.76,4.26' >' >' >' >'
70' Lys' 120.93' 7.81' 54.57' 32.29' 25.49' 27.85' 42.5' 4.43' 1.87,1.96' 1.76,1.31' 1.69' 3.06'
71' Ser' 113.54' 8.15' >' >' >' >' >' >' >' >' >' >'
72' Val' 125.7' 8.97' 61.92' 34.55' 21.84,20.79' >' >' 4.08' 1.87' 0.80,0.79' >' >'
73' Asp' 129.6' 9.5' 55.47' 39.07' >' >' >' 4.28' 2.42,2.96' >' >' >'
74' Gly' 101.43' 8.41' 45.38' >' >' >' >' 3.55,4.09' >' >' >' >'
75' Arg' 120' 7.56' 53.02' 32.07' 26.43' 42.24' >' 4.61' 1.71,1.97' 1.57,1.51' 3.13' >'
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76' Gln' 121.74' 8.45' 55.8' 28.82' 34.25' >' >' 4.37' 1.83,1.91' 2.19,2.12' >' >'
77' Ile' 122.22' 8.48' >' >' >' >' >' >' >' >' >' >'
78' Arg' 123.03' 8.43' 53.71' 32.69' 27.25' 43.31' >' 5.01' 1.72,1.69' 1.66,1.55' 3.30,3.23' >'
79' Val' 123.81' 8.71' 60.02' 34.42' 24.71,22.63' >' >' 5.41' 1.93' 1.08,1.06' >' >'
80' Asp' 125.2' 9.15' 52.12' 45.26' >' >' >' 5.2' 2.52,2.75' >' >' >'
81' Gln' 121.61' 9.18' 57.14' 29.77' 34.71' >' >' 4.43' 2.22,2.00' 2.47' >' >'
82' Ala' 126.79' 8.63' 53.27' 19.33' >' >' >' 4.41' 1.46' >' >' >'
83' Gly' 107.68' 8.66' >' >' >' >' >' >' >' >' >' >'
84' Lys' 120.6' 8.02' 55.96' 33.1' 24.62' 28.64' 41.88' 4.37' 1.73,1.84' 1.37,1.41' 1.65' 2.96'
85' Ser' 117.47' 8.31' >' >' >' >' >' >' >' ' >' >'
86' Ser' 122.94' 7.88' >' >' >' >' >' >' >' ' >' >'

























Met' 1' 0.764' 0.001' 0.238' 0.000' 28101.500' 79849.800' >0.648' 0.544' 0.047' 52.103' 11.248'
Ala' 2' 0.583' 0.001' 0.181' 0.000' 29733.400' 160024.000' >0.814' 0.697' 0.016' 212.340' 50.035'
Ser' 3' 0.643' 0.001' 0.246' 0.000' 90076.900' 183749.000' >0.510' 0.493' 0.018' 30.869' 5.087'
Asp' 4' 0.644' 0.001' 0.189' 0.000' 167704.000' 273680.000' >0.387' 0.609' 0.011' 44.226' 8.900'
Glu' 5' 0.591' 0.001' 0.151' 0.000' 287771.000' 471476.000' >0.390' 0.731' 0.013' 60.523' 15.861'
Gly' 6' 0.602' 0.001' 0.142' 0.000' 276860.000' 374206.000' >0.260' 0.777' 0.012' 36.114' 19.587'
Lys' 7' 0.587' 0.001' 0.136' 0.000' 309519.000' 394705.000' >0.216' 0.805' 0.016' 13.888' 25.890'
Leu' 8' 0.619' 0.001' 0.137' 0.000' 260088.000' 306973.000' >0.153' 0.794' 0.017' 0.000' 26.152'
Phe' 9' 0.624' 0.001' 0.135' 0.000' 276156.000' 315898.000' >0.126' 0.803' 0.013' 0.000' 28.702'
Val' 10' 0.580' 0.001' 0.130' 0.000' 303239.000' 323408.000' >0.062' 0.844' 0.016' 0.000' 44.716'
Gly' 11' 0.626' 0.001' 0.136' 0.000' 301014.000' 304286.000' >0.011' 0.796' 0.018' 0.000' 37.007'
Gly' 12' 0.667' 0.001' 0.131' 0.000' 309488.000' 343122.000' >0.098' 0.808' 0.015' 0.000' 39.707'
Leu' 13' 0.597' 0.001' 0.123' 0.000' 418271.000' 494064.000' >0.153' 0.848' 0.022' 0.000' 52.388'
Ser' 14' 0.621' 0.001' 0.133' 0.000' 312230.000' 342581.000' >0.089' 0.809' 0.019' 0.000' 35.323'
Phe' 15' 0.591' 0.001' 0.139' 0.000' 107749.000' 91356.900' 0.179' 0.809' 0.000' 0.000' 0.000'
Asp' 16' 0.601' 0.001' 0.145' 0.000' 340498.000' 385501.000' >0.117' 0.760' 0.009' 13.039' 20.591'
Thr' 17' 0.630' 0.001' 0.155' 0.000' 469340.000' 534256.000' >0.122' 0.738' 0.015' 8.990' 18.789'
Asn' 18' 0.615' 0.001' 0.142' 0.000' 388128.000' 407190.000' >0.047' 0.784' 0.014' 0.000' 25.746'
Glu' 19' 0.652' 0.001' 0.146' 0.000' 301775.000' 351865.000' >0.142' 0.750' 0.018' 0.000' 21.046'
Gln' 20' 0.665' 0.001' 0.132' 0.000' 479742.000' 576860.000' >0.168' 0.789' 0.015' 0.000' 32.050'
Ala' 21' 0.587' 0.001' 0.124' 0.000' 541600.000' 664480.000' >0.185' 0.858' 0.015' 0.000' 45.833'
Leu' 22' 0.617' 0.001' 0.121' 0.000' 493964.000' 570852.000' >0.135' 0.843' 0.000' 0.000' 0.000'
Glu' 23' 0.655' 0.001' 0.120' 0.000' 492125.000' 598051.000' >0.177' 0.797' 0.026' 0.000' 50.037'
Gln' 24' 0.672' 0.001' 0.137' 0.000' 538244.000' 590957.000' >0.089' 0.771' 0.016' 0.000' 31.851'
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Val' 25' 0.631' 0.001' 0.128' 0.000' 447595.000' 520284.000' >0.140' 0.798' 0.024' 0.000' 51.483'
Phe' 26' 0.618' 0.001' 0.130' 0.000' 358196.000' 429707.000' >0.166' 0.808' 0.017' 0.000' 36.874'
Ser' 27' 0.621' 0.001' 0.117' 0.000' 517460.000' 559578.000' >0.075' 0.852' 0.068' 0.000' 260.210'
Lys' 28' 0.648' 0.001' 0.134' 0.000' 607602.000' 677183.000' >0.103' 0.796' 0.015' 0.000' 32.624'
Tyr' 29' 0.635' 0.001' 0.127' 0.000' 348730.000' 413902.000' >0.157' 0.816' 0.020' 0.000' 46.524'
Gly' 30' 0.680' 0.001' 0.132' 0.000' 395228.000' 447984.000' >0.118' 0.787' 0.016' 0.000' 40.123'
Gln' 31' 0.696' 0.001' 0.152' 0.000' 379966.000' 471920.000' >0.195' 0.712' 0.012' 0.000' 15.058'
Ile' 32' 0.601' 0.001' 0.150' 0.000' 235877.000' 322848.000' >0.269' 0.780' 0.018' 34.853' 20.841'
Ser' 33' 0.593' 0.001' 0.145' 0.000' 244057.000' 310645.000' >0.214' 0.757' 0.009' 45.679' 18.900'
Glu' 34' 0.628' 0.001' 0.139' 0.000' 403206.000' 494537.000' >0.185' 0.784' 0.009' 0.000' 19.057'
Val' 35' 0.640' 0.001' 0.140' 0.000' 312692.000' 389944.000' >0.198' 0.774' 0.015' 0.000' 21.204'
Val' 36' 0.614' 0.001' 0.134' 0.000' 317962.000' 350770.000' >0.094' 0.810' 0.010' 0.000' 30.220'
Val' 37' 0.660' 0.001' 0.143' 0.000' 304563.000' 392547.000' >0.224' 0.755' 0.011' 0.000' 17.830'
Val' 38' 0.639' 0.001' 0.135' 0.000' 334082.000' 395334.000' >0.155' 0.791' 0.016' 0.000' 26.639'
Lys' 39' 0.667' 0.001' 0.135' 0.000' 319867.000' 358939.000' >0.109' 0.790' 0.012' 0.000' 31.387'
Asp' 40' 0.631' 0.001' 0.135' 0.000' 399821.000' 439862.000' >0.091' 0.803' 0.011' 0.000' 29.813'
Arg' 41' 0.598' 0.001' 0.132' 0.000' 298243.000' 351118.000' >0.151' 0.824' 0.022' 0.000' 33.402'
Glu' 42' 0.661' 0.001' 0.164' 0.000' 317467.000' 488479.000' >0.350' 0.670' 0.007' 58.997' 10.034'
Thr' 43' 0.659' 0.001' 0.142' 0.000' 270076.000' 362979.000' >0.256' 0.754' 0.013' 3.358' 17.106'
Gln' 44' 0.616' 0.001' 0.130' 0.000' 375294.000' 427324.000' >0.122' 0.819' 0.018' 0.000' 41.521'
Arg' 45' 0.620' 0.001' 0.145' 0.000' 352496.000' 470843.000' >0.251' 0.754' 0.008' 36.090' 16.038'
Ser' 46' 0.695' 0.001' 0.151' 0.000' 272046.000' 321808.000' >0.155' 0.711' 0.023' 0.000' 17.726'
Arg' 47' 0.634' 0.001' 0.138' 0.000' 280627.000' 327883.000' >0.144' 0.786' 0.016' 0.000' 25.715'
Gly' 48' 0.582' 0.001' 0.135' 0.000' 309652.000' 339905.000' >0.089' 0.814' 0.009' 0.000' 29.860'
Phe' 49' 0.584' 0.001' 0.117' 0.000' 550004.000' 582270.000' >0.055' 0.899' 0.000' 0.000' 0.000'
Gly' 50' 0.617' 0.001' 0.126' 0.000' 406090.000' 450994.000' >0.100' 0.838' 0.020' 0.000' 78.506'
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Phe' 51' 0.582' 0.001' 0.147' 0.000' 307838.000' 399385.000' >0.229' 0.765' 0.011' 86.358' 19.777'
Val' 52' 0.605' 0.001' 0.150' 0.000' 317629.000' 370103.000' >0.142' 0.758' 0.013' 31.874' 19.598'
Thr' 53' 0.608' 0.001' 0.139' 0.000' 300823.000' 332911.000' >0.096' 0.790' 0.009' 0.000' 24.773'
Phe' 54' 0.617' 0.001' 0.138' 0.000' 273759.000' 305546.000' >0.104' 0.794' 0.018' 0.000' 28.914'
Glu' 55' 0.641' 0.001' 0.139' 0.000' 379541.000' 431782.000' >0.121' 0.778' 0.020' 0.000' 26.638'
Asn' 56' 0.619' 0.001' 0.134' 0.000' 266516.000' 327801.000' >0.187' 0.801' 0.022' 0.000' 26.744'
Ile' 57' 0.635' 0.001' 0.132' 0.000' 444051.000' 547421.000' >0.189' 0.800' 0.015' 0.000' 27.110'
Asp' 58' 0.568' 0.001' 0.131' 0.000' 405444.000' 505733.000' >0.198' 0.841' 0.014' 13.639' 32.531'
Asp' 59' 0.590' 0.001' 0.151' 0.000' 316438.000' 411755.000' >0.231' 0.773' 0.020' 26.863' 21.282'
Ala' 60' 0.609' 0.001' 0.123' 0.000' 536983.000' 575890.000' >0.068' 0.824' 0.000' 0.000' 0.000'
Lys' 61' 0.633' 0.001' 0.121' 0.000' 432673.000' 596604.000' >0.275' 0.821' 0.017' 0.000' 32.547'
Asp' 62' 0.626' 0.001' 0.127' 0.000' 481318.000' 585417.000' >0.178' 0.804' 0.020' 0.000' 40.920'
Ala' 63' 0.630' 0.001' 0.147' 0.000' 427697.000' 547321.000' >0.219' 0.752' 0.019' 9.669' 19.197'
Met' 64' 0.654' 0.001' 0.121' 0.000' 476038.000' 578190.000' >0.177' 0.822' 0.060' 0.000' 203.150'
Met' 65' 0.627' 0.001' 0.123' 0.000' 467010.000' 569079.000' >0.179' 0.841' 0.020' 0.000' 43.391'
Ala' 66' 0.600' 0.001' 0.128' 0.000' 454660.000' 584254.000' >0.222' 0.829' 0.016' 0.000' 29.824'
Met' 67' 0.655' 0.001' 0.126' 0.000' 363442.000' 383661.000' >0.053' 0.828' 0.000' 0.000' 0.000'
Asn' 68' 0.649' 0.001' 0.112' 0.000' 531127.000' 629352.000' >0.156' 0.799' 0.000' 0.000' 0.000'
Gly' 69' 0.599' 0.001' 0.109' 0.000' 340963.000' 374240.000' >0.089' 0.899' 0.000' 0.000' 0.000'
Lys' 70' 0.630' 0.001' 0.124' 0.000' 427688.000' 482847.000' >0.114' 0.848' 0.018' 0.000' 78.370'
Ser' 71' 0.685' 0.001' 0.150' 0.000' 371135.000' 473773.000' >0.217' 0.728' 0.006' 0.000' 14.979'
Val' 72' 0.615' 0.001' 0.143' 0.000' 284482.000' 349874.000' >0.187' 0.779' 0.015' 12.824' 21.194'
Asp' 73' 0.651' 0.001' 0.119' 0.000' 197360.000' 205182.000' >0.038' 0.810' 0.055' 0.000' 57.615'
Gly' 74' 0.642' 0.001' 0.118' 0.000' 366500.000' 410483.000' >0.107' 0.841' 0.000' 0.000' 0.000'
Arg' 75' 0.611' 0.001' 0.145' 0.000' 350315.000' 390647.000' >0.103' 0.789' 0.019' 0.000' 27.143'
Gln' 76' 0.690' 0.001' 0.140' 0.000' 411763.000' 489819.000' >0.159' 0.772' 0.008' 0.000' 23.676'
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 Ile' 77' 0.645' 0.001' 0.142' 0.000' 304141.000' 417243.000' >0.271' 0.755' 0.016' 15.334' 17.605'
Arg' 78' 0.622' 0.001' 0.145' 0.000' 290348.000' 291755.000' >0.005' 0.765' 0.013' 0.000' 23.357'
Val' 79' 0.610' 0.001' 0.148' 0.000' 270604.000' 334971.000' >0.192' 0.761' 0.016' 18.124' 19.986'
Asp' 80' 0.635' 0.001' 0.142' 0.000' 329772.000' 388058.000' >0.150' 0.767' 0.010' 0.000' 20.999'
Gln' 81' 0.638' 0.001' 0.157' 0.000' 436037.000' 513983.000' >0.152' 0.721' 0.013' 17.245' 16.518'
Ala' 82' 0.622' 0.001' 0.154' 0.000' 401918.000' 525264.000' >0.235' 0.735' 0.015' 25.777' 16.933'
Gly' 83' 0.616' 0.001' 0.211' 0.000' 197636.000' 320119.000' >0.383' 0.637' 0.011' 90.735' 11.186'
Lys' 84' 0.637' 0.001' 0.233' 0.000' 129481.000' 299171.000' >0.567' 0.546' 0.010' 59.876' 5.787'
Ser' 85' 0.895' 0.001' 0.306' 0.000' >58080.000' 45619.100' >2.273' 0.274' 0.019' 184.480' 42.271'
Ser' 86' 1.012' 0.001' 0.421' 0.000' >303127.000' 294526.000' >2.029' 0.225' 0.008' 134.020' 6.075'
